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The electronic and steric effects of the ligand framework on reactivity of a series of 
Pt(II) complexes has been investigated. For this purpose, three sets of mononuclear 
Pt(II) complexes and one set of azine bridged dinuclear Pt(II) complexes were 
synthesized and characterized by various spectroscopic methods. Substitution 
reactions of the Pt(II) with chloride leaving group were studied in the presence of 10 
mM LiCl to prevent spontaneous parallel reaction due to hydrolysis or solvolysis. For 
the Pt(II) complexes with aqua molecules as leaving groups substitution reactions 
were studied in acidic aqueous medium. Thiourea nucleophiles of varying steric 
hindrance were used as the entering group throughout the studied systems. The 
reactions were studied under pseudo first-order conditions as a function of 
concentration and temperature using Stopped-flow and UV-Visible 
spectrophotometric techniques. DFT calculations were performed with the Gaussian 
09 program suite to account for the observed reactivity of the complexes. 
 
The first set of complexes (Chapter Three) deals with the series of mononuclear 
Pt(II) complexes with N^N^N chelated framework where the π-conjugation of the 
complexes were varied by either introducing quinoline ligand or imine bond to the 
well known bis(2-pyridylmethyl)amine ligand. The results showed that increasing 
electronic communication without increasing π-backbonding has little effect in 
increasing the reactivity of Pt(II) complex. Introduction of the quinoline moiety 
within the non-labile chelated framework of Pt(II) complexes results into a more 




In the second series presented in Chapter Four, the ligand 2,2’-dipyridylamine 
chelate was altered by incorporating an alkyl group of variable chain length spacing 
tertiary nitrogen of the bidentate chelate giving out analogues of cisplatin Pt(II) 
complexes. The substitution reactions of the coordinated aqua ligands were 
characterized by two separate steps. The first was assigned to the simultaneous 
displacement of the diaqua ligands whereas the second step corresponds to 
dechelation of the dipyridylamine ligand. This was confirmed by the NMR analysis. 
The trend in rate constant shows that introduction of the alkyl chain on the tertiary 
nitrogen joining the two pyridine moieties brings in the steric effect which blocks the 
approach of the nucleophile to the Pt(II) centre. In addition, the σ-donor effect of the 
pendant alkyl chain towards the tertiary bridging nitrogen is felt in the cis pyridine 
rings resulting into the decrease in their π-acceptor ability. The decrease in reactivity 
of the Pt(II) complexes with the increase in length of the alkyl chain is also supported 
by the dipole moments and the calculated electrophilicity indices. 
 
The third set of complexes (Chapter Five) comprise of novel azine bridged dinuclear 
Pt(II) complexes of the type [{PtCl(Py)2}2-μ-pzn] (ClO4)2 where py = pyridine, pzn = 
pyrazine linker and its derivatives. It was found that the introduction of pyridine 
ligands at each metal centre increases the substitution rates of diaqua complexes by a 
factor of 10 or 23 compared to [{cis/trans-Pt(NH3)2(OH2)}2(μ-pzn)](ClO4)4. This was 
attributed to the structural geometry which allows π-backbonding to take place 
where the electrons from the metal centres are accepted to the empty π*-orbitals of 
the pyridine sub units. The effect of the methyl σ-electron-donating groups present 
on the pyrazine linker and the trend in reactivity of these azine bridged dinuclear 
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complexes remained the same as those reported for [{cis/trans-Pt(NH3)2(OH2)}2(μ-
pzn)](ClO4)4.  
 
The last set of complexes (Chapter Six) aimed at investigating the role of trans effect 
as well as π-conjugation effects of the ligand on the reactivities of the Pt(II) centre. 
For this case N^S^N and N^N^N mononuclear Pt(II) complexes were investigated to 
account for the strength of π-back bonding versus the trans effect. Results have 
shown that the chloro ligand in Pt(N^S^N) complexes is more labile than Pt(N^N^N) 
complexes due to the high trans labilizing effect of the S-donor atom. Quinoline based 
Pt(II) complexes viz. [{N-(2-pyridinylmethyl)-8-Quinolinamine} platinum(II) 
chloride]Cl, (Pt2) and [{8-((2-pyridylmethyl)thiol)Quinoline} platinum(II) 
chloride]Cl, (Pt4) were found to react slower than their pyridine counterparts 
[{bis(2-pyridylmethyl)amine} platinum(II) chloride]ClO4, (Pt1) and {di-(2-picolyl) 
sulfide} platinum(II) chloride ]Cl, (Pt3) due to poor π-acceptor ability of quinoline.  
 
The experimental results in all sets of complexes investigated were supported by the 
DFT calculations performed with the Gaussian 09 program suite. The thermodynamic 
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Cancer is the most killer disease in which certain cells in our body grow in an uncontrolled 
way.1 It is one of the world’s most serious disease because some cancer cells penetrate the 
walls of lymphatic and/or blood vessels and travel through the lymph and blood systems 
and lodge in other organs where they again repeat the uncontrolled growth cycle forming 
new tumours. Tumours can grow and interfere with the digestive, nervous, circulatory 
systems and they can release hormones that alter body function. Genetic changes in the 
cancer cells can be inherited or more often changes happen because of the environmental 
factors such as exposure to carcinogens such as tobacco, asbestos, arsenic, radiation gamma 
and x-rays, sun and compounds in car exhaust fumes that are directly responsible for 
damaging DNA, promoting or aiding cancer.2 
 
Cancer treatment depends on the type of cancer, the stage of the cancer (how much it has 
spread), age, health status and additional personal characteristics. Advances in surgery, 
radiation, immunotherapy, hormonal therapy, gene therapy and chemotherapy are needed 
to improve the curability of cancer. Generally, there is no single treatment for cancer and 
patients often receive a combination of therapies with the aim of decelerating and stopping 
the cancer from spreading. Recently, coordination complexes either as drugs or pro-drugs 
have become very attractive probes as anticancer agents due to their ability to affect the 
natural processes, such as cell division and gene expression.3 This follows the earliest 
reports on the therapeutic use of transition metal complexes in cancer as from the 19th 
century after the discovery of cis-diamminedichloroplatinum(II), (cisplatin).4 The use of 
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cisplatin in treatment of cancer has encouraged investigators to search and develop many 
other platinum-based drugswhich are inherently more cytotoxic as well as those that 
exhibit a broader range of activitywithout causing too much damage to the healthy cells.5 
Since the subject of this thesis is ligand substitution reactions of Pt(II) complexes, it is 
appropriate to have a brief look at the chemistry of platinum. 
 
1.2 Chemistry of Platinum 
Platinum has six naturally occurring isotopes; 190Pt, 192Pt, 194Pt, 195Pt, 196Pt and 198Pt with 
195Pt being the most abundant comprising 33.83% of all platinum. It has two dominant 
oxidation states the +2 and +4, designated as Pt(II) and Pt(IV)respectively. 195Pt can also be 
found in the +5 and +6 oxidation states. In Pt(II)complexes, the coordination number of 
platinum is usually four with a preference of square planar geometry. The complexes of 
Pt(IV) have coordination number of six with an octahedral configuration. Both Pt(II) and 
Pt(IV) complexes can have cis and trans configurations. 
 
The chemical, physical and mechanical properties of platinum and its alloys make them 
uniquely versatile for a variety of medical applications. Platinum and its alloys are 
characterised by low corrosivity, high biocompatibility and good mechanical resistance 
appropriate for medical applications.6 Platinum’s biocompatibility makes it superlative for 
short-term and everlasting implantation in the body, a quality which is exploited in a range 
of treatments. Its inertness prevents corrosion inside the body minimizing chances of 
allergic and side reactions. In addition, platinum electrodes are found in pacemaker-like 
devices which are used to help people at risk of fatal disturbances in the heart's rhythm.7 In 
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some cases flexible tubes with platinum marker bands and guide wires are inserted into the 
body to diagnose or treat heart diseases. Since platinum is radio-optic it becomes clearly 
visible in X-ray images, enabling doctors to monitor the position of the device during 
treatment.7 
 
1.3 Platinum Based Anticancer Drugs 
Platinum substances have been used in cancer treatment for several decades as they trigger 
cell death upon DNA binding. Pt-based drugs with a variety of ligands around the Pt centre 
exist today in clinics and in clinical trials.8 This is because Pt complexes have ligand 
exchange kinetics which is in the same order of magnitude as the division of cancer cells, 
making them proper candidates to obstruct their multiplication9 with cisplatin being the 
parent compound among tumour active platinum complexes. 
 
1.3.1 Cisplatin 
The discovery of anticancer activity of cisplatin10 (Figure1.1) constitutes the most 
impressive contribution to the use of platinum metal in medicine. To date, cisplatin is highly 
effective in the treatment of testicular and ovarian cancers and also widely employed in 










The sensitivity of cells towards cisplatin is dependent on DNA platination because DNA is 
the ultimate drug target.12 Once administered, cisplatin enters the cell by either passive 
diffusion or active uptake by the cell (Figure 1.2) where hydrolysis of the drug takes place. 
This hydrolysis process is believed to be the key activation step before the drug reaches its 
intracellular target DNA. Since inside the cell there is a low concentration of chloride ion 
compared to that of water, water molecules then attack the Pt(II) centre and sequentially 
displace the two chlorine atoms.  
 
Figure 1.2: Schematic diagram of cisplatin uptake and binding to nuclear DNA.13 
 
Hydrolysed cisplatin causes platination of DNA, which involves mainly 1,2-intrastrand 
cross-link 60-65% (Figure 1.3) formed usually through the N7 atoms of vicinal guanine.14 
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Formation of cisplatin-DNA adducts causes distortion of the DNA double helix and results in 
inhibition of DNA replication.1a,15 Cisplatin-DNA adducts also serve as binding sites for 
cellular proteins such as repair enzymes, histones, transcription factors and high-mobility 
group (HMG) domain proteins.16 The binding of HMG proteins to cisplatin-DNA adducts has 
been suggested to enhance the anticancer effect of the drug.16,17 
 
 
Figure 1.3: Formation of DNA adduct with cisplatin.18 
 
The efficacy of cisplatin has been greatly hampered by drug resistance and severe side 
effects.19 Many tumours display inherent resistance to cisplatin while others develop 
acquired resistance after initial treatment,20 and metastasis tumours lack response to this 
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agent.21 Acute toxicity is another disadvantage of cisplatin, especially nephrotoxicity, 
neurotoxicity, ototoxicity, and emetogenesis, which cause patients to suffer from severe 
side effects.22 Furthermore, poor water solubility of cisplatin makes its use inconvenient in 
clinical practice.  
 
1.3.2 Cisplatin Analogous 
The limitations associated with the clinical use of cisplatin prompted a wide-cast search for 
more effective and less toxic alternative platinum antitumour agents. These efforts have led 
to the synthesis of thousands of platinum complexes by changing the nature of the leaving 
groups and carrier ligands.23 In the development of platinum compounds which are 
commonly known as second and third generation platinum drugs, the primary goal was to 
reduce the toxic side effects and to a lesser extent broaden the spectrum of activity.24 As 
such, many cisplatin analogous have been tested in cancer patients but most were found to 
be unsuitable for further development because of poor aqueous solubility, formulation 
difficulties and severe toxicity.23Those that have achieved routine clinical use and have 
been approved for clinical administration are analogous of cisplatin which are carboplatin, 



































Figure 1.4: Structures of cisplatin analogous 
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Carboplatin (cis-diammine-1,1-cyclobutanedicarboxylatoplatinum(II)) abbreviated as CBCD 
(Figure 1.4, (1)) is used in treating patients with ovarian, non-small cell lung, testicular, 
stomach, and bladder cancers.26 Carboplatin kills cancer cells by binding to DNA and 
interfering with the cell's repair mechanism, which eventually leads to cell death. 
Chemically Carboplatin differs from cisplatin by being a bigger molecule, with a less labile 
cyclobutanedicarboxylato ligand. This allows the drug to be retained longer in the body and 
reduces the rate of formation of toxic by-product. In its use carboplatin exhibits cross-
resistance in cisplatin resistant cell lines and it has not demonstrated any substantial 
advantages over cisplatin.27 
 
Oxaliplatin differs from cisplatin in that the amine groups of cisplatin are replaced by 
diaminocyclohexane (DACH) and the chloro groups are swapped by oxalate group. 
Oxaliplatin was the first Pt(II) drug to be used for the treatment of metastatic colorectal 
cancer which has recurred or become worse following initial therapy with a combination of 
other drugs.28 It has also been used in clinical trials for the treatment of other cancers but 
has found the most success in gastrointestinal neoplasms including gastric, esophageal and 
pancreatic cancers.28c Compared to cisplatin, oxaliplatin has increased cellular uptake due 
to the presence of oxalate group which increases the aqueous solubility of the complex and 
the DACH group which makes the complex less polar.  
 
Inside the cell oxaliplatin rapidly undergoes non-enzymatic transformation into reactive 
compounds following displacement of the oxalate group. The remaining dichloro(DACH) 
platinum complex exerts its cytotoxic effect mostly through DNA damage by forming 
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essentially three types of cross-link adducts; intrastrand, interstand and DNA-protein.28c,29 
The most commonly adduct (Figure 1.5) is the intrastrand between the neighbouring 
purine bases (1,2-GG or AG) at the N7 positions.30 These adducts were found to be more 
massive and hydrophobic than that of both cisplatin and carboplatin and subsequently 
were more effective in inhibiting DNA synthesis than cisplatin adducts. Nevertheless, 
oxaliplatin shows several limitations such as a reversible peripheral neuropathy 
characterized by paraesthesia and dysaesthesia in hands, feet and the oral region.31 The 
presence of the kinetically less labile carboxylate or oxalate in carboplatin and oxaliplatin, 
contributes to the reduced side effects observed in patients compared with those treated 
with cisplatin.23 
 
Figure 1.5: DNA adducts formed by oxaliplatin.30 
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Nedaplatin has a novel structure involving a glycolate ring bound to platinum atom as a 
bidentate ligand and two ammine ligands like cisplatin and carboplatin. Nedaplatin binds to 
DNA in a similar way to cisplain and therefore they have identical types of combined bases 
after reaction with DNA.32 As for cisplatin, after uptake the hydrolysis of the leaving group 
takes place where the glycolate portion of nedaplatin is cleaved, forming active species 
which exists in three different forms and at equilibrium depending on the pH condition 
(Figure 1.6). The active species bind to DNA thereby inhibiting its replication. Phase II 
studies have shown that nedaplatin has a spectrum of activity similar that of cisplatin but 
with lower nephrotoxcitiy.33 Myelosuppression associated with thrombocytopenia is the 
dose-limiting toxicity of nedaplatin.23,33 
 
Figure 1.6: Hydrolysis and DNA binding of nedaplatin.32 Charges of the complexes are 
omitted for clarity. 
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Lobaplatin has completed phase II clinical trials in the US, Australia, EU, Brazil and South 
Africa for the treatment of various cancers, including breast, esophageal, lung and ovarian 
cancers as well as Chronic myelogenous leukemia (CML).18 The antitumour activity of 
lobaplatin is believed to result from the formation of DNA-adducts, mainly as GG and AG 
intra-strand cross-links. It also influences the expression of the c-myc gene, which is 
involved in regulation of cell proliferation, differentiation and eventually death. This has 
been proposed to contribute to the increased antitumour activity of lobaplatin over 
cisplatin and carboplatin in a wide range of cancer lines.34 
 
1.3.3 Non-classical Pt(II) Drugs 
Cisplatin analogous generally form comparable adducts with DNA that translate into the 
same domain of spectral activity. Therefore, there is a need to develop compounds that will 
have different chemical structures and biological properties that are different from that of 
cisplatin analogous. Consequently, attention has been turned to the synthesis of ‘non-
classical’ platinum complexes which are capable of forming different DNA adducts/that 
display a different spectrum of anticancer activity compared to cisplatin.35 Examples of 
these non-classical platinum complexes include; platinum(IV) complexes, monofunctional 
complexes like cis-[Pt(NH3)2(Am)Cl]+ where Am =/pyridine, pyrimidine, or purine,36 trans 





1.3.3.1 MonofunctionalPt(II) Complexes 
Monofunctional complexes of Pt(II) are complexes with a stable tridentate ligand, while the 
fourth coordination place is occupied by a labile ligand, mostly a chloride or an aqua ligand. 
In early studies monofunctional Pt(II) complexes such as [PtCl(dien)]Cl, (dien = 
diethylenetriamine) and [PtCl(NH3)3]Cl were considered to be biologically inactive. The 
monofunctional binding of such complexes to DNA contributed to their inactivity because 
DNA conformation and downstream cellular processes were hardly affected.37,36 Recent 
investigations show that some monofunctional Pt(II) complexes (Figure 1.7) indeed exhibit 
significant antineoplastic activity.39 Moreover, the profile of cellular response to these 
monofunctional complexes is different from those of the classic bifunctional, 
charged/neutral platinum-based drugs.39a-c For example pyriplatin, (Figure 1.7(1)) is an 
excellent substrate for organic cation transporters expressed in human colorectal cancers 
and associated with the uptake of oxaliplatin. Pyriplatin DNA adducts block transcription 
nearly efficiently as cisplatin.  
 
Phenanthriplatin (2) destroys cancer cells with greater efficacy than either cisplatin or 
oxaliplatin. On another hand, monofunctional Pt(II) complex of 8-aminoquinoline 
derivatives (3) exhibited activity against many cancer cell lines. The higher cytotoxicity of 
complexes 2 and 3 in Figure 1.7 originates from their efficient cellular uptake and strong 
transcription inhibitory properties of their ligands.39a-c Platinum-acridinylthiourea (4) 
showed promising biological activity superior to cisplatin in a wide range of solid tumour 
cell lines at micromolar concentrations, especially in non-small cell lung carcinomas.39d,e 
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Good enough, the complex binds to DNA in a dual manner involving platinum coordination 



































Figure 1.7: Examples of monofunctional Pt(II) complexes with antitumour activity. 
 
Generally, toxicity of these new hybrid agents suggests that additional structural 
modifications of the tridentate ligand are still needed. In order to improve the potency and 
cellular uptake of monofunctional Pt(II) complexes, the tridentate stable ligand of the 
complexes has to be varied so that various N/S-heterocyclic ligands can be included. 
Modifications by the introduction of lipophilic ligands facilitate the uptake of the drug 
molecules across the cell membrane and affect the activity of the drug. In the same way, 
bulky ligands maintain the cytotoxicity of the complexes while significantly reducing their 
rate of deactivation by S-containing molecules (such as cysteine and glutathione) due to 
their slow ligand exchange reactions. Such modifications of the tridentate/bidentate carrier 
ligands of monofunctional Pt(II) complexes form part of this research as presented in 
Chapter Three, Four and Six of this thesis.  
 
1.3.3.2 Trans Geometry Platinum Compounds 
Previously, it has been generally accepted as a standard that a cis-configuration of the 
leaving groups is necessary for antitumour activity of platinum compounds.40 However, it 
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has been observed that certain trans-platinum complexes have both in vitro and in vivo 
antitumour activity through a different mode of binding to DNA. The trans analogue of 
cisplatin, trans diaminedichloroplatinum(II), transplatin, is inactive as it is kinetically not 
stable and therefore susceptible to deactivation. Substitution of one or both ammine ligands 
in transplatin with more bulky ligands retard ligand substitution reactions of the two 
chloride ions, thereby decreasing undesired reactions between platinum and cellular 
constituents and simplifying its interaction with DNA.41 The spectator ligands in these 
complexes can be categorized into; planar aromatic amines, alkylamines and iminoethers 
(Figure 1.8). These compounds in general are more active against cisplatin-resistant cell 
lines than their cis analogous.41 These results are encouraging and have forced the re-
























Figure 1.8: Examples of transPt(II) complexes with antitumour activity. 
 
1.3.3.3 Multinuclear Platinum Complexes 
Multinuclear platinum complexes contain two or more linked platinum centres that can 
each covalently bind to cellular DNA to form flexible, non-directional DNA adducts as well 
as long range DNA adducts to induce DNA conformational changes. The difference in the 
cytotoxic DNA adducts formed and the cell death mechanisms induced by multinuclear Pt 




1.3.3.3.1 Bi-Functional Platinum Centres 
Initially, the synthesis of multinuclear platinum complexes (Figure1.9) was based upon the 
linking of two cisplatin-like centres.43 The first complex developed was a simple cisplatin 
derivative (2,2/c,c), (1) with two [PtCl2(NH3)] centres linked by a flexible diaminechain.43f,h 
This kept with the traditional structure activity rules of a neutral complex consisting of a 
square planar platinum with two cis-chloro ligands and with at least one am(m)ine group. 
The replacement of the chloro ligands with malonate (2), to improve water solubility, 






















Figure 1.9: Dinuclear platinum complexes containing two linked cisplatin centres, where 
n=/2-6. 
 
While these complexes were capable of binding to DNA in a manner similar to cisplatin, 
they were also capable of forming longer range intra- and interstrand adducts.43 
Mechanistic studies demonstrated that the 2,2/c,c complexes (I) produced a high 
percentage of interstrand adducts.41e A similar approach was also adopted by Broomhead 
and co-workers (Figure1.10), who linked two cisplatin-like centres together using the 4,4’-
dipyrazolylmethane (dpzm) ligand.43a-d While single bridged complexes exhibited better 
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cytotoxicity than the double bridged complexes in three cancer cell lines, they were 
insoluble in water and did not show any significant advantage compared to cisplatin.43d 
NH3 NH3




















































Figure 1.10: Double and single bridged, multi-nuclear platinum complexes linked by the 
4,4’-dipyrazolylmethane (dpzm) ligand.43a,b,d 
 
1.3.3.3.2 Mono-Functional Platinum Centres 
While the synthesis of dinuclear complexes with two bi-functional platinum centres 
resulted in complexes that could bind to DNA in a different manner than cisplatin, the more 
important development was the subsequent synthesis of dinuclear complexes that 
contained mono-functional platinum centres.46 The first complexes, called 1,1/t,t and 
1,1/c,c, (Figure 1.11) represented a truly new class of metal based anticancer compounds, 
as they were cationic and contained only one chloro leaving group on each platinum centre. 
These complexes show good water solubility and excellent activity in both cisplatin 


















Figure 1.11: Dinuclear platinum complexes with charged mono-functional platinum 
centres.44,45(a) Charges of the complexes are omitted for simplicity. 
 
From all the multinuclear complexes tested, the first to enter clinical trials based on in vitro 
and in vivo trials was the tri-nuclear complex BBR3464 (Figure1.12). BBR3464 was more 
active than cisplatin in all cancer cell lines tested.47 For example, in an assay of seven 
human cancer cell lines the mean IC50 of BBR3464 (0.6 µM) was much lower than that 
observed for cisplatin (27.8 µM).48 Most importantly, BBR3464 shows activity in several 
cancer cell lines that have a natural resistance to cisplatin.49 From clinical trials it appears 
that BBR3464 is most useful in the treatment of non-small cell lung cancer, gastric cancer, 






















Data from the studies of the binding of DNA with multinuclear platinum complexes in 
different cancer cell lines shows some important structure-activity rules.47 The main factors 
consistent in designing multinuclear platinum drugs include; chain length and flexibility, 
hydrogen-bonding capacity and charge of the linking chain and the geometry of the leaving 
ligand with respect to the linker. For the aliphatic chains the ideal length of the linker 
appears to be eight atoms (two ammine and six methylene groups). For the polyamine 
family of multinuclear platinum complexes, it is evident that increasing the charge and the 
chain length results into high activity.50 However flexibility also appears to be a major 
factor. In studies where the dpzm ligand was used as the linker, their complexes were found 
to be less active than their aliphatic equivalents 1,1/t,t (n=6, 12) and BBR3464.43(a) The 
decrease in activity of the mentioned complexes was therefore attributed to the rigidity of 
the linker. Interestingly, these complexes were less reactive compared to azole and isomeric 
azine-bridged Pt(II) complexes due to their steric differences on their DNA adducts. 
Geometric isomerisation also plays a role for instance complexes with the chloro ligand 
trans to the bridging ligand are generally more active, particularly in cisplatin resistant cell 
lines.50 This type of dinuclear Pt(II) complexes form part of the research objectives and are 
further discussed in Chapter Five. 
 
1.4 Aims of the Study 
Pt(II) complexes have been used for the treatment of many diseases but with little 
understanding of their mechanism of action in biological systems. A search for new 
platinum drugs remains a continuous process and knowledge of the interaction of the 
different platinum complexes with sulfur-bonding bio-molecules therefore deserves much 
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attention. Pt(II) has high affinity for binding to sulfur donors, especially thiols, compared to 
nitrogen donor ligands such as DNA bases. Due to high intra-cellular concentrations of 
sulfhydryl groups (cysteine and glutathione), it has been hypothesised that sulfur 
containing nucleophiles initially bind to the platinum atom and then convert to 
thermodynamically more stable products platinum–DNA adducts.51 To date it is generally 
accepted that the antitumour activity of platinum drug can be ascribed to interactions 
between the metal complex and DNA, primarily with the genetic DNA, which is located in 
the nucleus. 
 
Ligand substitution reactions of Pt(II) complexes contribute to a better understanding of 
the precise biochemical mechanism of some Pt(II) complexes. The results of the 
substitution reactions with biologically relevant ligands could help to get more information 
on the possible interaction modes of Pt(II) complexes with in vivo targets and their 
representative application in the study of their antitumour properties. Moreover, the 
reactivity of the complexes will be useful in predicting the extent of drug of similar 
structure which reaches the target sites as well as the degree of side reactions, its 
circulation lifetime and more importantly the antitumour activity of the drug in the target 
sites.  
 
Within the aforementioned basic structural frameworks concerning the development of 
new clinically useful platinum based anticancer agents, it is clear that novel structures 
unrelated to those agents assigned to cisplatin and its analogous platinum complexes can 
circumvent cisplatin resistance and enhance their activity. For mononuclear Pt(II) 
19 
 
complexes, the choice of the bidentate or tridentate ligand adds stability to cationic 
platinum complexes and decreases the possibility of undesired substitution reactions at the 
chelate. In the development of multinuclear Pt(II) complexes, the nature and size of the 
linker plays a role in determining the biological activity of the resultant complexes. 
Therefore, to fulfil the main objective of this study, several complexes such as 
monofunctional Pt(II) complexes (Chapter Three and Six), bifunctional-platinum(II) 
complexes (Chapter four) and dinuclear platinum(II) complexes (with rigid linker, 
Chapter Five) have been synthesized and their mechanistic and kinetic investigations using 
thiourea as the strong sulfur nucleophiles evaluated. Thiourea nucleophiles were selected 
as entering nucleophile because of their biological relevance and their high nucleophilicity 
prevents a possible back reaction.52 The non-labile chelate ligand framework of the 
complexes was carefully electronically/sterically tuned to enable a systematic study of the 
reactivity of the complexes towards relevant nucleophile. The specific aims of the study 
undertaken are: 
1. To understand the electronic π-conjugation role of quinoline moiety on ligand 



















In this study the competing σ-donor effect of quinoline and π-acceptor property of 
pyridine in the set of complexes is examined.  





The electronic and steric effects of the alkyl group of variable chain length spacing 
tertiary nitrogen of the bidentate chelate is investigated. Results obtained were 
compared with those of Pt(bpy) (where bpy = N,N’-bipyridine) which also contains 
two pyridine rings in the bidentate chelate. 
3. To study the kinetics of novel dinuclear Pt(II) complexes containing four non-planar 
pyridine ligands. Possibility of pyridine rings to enter into electronic communication 
with the Pt(II) orbitals through π-backbonding is assessed. 
 
4. To investigate the role of trans and π-conjugation effects on ligand substitution 
reactions of Pt(II) complexes with tridentate N/S-donor ligands. The chapter 
examined the competing roles of π-backbonding through the extended chelate and 
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Substitution Reaction at Square-Planar Complexes 
2.1 General Introduction 
Square planar complexes are formed by the d8 systems of Pt(II), Pd(II), Ni(II), Au(III), Rh(I) 
and Ir(I). Ligand substitution reactions of these metal ions play a fundamental role in many 
chemical processes, for instance, in the treatment of tumours and in homogeneous 
catalysis.1 In anticancer therapy, drugs such as cisplatin are designed to inhibit tumour 
growth by substituting the chloride ligand with guanosine base of DNA.2 To date, most of 
the work done on substitution reactions of square-planar complexes involves the inert and 
stable platinum(II) complexes because their rate are conveniently slow. Other low-spin d8 
(nickel(II), palladium(II), gold(III) and rhodium(I)) systems have been studied and all 
appear to have the same general behaviour.3 Informative reviews4 have been written on the 
subject and only a brief summary will be given here along with some recent observations. 
 
2.2 Mechanism of Ligand Substitution Reactions at Square-Planar 
A simple ligand substitution reaction involves transfer of a lone pair of electron from a 
donor called nucleophile to an acceptor also called electrophile. In coordination chemistry, 
the central metal atom is an electrophilic reagent and the ligands are nucleophilic 
reagents.5,6 The mechanism of substitution reactions can be described as either associative, 




2.2.1 Associative, (A)  
This is the most common mechanism for coordinatively unsaturated metal complexes and 
square-planar complexes of which Pt(II) are prototypical examples.7,8 The mechanism 
proceeds mostly via a five coordinate transition state with an intermediate with a trigonal 
bipyramidal structure (Equation 2.1 and Figure 2.1). In this mechanism, if the 
concentration of the electrophilic reagent is maintained constant, then a kinetic effect 
proportional to the concentration of the nucleophilic reagent can be identified as the 
nucleophilic reagent is involved in the formation of transition state. Furthermore, the 
stereochemical specificity of such reactions can be accommodated readily in terms of the 
five-coordinated associated intermediate.  
XY3ML XY3MLY X3ML +→→+     (2.1) 
Intermediate 
where M = central metal atom, L = carrier ligand, X = leaving group and Y = incoming 
nucleophile 
Bond making
trigonal bipyrimidal transition stateleaving group final product with the same 
stereochemistry
incoming nucleophile attacks from top 



















Figure 2.1: Reaction pathway for the associative substitution reaction showing direct 
Substitution of leaving group X by incoming group Y. 
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2.2.2 Dissociative, (D)  
Dissociative mechanism of substitution is common in octahedral metal complexes of the 
first transition metal series because they have reached their maximum stable coordination 
number of six. In this mechanism, the leaving ligand is lost in the first step, producing an 
intermediate of reduced coordination number (Equation 2.2). A dissociative mechanism is 
expected to result in the formation of a mixture of two geometric isomers with different 
types of kinetic behaviour. For square planar complexes, a dissociative mechanism will only 
prevail in the presence of very bulky ligands, good leaving groups and strongly coordinating 
solvent.9 Bulky ligands clearly obstruct the nucleophile from reaching the metal centre. On 
the other hand, if the bond breaking between the metal centre and the leaving group 
dominates upon the approach of the nucleophile, dissociative mechanism will be favoured. 
The same will occur in the presence of strongly coordinating solvent. Because the solvent is 
usually provided in excess, it can easily knock out the leaving group enhancing the 
formation of the intermediate of reduced coordination number.  
Y3MLY3ML X3MLX3ML →+→+→     (2.2) 
intermediate  
 
2.2.3 Interchange, (I) 
In this instance, the leaving group and entering group are both involved in the formation of 
the activated complex (Equation 2.3). If the bond formation between the entering ligands 
and the metal centre dominates over its bond breaking with the leaving group, and shows 
sensitivity to the nature and concentration of the incoming ligand, then the mode of 
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activation becomes associatively-activated interchange mechanism (IA). On the other hand 
if the rate of reaction is affected by the leaving group and bond breaking dominates over 
bond formation the mode of activation turn out to be dissociatively-activated interchange 
mechanism, ID. The defining characteristic of interchange is the absence of an intermediate 
(Figure 2.2) in which the primary coordination number of the metal is modified.  
X YML-Y--ML-XYXML 333 +→→+     (2.3) 
 
Figure 2.2: Reaction profile10 for (a) associative, (b) dissociative and (c) interchange 
mechanisms. A true intermediate exists in (a) and (b) but not in (c). 
 
2.3 Kinetics Parameters 
2.3.1 Determination of Rate Constants 
Experimentally, the rate of a reaction is found to depend principally on the concentration of 
the reactants. To determine the reaction rate and hence the rate constant one need to 
monitor the concentration of one of the reactants as a function of time. This may be 
achieved by measuring the time dependence of a variable that is proportional to the 
concentration, such as absorbance. Kinetic measurements of ligand substitution reactions 
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of Pt(II) complexes are often done by following the change in absorbance at suitable 
wavelengths as a function of time. These substitution reactions mainly do not go to 
completion but rather towards equilibrium and can be written as;  
A + B C
k2
k-2        (2.4) 
or 
ML3X + Y ML3Y + X
k2
k-2  
where A = Metal centre (ML3X), B = Incoming nucleophile Y, X = leaving group, 2k .= second-
order rate constant for the direct attack of the entering nucleophile and 2−k  = 
second-order rate constant of the reverse reaction.  
 
The forward reaction is second-order while that of the reverse reaction is first-order. The 
overall reaction exhibits the mixed-order behaviour which complicates the study. Ligand 
substitution reactions for the forward reaction is therefore simplified by employing pseudo 
first-order conditions11 where concentration of the incoming nucleophile is at least ten fold 
excess of that of the metal complex ([B]0 >>>[A]0) and the rate of formation of product C  
can be expressed as, 
[ ] [ ] [ ] [ ] [ ] [ ]tCBACdBdAd 2tt2 −−==−=− kk
dtdtdt
    (2.5) 
Applying the mass balance at any time t,  
     [ ] [ ] [ ] [ ] [ ] [ ]tCBB andCAA 0tt0t −=−=    (2.6) 
and at equilibrium,  
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        [ ] [ ] [ ]  CAA e0e −=  and [ ] [ ] [ ]eCBB  0e −=    (2.7) 
Knowing that at equilibrium the rate of forward and backward reactions are equal, then, 
                                
[ ] [ ] [ ] [ ] 0CBAAd e2ee2 =−=− −kk
dt
     (2.8) 
This follows that, 
        [ ] [ ] [ ]eCBA 2ee2 −= kk        (2.9) 
Since [ ] [ ] [ ]t0t AAC −=  and at equilibrium [ ] [ ] [ ]e0e AAC −= , substituting this in Equation 
2.9 provides 
         [ ] [ ] [ ] [ ]( )e02ee2 AABA −= −kk      (2.10) 
and then, 
              [ ] [ ] [ ] [ ]e2ee202 ABAA −− += kkk      (2.11) 
Taking Equation 2.5 and substituting for [ ] [ ] [ ]t0t AAC −=  and then introducing it in 
Equation 2.11 gives 
                 
[ ] [ ] [ ] [ ] [ ] [ ] [ ]t2e2ee2tt2 AABA-BAdt
Ad
−− +−=− kkkk   (2.12) 
Under pseudo first-order conditions where [ ]0B >>> [ ]0A , Equation 2.12 becomes 
                 




  (2.13) 
               [ ]( ) [ ] [ ]( )et202 AAB −+= −kk     (2.14) 
Separation of the variables and integration gives 
                      
[ ]
[ ] [ ]( )[ ]











dtkk      (2.15) 
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which results in 
               
[ ] [ ]












−      (2.16) 
where [ ] 202obs B −+= kkk , [B]0 = initial concentration of the incoming nucleophile 
 
In ligand substitution reactions, second-order rate constants are determined by measuring 
the dependence of observed pseudo first-order rate constant, kobs on the initial 
concentration of the nucleophile, [Nu] using Equation 2.17. 
                            [ ] 22obs Nu −+= kkk                 (2.17) 
A plot of obsk  versus [ ]Nu  gives a straight line with the slope of 2k  and an intercept of 2-k . 
Plots of this type are common for the substitution reactions of square planar Pt(II) 
complexes, an example of which is shown in Figure 2.3. 
 
Figure 2.3: Typical plots of kobs versus the concentration of the incoming azole 
nucleophiles for the substitution reaction of a mononuclear Pt(II) complex in 
methanol solution.12  
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The magnitude of the second-order rate constant ( 2k ) calculated is a direct measure of the 
reactivity of the complex towards the nucleophile. A plot which passes through zero implies 
that the forward reaction is irreversible and directly goes to completion, whereas a non-
zero y-intercept signifies that the nucleophile Y is being substituted from the metal centre 
by the solvolysis process or there is a back reaction taking place.13,14 The two-term rate law 
































Figure 2.4: A proposed dual reaction pathway for an associative substitution mechanism 
at the Pt(II) centre11 where solv = solvent. 
 
In the presence of coordinating solvents (e.g. water or methanol) and good leaving group, 
the k-2 term may be attributed to the solvolysis pathway. In such cases, the k-2 pathway 
involves two sequential associative steps, viz. the rate-determining step in which a solvent-
metal complex is formed followed by rapid substitution of the co-ordinated solvent 
molecule by the entering nucleophile (Figure 2.4). This solvolysis pathway follows first-
order kinetics and is therefore independent of the concentration of the incoming 
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nucleophile. The second path involves direct nucleophilic attack by the entering ligand, Y 
and so the k2 is sensitive to the nature of the entering nucleophile.  
         [ ]Nu2obs kk =        (2.18) 
It is worth noting that in all substitution reactions reported in this thesis the k-2 term is very 
small thus, under pseudo first-order conditions the values of k2 can be calculated directly 
from Equation 2.18. Typical plots of Equation 2.18 are found in Figures 3.2, 4.5, 5.4 and 
6.3 in chapter three, four, five and six respectively. 
 
2.3.2 Activation Parameters 
In inorganic substitution reactions, apart from rate law, the magnitude of the activation 
parameters helps to elucidate the mechanism of the chemical reaction. These parameters 
can be determined by measurement of reaction rates and rate constants as a function of 
many chemical and physical variables among which includes temperature and pressure 
dependence.15 
 
2.3.2.1 Determination of Enthalpy of Activation (ΔH≠) and Entropy of 
Activation, (ΔS≠). 
The temperature dependence of the rate constant is very useful in determining the enthalpy 
of activation, ≠∆H  and entropy of activation, ≠∆S . The value of ≠∆H is a good estimate of 
the energy barrier necessary to activate reactants to the transition state. The entropy, ≠∆S  
reveals information on the degree of order at transition state which in turn is controlled by 
the degree of bond formation or bond breakage on going to the transition state. Both 
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≠∆H and ≠∆S  of the reactions are normally derived from the temperature dependence of 
their rate constants based on the transition state theory.16,17 The theory works on the 
assumption that many reactions between A (metal centre) and B (incoming nucleophile) 
proceed via a pre-equilibrium mechanism between the reactants and the transition-state 
species (activated complex, AB#) before it is converted to the product C.18 The mechanism 




A +B AB# C
      (2.19) 




k=−        (2.20) 
At equilibrium,  
      
[ ]




=≠K        (2.21) 
where K≠ = equilibrium constant of the activated complex 
Implying that,            eqeqeq [B][A]AB
≠= K#][       (2.22) 







      (2.23) 
where kb = Boltzmann’s constant (1.38 x 10-23 J/K) and h  = the Planck’s constant  
(6.626 x 10-34 J s).19  
but,                   tt2 [B][A]dt
d[A]
k=−       (2.24) 
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Therefore, comparing Equation 2.23 and 2.24 gives 
        ≠= Kkk
h
Tb
2        (2.25) 
To further describe the pre-equilibrium constant in thermodynamics, we have; 
                               ≠≠ −= K RTG  lnΔ        (2.26) 
where ≠GΔ  is the Gibbs activation energy which consists of the entropy of activation ≠SΔ  
and the enthalpy activation term, ≠HΔ 20 as shown in Equation 2.27. 
           ≠≠≠ −= STHG ΔΔΔ        (2.27) 
Combining Equations 2.26 and 2.27 to solve for ≠K ln  results into, 







≠ += ΔΔ ln        (2.28) 
The Eyring equation is finally obtained by substituting Equation 2.28 into Equation 2.25 












2       (2.29) 
Taking natural logarithm of both sides gives, 

























ln b2      (2.30) 
The values for ≠HΔ  and ≠SΔ can be determined from kinetic data obtained from a plot of 
T
k2ln  versus 
T
















Δ  from which the enthalpy of 
activation (ΔH≠) and the entropy of activation (ΔS≠) can be calculated, respectively. Typical 
example of the Eyring plots is shown in Figure 2.5. The magnitudes of ΔH≠ and ΔS≠ provide 
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information about how the enthalpy and entropy of the transition state differ from those of 
the reactants. Large and negative values of ΔS≠ indicate that the transition state is highly 
ordered and more compact than either the reactant or product species. On the other hand 
low values of ΔH≠ show the ease with which the new bond can form due to the 
electrophilicity of the metal centre. In an associatively-activated substitution reaction, the 
relative magnitude of the ΔH≠ values tend to be small while their values of ΔS≠ are usually 
negative when compared to those for dissociatively activated reactions whose values of ΔH≠ 
and ΔS≠ are usually large and positive.  


















Figure 2.5: Eyring plots for the reaction of Pt(II) complex with a series of neutral 




2.3.2.2 Determination of Activation Volume (ΔV#) 
Experimental determination of the entropy of activation is associated by lack of exactness 
and is subjected to large relative errors since the data are calculated from values extracted 
to infinite temperatures on the y-intercept. The more precise parameter is volume of 
activation, ΔV#. This can be determined from a series of experiments in which one measures 
the observed rate constants, kobs, as the pressure which is applied on a reaction mixture is 
varied. Measurement of activation volume is therefore useful in studies of ligand 
substitution reactions as it allows a precise assignment of the underlying substitution 
mechanism.21 However, for better diagnosis, it is still significant to include the values of the 
ΔV≠ and ΔS≠ for the purposes of making conclusive mechanism assignment.22 Pressure 
dependence of the rate constant results in the volume of activation as outlined below; 











Δ       (2.31) 














        (2.32) 
where ∆V = the difference between the partial molar volume of products and partial molar 
volume of reactants, K = equilibrium constant. 















 δln        (2.33) 
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where ≠∆V  = volume of activation and is equal to the difference in the partial molar 
volumes between the transition state and the reactants. 















 ln 2δ        (2.34) 
According to Equation 2.34, clearly if rate constant, k2 increases with increasing pressure, 
≠ΔV  is negative. On the other hand a positive ≠ΔV  denotes a decrease in k2 with increasing 
pressure. 
Integrating Equation 2.34 from P = 0 to P = P gives, 







     (2.35) 
where 02 )(k  = rate constant at zero pressure. 
Values of ≠ΔV can be determined from experimental measurements of rate constants at 
different pressures by plotting of 2 ln k  versus P. The slope of such a plot is equal to 
RT
V ≠− Δ . 
Volume of activations, ≠ΔV are usually considered to be the combination of an intrinsic 
contribution, intΔV ≠  resulting from changes in internuclear distances within the reactants 
during the formation of the transition state, and from an electrostrictive contribution, 
elecΔV ≠ . For substitution reactions involving charged species, the observed ≠ΔV  is 
dominated by elecΔV ≠ , whereas for solvent exchange reactions due to the absence of 




In ligand substitution reactions of Pt(II) square planar complexes 0<≠ΔV  for associative 
mechanism as it involves a volume collapse on going to the transition state. For dissociative 
mechanism the process towards transition state encompasses expansion in volume 
therefore, 0>≠ΔV .23  
 
2.4 Techniques of Studying Reaction Kinetics 
Experimental techniques have been developed to monitor reactions over timescales varying 
from hours or days all the way down to fractions of seconds. While it is somewhat simple to 
monitor the kinetics of a slow reaction occurring over minutes to hours or longer, highly 
specialized techniques are required in order to study fast reactions. Whatever the details of 
the experimental arrangement, any kinetics experiment essentially consists of mixing the 
reactants and initiating reaction on a timescale that is negligible relative to that of the 
reaction, and then monitoring the concentration(s) of one or more reactants and/or 
products as a function of time. Because rate constants vary with temperature, it is also 
important to determine and control accurately the temperature at which the reaction 
occurs.  
 
Various techniques can be used to study reaction kinetics. The list includes flow methods 
(e.g. stopped-flow or continuous flow), UV-Visible spectrophotometry, Nuclear Magnetic 
Resonance (NMR) spectrophotometry, conductivity measurements and gas 
chromatography.24 The choice of the technique to be used for the particular reaction 
depends on the nature and rate of the reaction. Since Pt(II) substitution reactions are either 
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fast or slow, flow and UV-Visible techniques are mainly used and so will be discussed here 
in detail. 
 
2.4.1 UV-Visible Spectrophotometry 
UV-Visible spectrophotometry is a sensitive technique which can detect samples of low 
concentrations in the range of 10-4 to 10-6 M.25 The method is useful for detecting electronic 
transitions originating from highest occupied molecular orbital (HOMO) to the lowest 
unoccupied molecular orbital (LUMO) of the compounds upon absorption of light in the 
ultraviolet and visible regions. In addition, it is used to track reactions in which the 
reactants and products have different absorption spectra. Figure 2.6 depicts that the 
instrument comprises of two sources of radiation spanning from the Visible and ultra-
violet, sample cubicles, monochromator, detector, output-readout system and an internal or 
external temperature control unit. For acquisition of the kinetic data special transparent 
tandem cuvettes made up of quartz or fused silica are used for initiating the reaction. These 
cuvettes have two sections that allow one to pre-equilibrate the reactants at the required 




Figure 2.6: Schematic diagram of a UV-Visible spectrophotometer.26 
 
The degree of interaction of the sample with radiation (transmittance or absorbance) is 
determined by measuring both the intensity of the incident radiation, 0I  (without the 
sample) and the transmitted intensity, I  (with the sample). The light transmitted from the 
sample is defined as follows: 
I
I
T 0=         (2.36) 
where 0I = the intensity of the incident light obtained from the solvent reference cell, I  = 
the intensity of the transmitted light from the power source after passing 
through the sample cell. 
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Absorbance is defined as follows, 
TA  log−=        (2.37) 
In ligand substitution reactions, absorbance values are used since the relationship between 
absorbance and both concentration of the reacting species and path length normally is 
linear and obeys Beer’s law (Equation 2.38). 
εclA =        (2.38) 
where, A = absorbance, ε = molar absorptivity (L mol-1 cm-1), c = concentration (mol dm-3),  
l = path length (cm). 
For the first-order reaction,  
X Y
k1
       (2.39) 
at any time t, the absorption is given by; 
[Y][X] YX εεAt +=       (2.40) 
where, At = the absorbance at any time, t, εX and εY = molar absorptivity of X and Y 
respectively 
When the reaction goes to completion, the absorption is given by 
0Y0X [Y][X] εεA +=∞       (2.41) 
where A∞ = absorbance upon completion of reaction, [X]0 and [Y]0 = initial concentration of 
X and Y respectively. 
The kinetic analysis relating the concentration or optical absorbance (Equation 2.38) can 
therefore be obtained from the integrated rate-law given on Equation 2.42. The 
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absorbance-time resolved data in kinetic reactions are used directly to evaluate the 
observed rate constants using this equation. 



















∞      (2.42) 
In this study slow substitution reactions were carried out on a Cary 100 Bio UV-Visible 
spectrophotometer with a cell compartment thermostated by a Varian Peltier temperature 
controller having an accuracy of ± 0.05 °C. UV-Visible scans were recorded at set time 
intervals over the wavelength range of 200 to 800 nm immediately after mixing the 
reactants. The obtained kinetic data were graphically analysed using the software package, 
Origin 7.527 to give the kinetic trace with the time taken for the reaction to go to 
completion. The time obtained from the kinetic trace gave the observed first-order rate 
constant, obsk . A typical set of scans and its kinetic trace is shown in Figure 2.7.  
 
Figure 2.7: UV-Vis scans for the substitution reaction of Pt2 (studied in Chapter 3) with 
thiourea in MeOH recorded at 25 °C. Inset is the kinetics trace obtained at  
 375 nm. 
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It is important mentioning that the UV-Visible absorption spectroscopy is also used to 
perform spectrophotometric titrations, especially in pKa determinations. The pKa values 
of the coordinated aqua ligand are important thermodynamic set of data used as indicator 
of the electrophilicity of the metal centre.28 
 
2.4.2 Flow Techniques 
Flow techniques are typically used to study reactions occurring on timescales of seconds to 
milliseconds. These can be either continuous flow or stopped flow techniques. The design 
of the flow instrument is usually associated with monitoring of reaction progress by UV-Vis 
spectrophotometry techniques where Equation 2.42 is used to evaluate the observed rate 
constants.  
 
2.4.2.1 Continuous Flow Techniques 
In the simplest continuous flow method, shown schematically on Figure 2.8 (a), reactants 
are mixed at one end of a flow tube, and the composition of the reaction mixture is 
monitored at one or more positions further along the tube. If the flow velocity along the 
tube is known, then measurements at different positions provide information on 
concentrations at different times after initiation of reaction. In a variation on this method, 
shown on Figure 2.8 (b), the detector may be in a fixed position, but a moveable injector 
may be used to inject one of the reactants into the flow tube at different positions relative to 




(a)                                                                                        (b) 
Figure 2.8: Schematic diagram of continuous flow kinetic system.29 
 
Continuous flow methods have the disadvantages that relatively large quantities of 
reactants are needed, and very high flow velocities are required in order to study fast 
reactions. These problems may be avoided by using a stopped flow techniques.30  
 
2.4.2.2 Stopped Flow Techniques 
Stopped flow methods (Figure 2.9) constitute commonly used tools for investigation of 
mechanisms of molecular kinetic processes in the time range from milliseconds to 
hundreds of seconds.31 In this study an Applied Photophysics SX 20 stopped-flow reaction 
analyser coupled to an online data acquisition system was used to study the fast reactions. 
The temperature of this instrument was controlled to within ± 0.1 °C.  
 
In the stopped flow experiments, small volumes of solutions are rapidly driven from 
syringes by a compressed gas-driven piston (800 kPa) into a high efficiency mixer to initiate 
a fast reaction at a specific temperature. The fresh reaction mixture is rapidly transferred 
into an observation cell while the previous contents of the cell are flushed out. The volume 
injected is limited by the stop syringe which provides the “stopped-flow”. The composition 
of the reaction mixture is then monitored spectrophotometrically at specified wavelength 
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where by the amount of light transmitted through the mixed solution undergo changes as 
the reaction proceeds in the static mixed solution. A photomultiplier unit converts the 
transmitted light into an electric current and a signal is fed to the computer over an 
appropriate time interval. The kinetic traces acquired under pseudo first-order conditions 
are then fitted to exponential functions to evaluate the pseudo first-order rate constant. 
Examples of the stopped flow kinetic traces are shown in Figures 4.3, 5.3 and 6.1 in 
Chapters Four, Five and Six respectively. 
 





2.5 Factors Affecting the Rate of Substitution 
2.5.1 The Role of Incoming Ligand 
Numerous investigations have established that associative mechanism of ligand 
substitution reactions in Pt(II) complexes depends on the nucleophilicity of different 
entering groups.33-38 The concept of nucleophilicity gives the quantitative measure of the 
ability of a Lewis base to act as the entering group and to influence the reaction rate in a 
nucleophilic substitution reaction. A scale of nucleophilicity is established by determining 
the relative rate of the reaction of a range of nucleophiles with a standard substrate. In 
inorganic chemistry the substitution reactions of trans-[Pt(py)2Cl2] in methanol solution is 
used as the standard and the nucleophilicity factor is usually expressed, as far as Pt(II) 






n log=         (2.43) 
where 2k  = the rate constant for the reaction of the entering nucleophile, 2-k  = the rate 
constant for attack of the solvent (methanol). 











R .  
The Ptn  index can be applied to other Pt(II) complexes according to the expression given in 
Equation 2.44.5,34,42 
( ) 2-Pt2  logS log knk +=       (2.44) 
Equation 2.44 shows that for a specific substrate except for complexes with π-acceptor 
ligands,34 there is linear free energy relationship between 2 log k  for a particular 
24 
 
nucleophile and nucleophilicity index, Ptn  value (Figure 2.10). This is because π-acceptor 
ligands are capable of forming metal-ligand π-bonding at the transitional state and then 
lowering the energy of the transition state. This also depends on the π-donor ability of the 
metal complex which makes some reagents more reactive towards some better π-donor 
metal complexes or less reactive to certain complexes.34 The slope S  of the plots in Figure 
2.10, is the nucleophillic discrimination factor and the intercept 2- log k , is the intrinsic 
factor. The former is dependent on the nature of the complex and is a relative measure of its 
ability to discriminate between the various entering nucleophiles.  
 
Figure 2.10: Plots of 2 log k  versus Ptn  for the determination of the nucleophilic 
discrimination factor, S  of Pt(II) complexes43  
 
A large value of S  means that the complex is very sensitive to changes in the nature of the 
nucleophillic reagent. The magnitude of -2k  is a measure of the "intrinsic" reactivity of the 
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platinum complex with the poorest nucleophillic reagent whose effect can be measured in 
any solution.42 Having such a poor nucleophile, the greatest burden is put on the complex to 
reach the activated complex of the reaction. If the value of -2k  is small, the tendency of the 
complex to react is minor and will rely more on the nucleophile. 
 
It is important to recall that nucleophilicity is a kinetic term which is most heavily 
correlated with the polarizability of the entering ligand, basicity and the nature of the 
substituent on the ligand. 
 
2.5.1.1 Polarizability of the Nucleophile 
It is known that polarizable molecules and ions such as thiourea, iodide ion and 
unsaturated systems are more nucleophilic than their basicities would warrant.44 In the 
case of uncharged nucleophiles, size dictates the nucleophilicity. This is because larger 
elements have bigger, more diffuse and more polarizable electron density. This density 
facilitates the formation of a more effective orbital overlap in the transition state of 
bimolecular nucleophilic substitution reactions, resulting in a transition state that is lower 
in energy and a nucleophilic substitution that occurs at a faster rate. This is also supported 
by the hard and soft acid-base theory. “Hard” nucleophiles prefers “hard” metal centres and 
“soft” nucleophiles prefers “soft” substrates or metal centres.45,46  
 
The term soft nucleophiles as used here refer to the relatively polarizable nucleophiles and 
hard refers to relatively non polarizable. Like soft bases, soft nucleophiles have high HOMO 
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energy making them efficient nucleophile.47 In solution, polarizable nucleophiles are better 
than non-polarizable nucleophiles because they can respond better to demand for charge 
reorganization. For ionic nucleophiles the polarizability of the nucleophilicity follows the 
order −−−− >>> FClBrI . This polarizability order explains the trend in reactivities of the 
ionic nucleophiles reported by a number of studies.33b,d,43,48 
 
2.5.1.2 Basicity of the Nucleophile 
Basicity have an important role in determining the nucleophilic reactivity toward Pt(II) 
complexes.12,33e,44,49 As already observed in the cases of Pd(II) complexes,50 the reactivity of 
Pt(II) complexes is linearly related to the basicity of the entering nucleophiles.51 Pitteri et 
al52 found that for the reversible substitution reaction, there is a relatively large 
dependence of reactivity upon the basicity of the nucleophile in the reverse as compared to 
the forward reactions. The observation suggests that the formation of the transition state 
involves a structure containing a well formed Pt–X and a weak Pt–Nu where X and Nu are 
leaving group and the incoming nucleophile, respectively. Generally, the relationship 
between basicity of the nucleophiles and the rate constant of a given substitution reaction 
can be described by Equation 2.44. 
( ) constantpα log a2 += Kk      (2.44) 
A plot of 2 log k  versus apK  is the straight line with the slope of α which indicates the ability 
of the platinum(II) centre to discriminate the incoming ligands of different basicity.42 The 
positive slopes indicate the increase of the electron density around the reactive metal 
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centre which is typical of associative mode of substitution behaviour. The negative slope is 
an indication of the solvolytic reverse reaction.14 
 
2.5.1.3 Substituents on the Nucleophiles 
In an associative mechanism for ligand substitution reactions, the transition state is more 
crowded than the ground state as there are a total of five groups around the electrophilic 
centre. As a result, the steric bulk and the size of the entering nucleophile play a dominant 
role in determining the rate of the substitution reaction. Steric hindrance merely slows 
down the associative attack of a bulky nucleophile, but does not alter the nature of the 
substitution mechanism suggesting that steric effects are more important than electronic 
effects.8,33 Extensive studies have rationalized the steric effect of the entering group.33,53 
Basically, larger entering group will hinder the approach of the entering group and will 
slow the formation of the five-coordinate activated complex leading to slow substitution 
reaction.  
 
2.5.2 The Nature of Non-participating Groups in the Complex  
2.5.2.1 Trans Effect 
The concept of the trans effect was introduced by Chernyaev in 1926 to explain the 
empirical observation that the rate of substitution of a ligand in a square planar or 
octahedral metal complex is dependent on the group trans to it much more so than groups 
in cis positions.54 Since then, the kinetics of many other systems has been explained by the 
trans effect.54,55,56 The trans effect is best defined as the effect of a coordinated ligand upon 
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the rate of substitution of ligands opposite to it. The ligand trans to the leaving group can 
influence the reaction rate by several orders of magnitude (105-106).57 
 
In general, the rate of substitution of the leaving group by the incoming group is faster if the 
trans ligand is a strong σ donor or a good π-acceptor.58 However, relatively hard pure σ-
donors like 3NH , OH2  and 
-OH  have a weak trans-directing effect. This apparent 
contradiction seems to indicate that there is another factor responsible to trans directing of 
substitution and it is the trans influence.  
 
Trans influence is the extent to which a ligand weakens the bond that is trans to itself. This 
is a purely thermodynamic effect and manifests itself as changes in bond lengths, force 
constants and vibrational frequencies.59 For example, for a series of trans-metal complexes 
if a trans ligand T  is changed, the XM −  bond length is very sensitive to the 
electronegativity of T (where T, M and X stands for trans ligand, metal centre and leaving 
group respectively). If the electronegativity decreases, the distance XM −  increases.59 This 
increase in length is as a result of a weakened bond in the ground state and leads to the 
increase in the reactivity of the association process. In general, the structural trans 
influence follows the order:59 




2.5.2.1.1 σ-donation Trans Effect 
Polarization theory considers the trans effect to be principally electrostatic in origin and 
transmitted through σ-bonds (σ-trans effect).60 In a square-planar complex and in the 
ground state strong σ-donor ligands donate electrons very effectively to the metal via  
σ-bonds. The effective donation is attributed by their good overlap with the metal orbital 
resulting into interaction which goes down low in energy (Figure 2.11). If the trans ligand 
is a strong σ-donor, the metal p-orbital bonds more favourably with it than the ligand trans 
to it. This results into elongation and weakening of the XM −  bond while strengthening the 
TM −  bond (Figure 2.12). In substitution reactions the weak bond will break easily leading 

















Figure 2.11: Sketch diagram showing the effect of σ-donor trans ligand on energies of 




The σ-trans effect order which is approximately the order of decreasing polarizability of the 
ligands is;7 -333 OHNHClBrCNCOCHISCNPRH >>>>>>>>>>
−−−−−−− . 
Since the polarizability of the metal ion is important, this theory readily accounts for the 
observation that the trans effect is greatest in the most polarizable or softest platinum(II) 
than palladium(II) complexes. 
T M X MT X
T M X MT X
(a)
(b)
flow of electrons 
 
Figure 2.12: σ-bonding effect.60 (a) Strong σ-donor ligand T , the σ-bond strength of TM −  
is much greater than that of XM − , (b) weak σ-donor trans ligand gets poorer 
overlap with the metal orbital. 
 
It is worth noting that as electrons are donated from the filled ligand orbital to the vacant 
metal orbital, this kind of interaction will diminish the total (positive) natural bonding 
order (NBO charge) of the Pt(II) centre due to an increase of electron density in the xy plane 
as shown by the complexes studied in Chapter six of this thesis. Increase in the rate of 
substitution reaction in Pt(II) complexes as a result of trans σ-donation effect has been 




2.5.2.1.2 π-back-donation Trans Effect  
In the π-trans effect theory for square-planar complexes,62,63 the trigonal bipyramidal 
intermediate can be stabilized by removal of electron density from π-orbitals of the 
entering group Y (via metal d orbitals) to π-acceptor orbitals of the trans ligand T (Figure 
2.13).64 This electronic communication through π-bonding is only possible if the three 
ligands and the metal centre all lie in the same plane at transition state facilitating the 
effective delocalization of the extra charge from the metal. π-back bonding also favours low 
energy of the transition state which results into a low activation energy for the substitution 
reaction (Figure 2.14).7,65 Calculation of the overlap of the valence orbitals of several 





−−−−− . The overall trans effect trend is 
therefore the combination of the σ- and π-trans effects as follows;7 



















Figure 2.14: Activation energy and the trans effect.8a 
 
Unlike σ-donor groups, π-acceptor groups increases the total (positive) NBO charge of the 
Pt(II) atom by a decrease of electron density in the xz plane through π-back-donation. It 
also facilitates a nucleophilic attack in the xz plane and stabilizes corresponding 
pentacoordinated transition state.67 Systematic alteration of the position of π-acceptor 
groups (cis/trans) affects the electronic communication in the system hence affecting the 
reactivity of the Pt(II) centre with cis π-back bonding found to be stronger than trans π-
back bonding.68 Hitherto, it has been generally acknowledged that increase in π-surface and 
hence π-acceptor properties in the system accelerates the nucleophilic substitution process 
of Pt(II) complexes.33 However, a recent study33b has found that increased π-surface of 
isoquinoline does not enhance the rate of substitution reactions but rather it slows the 
reactivity by a magnitude of three due to the fact that isoquinoline is a net σ-donor. A detail 
kinetic study on the effects of π-acceptor ligands and trans effect is presented in Chapter 
Three and Six of this thesis.  
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2.5.2.2 The-cis Effect 
The ligands cis to the leaving group exert only a small electronic effect and is observed for 
poor nucleophiles only. The cis effect becomes important if the cis ligands are bulky as they 
block the open axial sites for the incoming group33f,34,69 and in some cases may cause a 
mechanistic change from an associative to a dissociative mechanism. This is because, in 
associative ligand substitution reactions, a trigonal-bipyramidal transition state is greatly 
strained by cis blocking but not nearly so crowded by trans blocking. A survey in literature 
shows that cis blocking causes the relative drop in the rate of reaction by a factor of 
thousands compared to trans blocking.5 Apart from cis steric hindrance, electronically, cis σ-
donor effect also increases the electron density at the metal centre and slows down the 
reactivity of the Pt(II) complex43,70 with cis π-effect having an opposite influence. 
 
2.5.3 Role of the Leaving Group 
It is difficult to generalize the effect of the leaving group on the rate of substitution reaction 
because it is dependent on the nature of the reaction centre, nature of incoming 
nucleophiles and the nature of the trans ligand.71 For systems in which marked leaving 
group effects occur, it is suggested that bond breakage of the five-coordinate intermediate 
produced during an associative substitution process may contribute significantly toward 
the observed kinetic parameters and may even be the rate-determining step under extreme 
conditions like strongly bonded leaving groups.59 One of the most extensive series of 




( )[ ]( ) ( )( )[ ]( ) 1nx21xn2 XNudienPtNuXdienPt −+−−− +→++   (2.45) 
In this case the three other coordination positions are rendered inert by using the strongly 
complexing dien ligand, and the entering ligand (Nu) was always pyridine (py). The rates in 
aqueous solution obtained from reaction Equation 2.45 are given in Table 2.1 and the rate 
constant for the displacement of X  decreases in the order;7,34 
−
3NO  > OH2  > 
−Cl  > −Br  > −I  > −3N  > 
−SCN  > −2NO  > 
−CN  
 
A substantial difference in the relative rates of different leaving groups observed indicates 
that a considerable perturbation of the XPt −  bond at the transition state does not lead to a 
dissociation process but merely requires that XPt −  bond breaking make a contribution 
comparable to that of pyPt −  bond forming. It is worth stating that the leaving groups high 
in the trans-effect series are substituted more slowly. This is consistent with the combined 
σ- and π-trans-effect theory which suggests that good trans-effect groups will be strongly 
bonded to the metal. The reverse that a poor trans activator/labilizer is readily replaced 
need not be true. For example −OH  is a very poor trans labilizer but is very difficult to 
substitute. Another poor trans labilizer that is an inert leaving group is 3NH .7 Generally, 
groups which best stabilize a negative charge are the best leaving groups, as for example 





Table 2.1: Effect of the leaving group on rates of reaction of Pt(II) complexes in water at 
25 oC.7,34 
Leaving group, X kobs, s-1 
−
3NO  very fast 
OH2  1900 
−Cl  35 
−Br  23 
−I  10 
−
3N  0.83 
−SCN  0.3 
−
2NO  0.05 
−CN  0.017 
 
2.5.4 Effect of the Metal Centre 
In general, the square-planar complexes of Pd(II) and Ni(II) are much more labile than 
analogous Pt(II) complexes.72 This order of reactivity is ascribed to the tendency of forming 
5-coordinate intermediate complexes. The more readily the formation of a 5-coordinate 
intermediate complex, the greater the stabilization of the transition state and so the greater 
the rate enhancement of the associative substitution.  
 
2.5.5 Effect of the Solvent 
The solvent dependence of the reaction rates of Pt(II) complexes provides another test of 
the suggestion of associative activation involving solvent for the 2−k  term in the rate law 
Equation 2.17. van Eldik and Weber studied the influence of solvent on ligand substitution 
reactions of Pt(II) complexes as function of the π-acceptor properties of the spectator 
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chelate.73 It was found that in the case of alcoholic solvents, there was an increase in the 
second-order rate constant with increasing length of the carbon chain of the alcohol and 
ascribed it to a possible role of van der Waals forces in stabilizing the transition state of the 
substitution process. An increase in rate constant was also observed in going from 
methanol to water, which is in line with the expected trend in terms of the polarity of the 
solvent, viz. a more polar solvent will stabilize the polar transition state formed through the 
associative attack of the neutral nucleophile.  
 
The 2−k  term is important in solvents that are capable of coordinating with Pt(II) (Table 
2.2) as the rate of reaction is found to be independent of the concentration of the incoming 
group but dependence on the nucleophilicity of the solvent. From Table 2.2 it can be seen 
that pyridine and dimethylsulfoxide (DMSO) are top in the series and therefore are better 
nucleophiles towards Pt(II) centre.69b In solvents that are poor entering groups such as 
chloroform and dichloromethane, the 2k  term for reaction is more important.  
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Pyridine  1.4 
Dimethylsulfoxide  0.3 
Hexamethylphosphoramide  0.2 
Triethylamine  0.1 




Ethylene glycol -0.2 
Acetonitrile -0.2 
i-Propanol -0.3 


















Generally, to have a complete understanding of the factors governing reactivity of Pt(II) 
complexes towards ligand substitution reactions, one has to perform a systematic study in 
which all other structural features within the series of complexes under study are kept 
constant while the feature of interest is varied. In this thesis the electronic and steric effects 
of the ligand framework on reactivity of a series of mononuclear and dinuclear Pt(II) 
complexes has been investigated. The leaving group was varied from chloride to water 
depending on the solubility of the complexes whereas the entering group in all systems 
investigated was thiourea nucleophiles of different steric demand. The details of the result 
for the substitution reactions of the complexes and the aforesaid nucleophiles as specified 
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Understanding the Electronic and π-conjugation Roles of Quinoline on Ligand 
Substitution Reactions of Pt(II) Complexes. 
Abstract 
A kinetic and mechanistic study of chloro substitution by thiourea nucleophiles viz. thiourea 
(TU), N-methylthiourea (MTU), N,N-dimethylthiourea (DMTU) and N,N,N’,N’-
tetramethylthiourea (TMTU) in the complexes bis-(2-pyridylmethyl)amine platinum(II) 
chloride (Pt1), N-(2-pyridinylmethyl)-8-quinolinamine platinum(II) chloride (Pt2), N-(2-
pyridinylmethylene)-8-quinolinamine platinum(II) chloride (Pt3) and bis(8-
quinolinyl)amine platinum(II) chloride (Pt4) was undertaken under pseudo first-order 
conditions using UV-Visible spectrophotometry. The study showed that lability of the chloro 
leaving group is dependent on the strength of π-interactions between the filled dπ-orbitals 
of the metal with the empty π*-orbitals of the chelating ligand in the following manner; Pt1 
> Pt3 > Pt2 > Pt4. Introduction of the quinoline moiety within the non-labile chelated 
framework of the Pt(II) complexes results into a more electron-rich metal centre which 
retards the approach of the nucleophile through repulsion. Moreover, the net σ-effect of the 
ligand moiety plays a significant role on controlling the reactivity of the complexes. The 
experimental results are interpreted with aid of computational data obtained by DFT 
(B3LYP(CPCM)/LANL2DZp//B3LYP/-LANL2DZp) calculations. The mode of substitution 
remains associative as supported by negative entropies and the dependence of the second-





The rate of substitution on square-planar Pt(II) tridentate chelates of the type [Pt(NNN)X]+ 
where X= chloride or aqua ligand can be varied by tuning structural, steric and electronic 
properties of the non-labile ligands.1 Most of the studies have involved monofunctional 
tridentate Pt(II) complexes; [Pt(dien)Cl]+,2 [Pt(bpma)Cl]+,3 [Pt(terpy)Cl]+,3,4 and 
[Pt(tpdm)Cl]+.5, (where dien = diethylentriamine, bpma = bis-(2-pyridylmethyl)amine, 
terpy = 2,2′:6′,2″-terpyridine and tpdm = terpyridinedimathane). These complexes are 
highly stable even under acidic conditions due to the chelate effect and synergistic 
combination of σ-donor and π-acceptor N-heterocyclics that incorporate five-membered 
rings.6 
 
van Eldik and co-workers3c,7,8 have reported that reactivity of Pt(terpy), Pt(bpma) and 
Pt(dien) increased in the order of Pt(terpy) >> Pt(bpma) >Pt(dien) by introduction of π-
backbonding by systematically displacing amine ligands by pyridine donor groups. The 
higher reactivity of approximately 3-5 orders of magnitudes reported for Pt(terpy) 
compared to Pt(bpma) and Pt(dien) was attributed to effective communication through π-
backbonding of the in-plane pyridine moieties in the terpy ligand. This was shown to 
increase the electrophilicity of the metal centre and stabilize the five-coordinate transition 
state relative to the ground state during an associative substitution process. In a related 
study, it was found that cis-π backbonding is stronger than trans-π backbonding.9 On the 
other hand, cis-σ-donor effect has been reported to slow down the lability of the leaving 
group in Pt(II) complexes1a, 6,9 through the accumulation of electron on the Pt centre while 
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the trans-σ-donor effect accelerates the rate of substitution reaction by the well-known 
trans labilization effect.10 In recent studies by our group, it was shown that if one of the 
outer pyridine rings in the terpy system is substituted by isoquinoline ligand in the cis-
position, a net cis-σ-donor effect is experienced by the complex, slowing down the lability of 
the leaving group.11 When the pyridine group is replaced by a pyrazine moiety the lability of 
the leaving group is enhanced due to stronger π-acceptor properties of pyrazine as a 
ligand.12 Thus, in principle, such tuning of the lability of the leaving group in Pt(II) 
complexes plays an important role in the development of new antitumour agents. This is 
evident by the number of platinum-based complexes that have been synthesized and 
investigated for their anticancer efficacy since the discovery of [cis-
diamminedichloridoplatinum(II)], (cisplatin) in 1969,13 which is greatly hampered by 
severe side effects and drug resistance.14 
 
To extend my understanding of the role played by σ-donation of quinoline moiety and the 
π-conjugation system on ligand substitution reactions in tridentate monofunctional Pt(II) 
complexes, a series of ligands with quinoline ring systems coordinated to Pt(II) via 
amine/imine bond was undertaken. Based on data available in the literature the 
expectation was that by increasing the electronic communication through π-conjugation the 
reactivity of the Pt(II) centre towards substitution would be enhanced, but this will be in 
competition with quinoline’s σ-donation. Therefore, Pt(II) compounds; bis-(2-
pyridylmethyl)amine platinum(II) chloride, (Pt1), N-(2-pyridinylmethyl)-8-quinolinamine 
platinum(II) chloride, (Pt2), N-(2-pyridinylmethylene)-8-quinolinamine platinum(II) 
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chloride, (Pt3) and bis(8-quinolinyl)amine platinum(II) chloride, (Pt4) were synthesized 
and their kinetics investigated using sulfur donor nucleophiles; thiourea (TU), 1-methyl 
thiourea (MTU), 1,3-dimethyl-2-thiourea (DMTU), and 1,1,3,3,-tetramethyl-2-thiourea 
(TMTU). Thiourea nucleophiles were chosen due to their good nucleophilicity, high 
solubility and can act as good model compound for thiolate and thioether present in the 
cell. The structures of the complexes studied are summarized in Figure 3.1. DFT 




















Pt1 Pt2 Pt3 Pt4  
Figure 3.1: Structures of investigated Pt(II) complexes (charges are omitted for clarity). 
 
3.2 Experimental 
3.2.1 Materials  
All synthetic work was performed under an inert atmosphere of nitrogen. Solvents used for 
synthesis and kinetic measurements were dried by standard methods15 and distilled prior 
to use. Tris(dibenzylideneacetone)dipalladium(0) (97%), rac-2,2’-bis(diphenylphosphino)-
1,1’-binaphthyl (97%), 8-bromoquinoline (98%), 8-aminoquinoline (98%), NaOtBu (97%), 
pyridine-2-carboxyaldehyde (99%), 2-picolylchloride hydrochloride (98%), lithium 
perchlorate (98%), sodium borohydride (98%), 2-picolylamine, BPMA (99%) and thiourea 
nucleophiles were obtained from Aldrich. Potassium tetrachloroplatinate, (K2PtCl4 99.99%) 
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was obtained from Strem. All other chemicals were of analytical grade and were used as 
supplied.  
 
3.2.2 Synthesis of the Ligands 
Bis(8-quinolinyl)amine, (BQA): Into a two necked flask (100 mL) was filled with 
tris(dibenzylideneacetone)dipalladium(0) (22 mg, 0.024 mmol), rac-2,2’-
bis(diphenylphosphino)-1,1’-binaphthyl (29.87 mg, 0.048 mmol) and dry toluene (10 mL) 
under an inert atmosphere of nitrogen. The resulting solution was stirred for 5 min and 8-
bromoquinoline (0.16 mL, 1.201 mmol), 8-aminoquinoline (0.1737 g, 1.205 mmol), and 
additional dry toluene (20 mL) were added. The subsequent addition of NaOtBu (0.1387 g, 
1.437 mmol) resulted in a red solution that was left stirring vigorously for 3 days at 110 ˚C. 
The solution was then allowed to cool and filtered through a silica plug and extracted with 
dichloromethane to ensure complete removal of the desired product. Concentration of the 
collected extracts and removal of solvent yielded a crude red solid. Purification by flash 
chromatography on silica gel (4:1 toluene:ethyl acetate) yielded an orange solid as a 
spectroscopically pure compound. Character identification data for BQA compared 
favourably with that previously reported data.16 Yield: 24.7 mg, Orange solid (76%). 1H 
NMR (CDCl3, 400 MHz,): δ/ppm = 10.64 (s, 1H), 8.92 (dd, 2H), 8.15 (dd, 2H), 7.90 (d, 2H), 
7.53-7.44 (m, 4H), 7.33 (d, 2H). 13C NMR (CDCl3, 400 MHz,): δ/ppm = 148.1, 140.0, 138.8, 
136.2, 129.0, 127.1, 121.6, 117.9 and 110.1. Anal. Calcd. for C18H13N3: C 79.70, H 4.80, N 
15.50. Found C 79.63, H 5.01, N 15.24. TOF MS ES+: m/z, [M+Na]+ = 294.10. 
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N-(2-pyridinylmethyl)-8-quinolinamine, Qui-py: Published method17 was followed with 
minor modifications. To a suspension of anhydrous MgSO4 (20 mmol) in CH2Cl2 (30 mL) 
was added 2-pyridinecarboxaldehyde (5 mmol) followed by 8-aminoquinoline (5 mmol). 
After the mixture had been stirred for 3 h at room temperature, the suspension was filtered, 
washed with CH2Cl2 and the solvent removed under vacuum. The yellow oil which resulted 
was dissolved in 20 mL CH3CN and cooled to -5 ˚C followed by addition of glacial acetic acid 
(0.3 mL, 5 mmol). The resulting imine compound was reduced by careful addition of 
suspension of sodium borohydride (0.3783 g, 10 mmol) in absolute ethanol (10 mL) over a 
period of 1 h at -5 ˚C. A white precipitation was formed. The colour of the solution changed 
from yellow to red by the end of addition. After stirring for 18 h at room temperature, the 
reaction mixture was quenched with 5 M HCl (30 mL) and finally heated at 60 ˚C for 2 h 
until no more hydrogen was evolved. The resultant white precipitate was filtered off and 
the filtrate concentrated in vacuo and then redissolved in water (20 mL). The resulting 
yellow aqueous solution was basified by adding NaOH under ice-water temperature. The 
obtained oil was extracted with ether and dried over MgSO4. Evaporation of the solvent 
yielded brown oil. Yield: 686.7 mg, (63%). 1H NMR (CDCl3, 400 MHz,) δ/ppm =9.82( s,1H), 
8.76(td, 1H), 8.62 (d, 1H), 8.05(ddd, 1H), 7.60 (td, 1H), 7.42-7.29 (m, 2H), 7.14 (dd, 1H), 
7.09(dd, 1H), 6.92(dd, 1H), 6.61 (d, 1H), 4.47 (s, 2H). 13C NMR (CDCl3, 400 MHz,): δ/ppm = 
159.3, 149.3, 147.6, 136.7, 136.3, 127.7, 127.4, 122.0, 121.4, 121.3, 116.3, 114.5, 110.2, 




3.2.3 Synthesis of Platinum(II) Complexes 
The preparations of platinum precursors; Pt(COD)Cl2,18 and cis/trans-PtCl2(SMe2)2 19 were 
carried out following literature procedures and their purity was confirmed by NMR, 
microanalysis and mass spectra. 
 
Pt1: The complex was synthesized according to the literature procedure20 with minor 
modifications. To a solution of K2PtCl4 (0.2 g, 0.48 mmol) dissolved in 0.005 m HCl (100 mL) 
was added bis(2-pyridylmethyl)amine (0.1 mL). The solution was stirred under reflux for 3 
days and then cooled to room temperature. The colourless solution was filtered and 
concentrated to about 10 mL. Addition of saturated NaClO4 solution (2–3 mL) produced the 
precipitate of the desired complex. The title compound was collected by filtration and 
sequentially washed with small amounts of water, ethanol and ether, and dried under 
vacuum. Yield: 242.3 mg, yellow powder (95 %). 1H NMR (DMSO-d6, 400 MHz,): δ/ppm = 
8.82(dd, 2H), 8.60 (br s, 1H), 8.23(ddd, 2H), 7.76 (d, 2H), 7.63 (t, 2H), 4.92(m, 2H), 4.51 (dd, 
2H). 13C NMR (DMSO-d6, 400 MHz): δ/ppm = 167.4, 149.4, 141.4, 125.7, 123.4, 59.4. 195Pt 
NMR (DMSO-d6) δ/ppm: -2344.8. Anal. Calcd. for C12H13N3PtCl2O4: C 27.22, H 2.46, N 7.94. 
Found C 26.72, H 2.45, N 7.62. TOF MS ES+: m/z, [M + H]+ = 430.05. 
 
Pt2: The solution of N-(2-pyridylmethyl)-8-quinolinamine (0.1177 g, 0.47 mmol) dissolved 
in MeOH (5 mL) was added to a refluxing solution of cis/trans-[PtCl2(SMe2)2] (0.1821 g, 
0.47 mmol) in MeOH (15 mL). The solution was allowed to reflux for 12 h to give the olive 
green residue that was collected by filtration, washed with methanol, ethanol and diethyl 
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ether and dried under reduced pressure. Yield: 15.1 mg, (57 %). 1H NMR (DMSO-d6, 400 
MHz,): δ/ppm =8.91 (d, 1H), 8.78(dd, 1H), 8.64 (dd, 1H), 8.54 (dd, 1H), 8.40 (td, 1H), 8.29 
(ddd, 1H), 8.17-8.09 (m, 1H), 7.93 (m, 1H), 7.76 (m, 2H), 7.64 (m, 1H), 7.57 (s, 2H). 13C NMR 
(DMSO-d6, 400 MHz,): δ/ppm = 159.8, 148.7, 147.6, 135.7, 135.3, 128.7, 128.4, 125.0, 122.4, 
121.7, 115.3, 113.5, 109.2, 106.6, 51.1. 195Pt NMR (DMSO-d6) δ/ppm: -2514.8. Anal. Calcd. 
for C15H13N3PtCl2: C 35.93, H 2.59, N 8.38. Found C 35.44, H 2.39, N 7.91. TOF MS ES+: m/z, 
[M+H]+ = 466.04. 
 
Pt3: The complex was synthesized following metal-assisted condensation of pyridine-2-
carboxaldehyde and 8-aminoquinoline as proposed by Bortoluzzi et al.21 whereby a 
suspension of cis/trans-PtCl2(SMe2)2 (0.22 g, 0.57 mmol) in 20 mL of methanol was heated 
to 50 ˚C until the complete dissolution of the complex. A solution containing 8-
aminoquinoline (0.082 g, 0.57 mmol) and pyridine-2-carboxyaldehyde (0.05 mL, 0.57 
mmol) in 10 mL of methanol was added dropwise. The resulting solution was stirred at 
room temperature for 3 h. Subsequently, excess of lithium perchlorate (0.35 g, 2.85 mmol) 
was added. A brown solid started to precipitate slowly. After maintaining the reaction 
mixture at -25 ˚C overnight, the product was filtered, washed with methanol, ethanol and 
diethyl ether. Yield: 218.2 mg, (68 %). 1H NMR (DMSO-d6, 400 MHz,): δ/ppm = 9.88(s, 1H), 
8.86 (dd, 1H), 8.54(d, 1H), 8.50 (dd, 1H), 8.32 (d, 1H), 8.30 (td, 1H), 8.19 (dd, 1H), 7.99 (d, 
1H), 7.62 (ddd, 1H), 7.50 (t, 1H), 7.42 (d, 1H). 13C NMR (DMSO-d6, 400 MHz): δ/ppm = 
166.9, 156.9, 149.0, 150.8, 149.6, 148.8, 147.5, 144.5, 141.4, 140.1, 129.6, 129.1, 126.8, 
9 
 
122.9, 122.1, 120.3. 195Pt NMR (DMSO-d6) δ/ppm: -2536.3 Anal. Calcd. for C15H11N3PtCl2O4: 
C 31.97, H 1.95, N 7.46. Found C 31.48, H1.92, N 7.91. TOF MS ES+: m/z, [M + H]+ = 464.03. 
Pt4: To a reaction vessel containing BQAH (132.1 mg, 0.487 mmol) and (COD)PtCl2 (182 
mg, 0.487 mmol) dissolved in THF (10 mL), triethylamine (88 μL, 0.63 mmol) was added. 
The vessel was sealed and stirred at 95 ˚C for 48 h under nitrogen atmosphere. The 
resulting purple solution was cooled and dried in vacuo, extracted with CH2Cl2 (30 mL), and 
filtered through celite on a sintered-glass frit. The solvent was removed under reduced 
pressure, and the precipitate washed with methanol (3 x 30 mL), hexane (2 x 10 mL) and 
diethyl ether (2 x 10 mL) and then dried in vacuo to give the desired product with spectral 
data consistent with those reported in previous study.16 Yield: 158 mg, purple powder, 
(65%). 1H NMR (CDCl3, 400 MHz,): δ/ppm = 9.17 (d, 2H), 8.24 (d, 2H), 7.64 (d, 2H), 7.45 (t, 
2H), 7.38 (m, 2H), 7.04 (d, 2H). 13C NMR (CDCl3, 400 MHz,): δ/ppm = 148.9, 148.7, 148.4, 
138.8, 131.4, 129.3, 121.2, 115.7, 113.4. 195Pt NMR (DMSO-d6) δ/ppm: -2556.1 Anal. Calcd. 
for C18H12N3PtCl: C 43.16, H 2.40, N 8.39. Found C 42.86, H 1.98, N 7.91. TOF MS ES+: m/z, 
[M]+ = 500.04. 
 
3.2.4 Preparation of Complex and Nucleophile Solutions for Kinetic Analysis 
Platinum(II) complexes of known concentration were prepared by dissolving a specified 
amount in 2 % DMF to enhance the solubility and topped up with 98 % of methanolic 
solvent system of 0.1 M ionic strength (NaClO4/LiCl). Solutions of the nucleophiles were 
prepared shortly before use by dissolving in a 0.1 M NaClO4 solution in methanol whose 
ionic strength had been adjusted by addition of 10 mM LiCl to prevent any solvolysis of the 
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complexes. The ionic strength of the solution was maintained using sodium perchlorate 
monohydrate (NaClO4.H2O) because the perchlorate ion, (
−
4ClO ), does not coordinate to 
Pt(II).22,23 The stock solution of each nucleophile of concentration approximately 50-fold in 
excess of the complex was then diluted with the 0.1 M ionic strength solution to afford 
serial concentrations which were 40; 30; 20 and 10-fold in excess over that of the metal 
complex. These concentrations of the nucleophiles were chosen to maintain pseudo first-
order conditions and to push the reactions to completion.  
 
3.2.5 Instrumentation and Measurements 
1H, 13C and 195Pt NMR spectra were recorded on a Bruker Avance III 500 or Bruker Avance 
III 400 at frequencies of 500 MHz or 400 MHz and 125 MHz/100 MHz using either a 5 mm 
BBOZ probe or a 5 mm TBIZ probe. All proton and carbon chemical shifts are quoted 
relative to the relevant solvent signal. All data were recorded at 30 ̊C unless stated 
otherwise. The mass spectrometric data of the ligands and complexes were acquired on a 
Waters Micromass LCT Premier spectrometer. Selected NMR and mass spectra are 
represented as supporting information in Figures SI 3.1-3.15. Elemental compositions of 
the ligands and complexes were performed on Carlo Erba Elemental Analyzer 1106. A 
Varian Cary 100 Bio UV-Visible spectrophotometer thermostated to within ± 0.05 ˚C was 




3.2.6 Kinetic Measurements 
Spectral changes resulting from mixing of the Pt(II) complex and nucleophile solutions 
were recorded over the wavelength range 200 to 650 nm to establish a suitable wavelength 
for kinetic measurements. The identified wavelengths are summarized in Supporting 
information, (SI) Table S1 3.1. All kinetics reactions were studied as a function of 
concentration and temperature under pseudo first-order conditions. The kinetic data 
obtained were graphically analysed using the software package, Origin 7.5.24 All reported 
rate constants represent an average value of at least three independent kinetic runs for 
each experimental measurement. The temperature dependence of the rate constants were 
studied over a range of 15-35 ∘C at a 5 ∘C intervals with the nucleophile concentration being 
held constant at 30 times the concentration of the metal complex.  
 
3.2.7 Computational Modelling 
Density functional theoretical (DFT) calculations were performed with the Gaussian 09 
program suite25 using the B3LYP method,26 a three parameter hybrid functional method, 
utilizing the LANL2DZ (Los Alamos National Laboratory 2 Double ζ)27 basis set. The 
influence of the bulk solvent was evaluated via single-point computations using the CPCM28 
formalism, i.e., B3LYP(CPCM)/LANL2DZp//B3LYP/-LANL2DZp and methanol as solvent. 





3.3.1 Computational Analysis 
In an effort to understand the interplay of structural and electronic properties of the Pt(II) 
complexes, Density Functional Theoretical (DFT) calculations were undertaken. As 
mentioned earlier computational calculations for all the chloro platinum(II) complexes 
were modelled as cations except for Pt4 complex which was gauged as a neutral 
complex.16,29 The geometry optimized structures and the mapping of the frontier molecular 
orbitals of the complexes are shown in Table 3.1. The key geometric data from DFT 
calculations are presented in Table 3.2. The HOMO-LUMO gap increases in the order of 
2.890 < 3.357 < 3.511 < 3.571 for Pt4, Pt3, Pt2 and Pt1 respectively. One would expect the 
increase in π-conjugation would result in increase in the electrophilicity at the metal centre 
through π-backbonding however; for example in Pt2 complex the direction of the HOMO 
map is on the dz2-orbital of the metal centre signalling lack of or minimum chance of π-
backbonding between the metal centre and the ligand. The LUMO in all complexes is mostly 
centred on the aromatic rings of the ligands with only a small contribution from the d-
orbital on the Pt atom. The electrophilicity index (ω) (Table 3.2) as the measure of energy 
lowering due to maximal electron flow between donor and acceptor for Pt4 is found to be 
very small compared to other complexes indicating that it is a poor electrophile and 
expected to be the least reactive complex in the series. It is evident from the optimized 
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Pt–Nq/py 2.040 2.037 2.037 2.029 
Pt–Nq/py 2.040 2.040 2.047 2.029 
Pt–Cl 2.440 2.437 2.434 2.475 


















Hint: Nq and Npy stands for quinoline and pyridine respectively. 
15 
 
3.3.2 Kinetic Measurements 
Substitution of labile chloride from each of the Pt(II) complexes (Figure 3.1) by neutral 
sulfur containing nucleophiles, viz. thiourea (TU), 1-methylthiourea (MTU), 1,3-dimethyl-2-
thiourea (DMTU), and 1,1,3,3-tetramethyl-2-thiourea (TMTU) was investigated under 
pseudo first-order conditions and followed on a UV-Visible spectrophotometer. Spectral 
changes resulting from mixing the complex and nucleophile (TU, MTU, DMTU and TMTU) 
were recorded over the 200-650 nm wavelength range and typical representative spectra 
with the corresponding kinetic trace as an inset are shown in Figure 3.2. The presence of 
certain isosbestic points in the spectra (at 405 nm) indicates the conversion of the reactants 
to the product(s).30  
 
Figure 3.2: UV-Visible spectra recorded as a function of time for the reaction between 
Pt2 (0.2 mM) and TU (6 mM) at 25 ̊C in MeOH, I = 0.1 M NaClO4/LiCl. Inset: 




All the kinetic traces for the substitution reactions gave an excellent fit to first-order 
exponential decay to generate observed pseudo first-order rate constants, ( obsk ). These obsk  
were plotted against the concentration of the entering nucleophile to generate the second-
order rate constants, 2k  from the slopes. The plots gave straight-line fits with zero 
intercepts as shown in the representative plots in Figure 3.3 (also Figures SI 3.16-3.19) 
for each of nucleophiles suggesting the absence of solvolytic or parallel reactions.22 
Therefore, the rate law can be described by Equation 3.1. The values of the 2k  
representing the direct attack of the nucleophiles on the Pt(II) metal complexes are 
summarized in Table 3.3.  
[ ]Nuobs 2kk =       (3.1) 
where Nu= TU, MTU, DMTU and TMTU. 


















Figure 3.3: Dependence of obsk  on the concentration of entering nucleophile for chloride 
substitution on Pt2 (0.20 mM) in methanol, I = 0.1 M (NaClO4/LiCl), T = 25 °C. 
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Kinetic measurements were also carried out at different temperatures to obtain different k2 
values for calculating entropy of activation (∆S≠) and enthalpy of activation (∆H≠). These 
were obtained from the Eyring plots (Figure 3.4 also Figure SI 3.20-3.23) by treating the 


















ln    (3.2) 
The activation data from the plots are summarized in Table 3.3. 




















Figure 3.4: Eyring plots for the reaction of Pt3 with a series of neutral 






Table 3.3: Summary of 2k  values and activation parameters, ∆H≠ and ∆S≠. 











50.0 ± 0.7 
43.3 ± 0.7 
16.2 ± 0.4 
     3.4 ± 0.04 
50 ± 2 
62 ± 4 
75 ± 3 
77 ± 1 
-130 ± 6 
     -91 ± 15 
     -58 ± 10 











28.6 ± 0.3 
24.0 ± 1.0 
12.8 ± 0.1 
  4.9 ± 0.1 
59 ± 3 
50 ± 2 
51 ± 1 
50 ± 2 
-104 ± 10 
-135 ± 6 
-138 ± 3 










30.6 ± 0.8 
28.8 ± 0.4 
14.3 ± 0.3 
   5.5 ± 0.1 
48 ± 2 
50 ± 1 
52 ± 2 
47 ± 2 
-141 ± 6 
-136 ± 4 
-129 ± 7 










8.9 ± 0.2 
8.1 ± 0.1 
4.8 ± 0.1 
2.8 ± 0.1 
53 ± 1 
49 ± 1 
51 ± 1 
40 ± 2 
-129 ± 2 
-144 ± 5 
-143 ± 3 
-181 ± 7 
 
3.4 Discussion 
The current study focuses on understanding the competing effect of increasing π-
conjugation through fusing the aromatic rings around the Pt(II) metal centre and the net σ-
donor effect of quinoline moiety which has both π-acceptor/donor phenyl as well as 
electron deficient pyridine ring.32 
 
Using the substitution rate constant for coordinated chloro with TU in Pt1, as a reference, 
the reactivity trend follows Pt1 > Pt2 ≃ Pt3 > Pt4 with Pt1 reacting five times faster than 
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Pt4. A similar trend in reactivity is observed for the other nucleophiles as indicated in 
Table 3.3. The observed reactivity of the investigated complexes can be accounted for in 
terms of the electronic effects.  
 
The π-conjugation of the complexes in this study was varied by introducing quinoline ligand 
and the imine bond. The role of extended π-conjugation on reactivity of Pt(II) complexes 
has been reported in literature.1-5,8,11,12 The study showed that the reactivity of the 
associative substitution reaction on Pt(II) metal complexes could be increased stepwise by 
increasing the π-conjugation around the metal starting from Pt(dien) to Pt(terpy).8 Jaganyi 
et al have reported that extending π-conjugation beyond the first pyridine ring surrounding 
the Pt(II) metal centre results in increased substitution reaction in the case of 2’-pyridyl-
1,10-phenanthroline moiety but reduction in case of isoquinoline ligand moiety.11 The 
increase in reactivity due to increase in conjugation as reported in literature1,8,11,12 is 
contrary to the reactivity of the complexes investigated in this study, where Pt4 which is 
highly conjugated is the least reactive complex in the series. This anomaly can be explained 
by looking at the electronic properties of quinoline ligand which is more basic compared to 
pyridine as more resonance structures can be drawn to delocalize the positive charge on 
the conjugate acid.33 The basicity nature of the quinoline ligands means an increase in σ-
inductive effect to the complex which diminishes the π-acceptability of the ligand which is 
in agreement with the fact that quinoline forms a number of charge transfer complexes by 
acting as a σ-donor.34 The net effect of this is destabilization of the 18-electron five 
coordinate transition state resulting in reduced reactivity. 
20 
 
In addition, according to Betley et al.35 bis(8-quinolinyl)amine (BQA) ligand is a typical 
monoanionic when coordinated to a metal centre making the resulting complexes 
appreciably more electron-rich than the Pt(terpy). Therefore, the weak substitution 
behaviour of Pt4 is due to the electron rich environment around the metal centre and the 
poor π-acceptor ability of the quinoline ligand.34,36 This is supported by the DFT calculation 
which shows the electrophilicity index of the complexes as a whole decreases from Pt1 to 
Pt4 with exception of Pt3. This is because the introduction of the imine bond in Pt3 
changes the nature of the trans effect and accounts for its DFT values falling out of the line 
with that of the other complexes. DFT calculation also show that the Pt–Nq bond length is 
shorter in Pt4 compared to the other complexes an indication of stronger σ-interaction 
between the Pt metal and the cis nitrogen atoms. This is supported by NBO charge which 
shows Pt4 to be less positive than the rest. 
 
The increase in π-conjugation is reflected in the HOMO-LUMO energy gap which decreases 
from Pt1 to Pt4 indicating that complexes becomes softer and as such should be more 
reactive.37 This is counteracted by the electrophilicity and the dipole moment of the 
complexes which are in agreement with the reactivity trend. It can therefore be concluded 
that the electron-rich environment around the ligand moiety is responsible for decreasing 
the electrophilicity of the complexes as observed. This in turn retards the entry of the 
incoming nucleophiles through repulsion, slowing the rate of substitution of the chloride. It 
is clear that π-backbonding in these systems is weaker than the dominant σ-donation from 
the quinoline moiety.  
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From the DFT calculations, the π*-orbitals of BQA ligand are of appropriate symmetry to 
mix with a filled metal dπ-orbital, however, the LUMO energies in Pt4(2.284 eV) is very 
high (Table 3.2) in relation to Pt1(-3.396 eV), Pt2(-2.860 eV) and Pt3(-3.595 eV). The rise 
in the LUMO energy describes Pt4 as a poor electrophile37a and is expected to result in 
dampening the general reactivity. The increase in the LUMO energy levels with expansion of 
the π-system observed for Pt4 and Pt2 is attributed to either increase in total antibonding 
character or an increased localization of the π*-orbital on the complexes.38, 39,40 
 
What is observed is that by introducing an imine bond in Pt3 results in a slight increase in 
the reactivity of Pt3 compared to Pt2. This is mostly due to the increase in π-
communication which increases the π-backbonding of Pt(II) metal centre and the change in 
the trans effect.5,41,42 The fact that the reactivity does not almost change moving from Pt2 to 
Pt3 is in support that the net σ-effect around the ligand moiety is stronger and controls the 
reactivity of these complexes. What is also noted from the DFT calculation is that the 
introduction of quinoline increases the planarity of the complexes from Pt1 to Pt4. 
However, even though this has significant effect on the π-backbonding, it had little or no 
effect in influencing the reactivity trend of the complexes investigated. In all Pt(II) 
complexes investigated, the trend in dipole moment is in accord to the reactivity of the 
complexes given that the parameter correlate to the π-withdrawing character of the 
complex.43 Pt1 contain two π-acceptor pyridine rings in cis position relative to the leaving 
ligand. The π-acceptor ligands withdraw electron density from the Pt(II) centre, making it 
more electrophilic for a nucleophilic attack and stabilization of the electron-rich five-
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coordinate transition state. This result in a reduction of the activation barrier and an 
acceleration of the reaction observed for Pt1. 
 
The reactivity of the nucleophiles follows the trend TU > MTU > DMTU > TMTU for all 
complexes and is in agreement with the steric hindrance and their sizes. The large negative 
values of entropy, ≠∆S  and positive enthalpy, ≠∆H  of activation support an associative 
mechanism that is typical of Pt(II) square planar complexes.44,45  
 
3.5 Conclusion 
This study has shown that tuning electronic communication at platinum(II) metal centre 
towards ligand substitution reactions using quinoline-based ligand has an opposite effect to 
that reported for pyridine ligand. It is evident that increasing electronic communication 
without increasing π-backbonding has little effect in increasing the reactivity of Pt(II) 
complex. In Pt4, the electronic communication based on the number of aromatic rings 
jointed together is greater than for the Pt-terpy system but the difference in reactivity is 105 
slower. This is because of the σ-inductive effect of the quinoline ligands towards the metal 
centre which weakens the π-backbonding effect of the aromatic system. This effect is very 
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3.7 Supporting Information (SI)  
The available SI at the end of this chapter includes a number of NMR and mass spectra, 
wavelengths for kinetic measurements, concentration dependence and Eyring plots for 
determination of second order rate constant and activation parameters, planarity and 













































































Figure SI 3.4: 195Pt NMR spectrum of Pt4 
 
 
































Figure SI 3.6: 1H NMR spectrum of Qui-py 
 

















































Figure SI 3.9: 195Pt NMR spectrum of Pt2 
 
































Figure SI 3.11: 1H NMR spectrum of Pt3 
 























Figure SI 3.13: 1H NMR spectrum of Pt1 
 
 



























Table S1 3.1: Summary of the wavelengths (nm) used for monitoring the kinetic 
reactions between a series of Pt(II) complexes with tridentate ligands 
















Pt2 DMTU 368 









 TMTU 443 
 TU 305 
 MTU 288 
Pt4 DMTU 300 











Table SI 3.2: Average observed rate constants, obsk , s-1, for the displacement of the chloro 
ligand in Pt4, Pt2, Pt3 and Pt1 by thiourea, (TU) nucleophile, T = 298 K, I = 
0.1 M NaClO4/LiCl (0.09 M NaClO4 + 0.01 LiCl). 
Pt4 Pt2 Pt3 Pt1 
[TU] /M obsk  /s-1 [TU] /M obsk  /s-1 [TU] /M obsk  /s-1 [TU] /M obsk  /s-1 
0.002 1.93E-4 0.0013 4.31E-4 0.001 2.89E-4 0.001 5.80E-4 
0.004 4.08E-4 0.0026 7.88E-4 0.002 6.31E-4 0.002 0.0010 
0.006 5.44E-4 0.0039 0.0012 0.003 0.0010 0.003 0.0015 
0.008 7.38E-4 0.0052 0.0015 0.004 0.0012 0.004 0.0020 



































Figure SI 3.16:  Dependence of the pseudo first-order rate constants ( obsk ) on 
the entering TU nucleophile concentration for chloride 
substitution on Pt4, Pt2, Pt3 and Pt1 in methanol, I = 0.1 M 










Table SI 3.3: Average observed rate constants, obsk , s-1, for the displacement of the chloro  
ligand in Pt4, Pt2, Pt3and Pt1 by 1-methyl thiourea (MTU) nucleophiles, T = 
298 K, I = 0.1 M NaClO4/LiCl (0.09 M NaClO4 + 0.01 LiCl). 
Pt4 Pt2 Pt3 Pt1 
[MTU]/M obsk  /s-1 [MTU]/M obsk  /s-1 [MTU]/M obsk  /s-1 [MTU]/M obsk  /s-1 
0.002 1.63E-4 0.0013 2.910E-4 0.001 2.920E-4 0.001 4.028E-4 
0.004 3.12E-4 0.0026 5.907E-4 0.002 5.486E-4 0.002 8.125E-4 
0.006 4.82E-4 0.0039 0.0011 0.003 8.468E-4 0.003 0.00124 
0.008 6.50E-4 0.0052 0.0012 0.004 0.00113 0.004 0.0018 


































Figure SI 3.17: Dependence of the pseudo first-order rate constants ( obsk ) on the 
entering MTU nucleophile concentration for chloride substitution on 











Table SI 3.4: Average observed rate constants, obsk , s-1, for the displacement of the chloro 
ligand in Pt4, Pt2, Pt3 and Pt1 by 1,3-dimethyl-2-thiourea (DMTU) 
nucleophile, T = 298 K, I = 0.1 M NaClO4/LiCl (0.09 M NaClO4 + 0.01 LiCl).  
Pt4 Pt2 Pt3 Pt1 
[DMTU]/M obsk  /s-1 [DMTU]/M obsk  /s-1 [DMTU]/M obsk  /s-1 [DMTU]/M obsk  /s-1 
0.002 1.075E-4 0.0013 1.668E-4 0.001 1.916E-4 0.001 3.083E-4 
0.004 2.170E-4 0.0026 3.227E-4 0.002 3.558E-4 0.002 6.171E-4 
0.006 2.939E-4 0.0039 5.107E-4 0.003 5.020E-4 0.003 8.852E-4 
0.008 3.900E-4 0.0052 6.672E-4 0.004 6.223E-4 0.004 0.00118 


































Figure SI 3.18: Dependence of the pseudo first-order rate constants, obsk  on the 
entering DMTU nucleophile concentration for chloride substitution on 










Table SI 3.5: Average observed rate constants, obsk , s-1, for the displacement of the chloro 
ligand in Pt4, Pt2, Pt3 and Pt1 by 1,1,3,3-tetramethyl-2-thiourea (TMTU) 
nucleophile, T = 298 K, I = 0.1 M NaClO4/LiCl (0.09 M NaClO4 + 0.01 LiCl). 
Pt4 Pt2 Pt3 Pt1 
[TMTU]/M obsk  /s-1 [TMTU]/M obsk  /s-1 [TMTU] /M obsk  /s-1 [TMTU] /M obsk  /s-1 
0.002 3.790E-5 0.0013 5.853E-5 0.001 6.319E-5 0.001 6.038E-5 
0.004 7.238E-5 0.0026 1.131E-4 0.002 1.356E-4 0.002 1.306E-4 
0.006 1.038E-4 0.0039 1.557E-4 0.003 1.761E-4 0.003 1.924E-4 
0.008 1.355E-4 0.0052 2.126E-4 0.004 2.166E-4 0.004 2.589E-4 
























Figure SI 3.19: Dependence of the pseudo first-order rate constants, obsk  on the 
entering TMTU nucleophile concentration for chloride 
substitution on Pt4, Pt2, Pt3 and Pt1 in methanol, I = 0.1 M 









Table SI 3.6: Temperature dependence of 2k / M-1 s-1 for the displacement of chloro ligands 
in Pt4, Pt2, Pt3 and Pt1 by thiourea (TU) nucleophile at 30-fold excess over 
[Pt], I = 0.1 M NaClO4/LiCl (0.09 M NaClO4 + 0.01 LiCl). 
Pt4 Pt2 Pt3 Pt1 
T
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2k   
0.00347 -13.9430 0.00347 -13.3801 0.00347 -13.2893 0.00347 -12.836 
0.00341 -13.5717 0.00341 -12.9495 0.00341 -12.85559 0.00341 -12.5203 
0.00336 -13.2137 0.00336 -12.4375 0.00336 -12.57993 0.00336 -12.2018 
0.0033 -12.8647 0.0033 -12.1018 0.0033 -12.2425 0.0033 -11.7880 

























Figure SI 3.20: Eyring plots for the reaction of Pt4, Pt2, Pt3 and Pt1 with TU 












Table SI 3.7: Temperature dependence of 2k / M-1 s-1 for the displacement of chloro ligands 
in Pt4, Pt2, Pt3 and Pt1 by 1-methylthiourea (MTU) nucleophile at 30-fold 
excess over [Pt], I = 0.1 M NaClO4/LiCl. 

































2k   
0.00347 -14.0057 0.00347 -13.3892 0.00347 -13.5594 0.00347 -13.1930 
0.00341 -13.6849 0.00341 -12.9740 0.00341 -13.0862 0.00341 -12.8487 
0.00336 -13.3337 0.00336 -12.6178 0.00336 -12.7712 0.00336 -12.3895 
0.0033 -12.9568 0.0033 -12.3641 0.0033 -12.4632 0.0033 -12.0729 

























Figure SI 3.21: Plots of T
1ln  versus T
1  for the reaction of Pt4, Pt2, Pt3 and Pt1with MTU 














Table SI 3.8: Temperature dependence of 2k / M-1 s-1 for the displacement of chloro ligands 
in Pt4, Pt2, Pt3 and Pt1 by 1,3-dimethyl-2-thiourea (DMTU) nucleophile at 
30-fold excess over [Pt], I = 0.1 M NaClO4/LiCl  
Pt4 Pt2 Pt3 Pt1 
T






































0.00347 -14.5714 0.00347 -14.0292 0.00347 -13.4055 0.00347 -14.4637 
0.00341 -14.1699 0.00341 -13.6484 0.00341 -13.0581 0.00341 -13.8058 
0.00336 -13.8292 0.00336 -13.2767 0.00336 -12.72683 0.00336 -13.2939 
0.0033 -13.5078 0.0033 -12.9819 0.0033 -12.4068 0.0033 -12.8767 



































Figure SI 3.22: Plots of T
1ln  versus T
1  for the reaction of Pt4, Pt2, Pt3 and Pt1 with 











Table SI 3.9: Temperature dependence of 2k / M-1 s-1 for the displacement of chloro ligands 
in Pt4, Pt2, Pt3 and Pt1 by 1,1,3,3-tetramethyl-2-thiourea (TMTU) 
nucleophile at 30-fold excess over [Pt], I = 0.1 M NaClO4/LiCl.  
Pt4 Pt2 Pt3 Pt1 
T
































0.00347 -14.8638 0.00347 -14.9683 0.00347 -15.0448 0.00347 -15.2822 
0.00341 -14.6817 0.00341 -14.6214 0.00341 -14.7858 0.00341 -15.0834 
0.00336 -14.3414 0.00336 -14.253 0.00336 -14.4649 0.00336 -14.8701 
0.0033 -14.0483 0.0033 -13.9947 0.0033 -14.0829 0.0033 -14.7227 




























Figure SI 3.23: Eyring plots for the reaction of Pt4, Pt2, Pt3 and Pt1 with TMTU 
nucleophile at various temperatures in the range of 15-35 ̊C 
 










Figure SI 3.25: Electron density surface painted according to the value of the electrostatic 
potential (ESP) of the investigated complexes. The colours used in 
rendering a mapped surface are based on a uniform scaling between 
minimum and maximum ESP values (in Hartrees) as specified in the text 
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Kinetic and Mechanistic Studies of Cisplatin Analogues Bearing  
2,2'-Dipyridylalkylamine Ligands. 
Abstract 
A series of mononuclear Pt(II) complexes of the type diaqua(2,2’-
dipyridylalkylamine)platinum(II) (where the alkyl group = methyl, ethyl, propyl, butyl and 
hexyl) were synthesized to investigate their substitution behaviour and the influence the 
alkyl chain bonded to the tertiary nitrogen atom joining the two pyridine rings will have on 
the reactivity of the chosen complexes. The trend in rate constant shows that introduction 
of the σ-donating alkyl chain on the tertiary nitrogen joining the two pyridine moieties 
reduces the π-acceptability of the cis coordinated pyridine rings resulting into a less 
reactive Pt(II) centre which cause a decrease in the reaction rate. This is well supported by 
data from DFT calculations. It is also evident that the alkyl chain also brings in the steric 
effect which blocks the approach of the nucleophile to the Pt(II) centre. The boat like 
structure of the six-membered chelate ring also contributes to the steric effect. The study 
has also shown that two substitution processes going through an associative mode of 
activation are observed. The first being the simultaneous substitution of the two aqua 
molecules and the second is due to the dechelation of the ligand an indication of possible 




4.1 Introduction  
The kinetic study on the interaction of various platinum(II) complexes with nucleophiles 
often reveals an important chemical behaviour of these compounds in the area of 
chemotherapy. This work reports the kinetics of Pt(II) complexes featuring 2,2’-
dipyridylamine, (dpa). 2,2’-Dipyridylamine is an aromatic amine which behaves as a neutral 
or monoanionic ligand. The NH group is usually not involved in coordination because of 
geometrical constraints and the two pyridine rings are flexible in their coordination to 
metal centres, leading to different coordination modes such as monodentate, chelating 
bidentate and bridging tridentate.1,-6 It is well established that upon coordination with the 
metal centers, dpa forms six-membered chelate ring with the pyridyl rings adopting either 
nearly co-planar or inclined pyridyl ring planes. This property of dpa and its derivatives 
affect either the electronic or stereo chemical properties of the systems and have been 
observed in a number of metal complexes.7  
 
To date, platinum(II) complexes of 2,2’-dipyridylamine, (dpa) have received increasing 
attention and have been investigated due to their potential use as anticancer agents owing 
to their structural similarity to cisplatin.8,9 Reactions with model nucleobases and 
cytotoxicity of mononuclear complexes with a 2,2’-dipyridylamine ligand system, have been 
extensively studied.10-11 Results show that 2,2’-dipyridylamine unit provides a favourable 
structural feature for an unhindered DNA-complex interaction12 leading to significant 




Substitution reactions on Pt(II) complexes with N-N/N-S bidentate ligands such as 
ethylenediamine (en), bipyridine (bpy), aminomethylpyridine (amp) and 
thiomethylpyridine (mtp) have been investigated.15 Results show that the lability of the 
leaving groups depends on the electronic and steric effect of the bidentate ligand. For 
example, substitution reactions of the complexes cis-[Pt(NH3)2Cl2], [Pt(SMC)Cl2]–, 
[Pt(en)Cl2], and [Pt(dach)Cl2], (where SMC =S-methyl-L-cysteine, en = ethylenediamine and 
dach = 1,2-diaminocyclohexane), follow the trend [Pt(SMC)Cl2]– > cis-[Pt(NH3)2Cl2] 
>[Pt(en)Cl2] > [Pt(dach)Cl2].15a The high reactivity of [Pt(SMC)Cl2]– was attributed to the 
strong trans-labilization effect of coordinated sulfur donor, because the strong σ-donating 
effect of sulfur leads to elongation of the Pt–Cl bond in the trans position and therefore 
making it more labile. Similar results on trans labilizing effect of sulfur were also reported 
by van Eldik et al.15c,e The reactivity of the complexes cis-[Pt(NH3)2Cl2], [Pt(en)Cl2], 
[Pt(dach)Cl2) depends on the steric effects. [Pt(dach)Cl2] is reported to be the most 
sterically congested complex because of the cyclohexane ring which also imparts some 
positive inductive to the metal centre and making it less electrophilic.15a,b In a related study 
where the π-acceptor groups of the bidentate ligand were varied, it was found that the 
electrophilicity on the Pt(II) centre increased due to the electron-withdrawing properties of 
the π-acceptor groups, which results in increasing reaction rates for nucleophilic 
substitution reactions especially when two pyridine rings are adjacent to each other.15d  
 
To extend the understanding on the effect of π-acceptors on the thermodynamic and kinetic 
properties of Pt(II) complexes, a series of five Pt(II) complexes with dpa ligands (Figure 




dypyridylpropylamine)platinum(II), (Ptdppa), diaqua(2,2’-dipyridylbutylamine) 
platinum(II), (Ptdpba) and diaqua(2,2’-dipyridylhexylamine) platinum(II), (Ptdpha) were 
therefore chosen and their kinetic behaviour undertaken so as to provide an understanding 
on their interactions with sulfur-donor nucleophiles. The ligand 2,2’-dipyridylamine chelate 
was altered by incorporating an alkyl group of variable chain length spacing tertiary 
nitrogen of the bidentate chelate. This endowed surfactant properties to the resulting Pt(II) 
complexes known to improve diffusion through cell membrane and hence facilitating their 
entrance into the cell compared to cisplatin.16 For comparison purposes kinetic data for 
Pt(bpy) (where bpy = N,N’-bipyridine) which also contains two pyridine rings in the 
bidentate chelate were included. The two pyridine rings of Pt(dpa) complexes are flexible in 
the coordination compared to that of Pt(bpy). This is expected to affect the electronic 
properties of the Pt(II) centre and hence the substitution reactions. The thiourea 
nucleophiles were chosen because of their good solubility, neutral character, different 
nucleophilicity, steric hindrance, binding properties, and biological relevance.17 In addition, 
thiourea is a very useful nucleophile since it combines the ligand of thiolates (σ-donor) and 































Figure 4.1: Structures of the complexes investigated. 
 
4.2 Experimental  
4.2.1 Chemicals 
Potassium tetrachloroplatinate, K2PtCl4, (99%) was purchased from Strem Chemicals. The 
nucleophiles thiourea (TU, 99%), 1,3-dimethyl-2-thiourea (DMTU, 99%), 1,1,3,3-
tetramethyl-2-thiourea (TMTU, 98%) and ligands methyl iodide (99%), 1-bromoethane, 
(99%), 1-bromopropane (97%), 1-bromobutane (98%), 1-bromohexane and 2,2’-
dipyridylamine (97%) were obtained from Aldrich and used without further purification. 
AgClO4 (99.99%, Aldrich) was stored under nitrogen and used as supplied. Ultrapure water 
(PureLab Systems) was used in all experiments. All other reagents used were of analytical 
grade quality and were used without further purification. 
 
4.2.2 Synthesis of the Ligands 
The ligands namely; (2,2’-Dipyridyl)methylamine, (dpma), (2,2’-Dipyridyl)ethylamine, 
(dpea), (2,2’-Dipyridyl)-1-propylamine, (dppa), (2,2’-Dipyridyl)-1-butylamine, (dpba) and 
(2,2’-Dipyridyl)-1-hexylamine, (dpha) were synthesized using the same procedure11 
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starting from 2,2’-dipyridylamine and their respective bromo alkyl halides. For dpma, 
methyl iodide was used as a precursor. 
 
To a suspension of potassium hydroxide (1.3 g, 0.02 mol) in 15 mL of DMSO, 2,2’-
dipyridylamine (0.0855 g, 0.5 mmol) was added. The mixture was stirred at room 
temperature for 45 min after which respective alkyl halide (0.5 mmol) was added. After 
stirring at room temperature for a further period of 60 minutes, 20 mL of water was added. 
The solution was extracted with diethyl ether (30 mL) and the organic extracts dried over 
MgSO4. The solvent was removed in vacuo to yield the desired ligand. All ligands were 
characterized by NMR spectroscopy and LC-MS and used for complex-formation without 
further purification. 
 
dpma, Brown oil, yield 49.3 mg (53.3 %). 1H NMR (CDCl3, 400 MHz): δ = 8.23 (ddd, 2H), 
7.44 (ddd, 2H), 7.06 (td, 2H), 6.76 (dd, 2H), 3.53 (s, 3H). 13C NMR (CDCl3, 400 MHz): 157.6, 
148.1, 137.1, 116.9, 114.4 and 36.1. TOF MS ES+: m/z [M+H]+ = 186.01.  
 
dpea, Yellow oil, yield 55.4 mg (55.7 %). 1H NMR (CDCl3, 400 MHz): δ = 8.10 (dd, 2H), 7.31 
(dddd, 2H), 6.86 (brd, 2H), 6.64 (dddd, 2H), 4.00 (t, 2H), 1.03(t,3H). 13C NMR (CDCl3, 400 
MHz): 157.0, 148.1, 137.0, 116.8, 114.6, 39.2 and 13.3. TOF MS ES+: m/z [M+H]+ = 200.12. 
  
dppa, Brown oil, yield 54.5 mg (51.2 %). 1H NMR (CDCl3, 400 MHz): δ = 8.15 (dddd, 2H), 
7.36 (dddd, 2H), 6.91 (dddd, 2H), 6.68 (dddd, 2H), 3.96 (t, 2H), 1.55 (m, 2H), 0.76 (t, 3H). 13C 
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NMR (CDCl3, 400 MHz): 157.4, 148.1, 137.0, 116.7, 114.6, 49.81, 21.3 and 36.1. TOF MS ES+: 
m/z [M+H]+ = 214.13.  
 
dpba, Brown oil, yield 60.5 mg (53.3 %). 1H NMR (CDCl3, 400 MHz): δ = 7.93 (dddd, 2H), 
7.15 (dddd, 2H), 6.70 (dddd, 2H), 6.48 (dddd, 2H), 3.78 (t, 2H), 1.28 (m, 2H), 0.98 (m, 2H), 
0.53 (t, 3H). 13C NMR (CDCl3, 400 MHz): 147.8, 136.9, 115.9, 114.7, 47.7, 30.0, 19.9 and 13.7. 
TOF MS ES+: m/z [M+H]+ = 228.15.  
 
dpha, Brown oil, yield 69.6 mg (54.6 %). 1H NMR (CDCl3, 400 MHz): δ = 7.84 (dddd, 2H), 
7.07 (dddd, 2H), 6.62 (brd, 2H), 6.39 (dddd, 2H), 3.68 (t, 2H), 1.20 (m, 2H), 0.83 (m, 6H), 
0.40 (t, 3H). 13C NMR (CDCl3, 400 MHz): 157.0, 147.8, 136.8, 115.7, 114.5, 47.8, 30.5, 27.8, 
25.9, 22.2 and 13.7. TOF MS ES+: m/z [M+H]+ = 256.18. 
 
4.2.3 Synthesis of the Complexes 
The complexes Ptdpma, Ptdpea, Ptdppa, Ptdpba and Ptdpha were synthesized from their 
respective ligands according to a literature method.9b To a stirred red solution of 0.2075 g 
(0.5 mmol) K2PtCl4 dissolved in 25 mL of water, the corresponding ligand (0.5 mmol) 
dissolved in a small amount of water was added. The reaction mixture was stirred 
overnight at 50 °C. The resulting yellow precipitate was collected, washed with water, 
ethanol, methanol and diethyl ether and dried in vacuum. The purity of the complexes was 




Ptdpma, Yield 132.3 mg, (52.3 %). 1H NMR (DMSO-d6, 400 MHz) δ = 8.84 (ddd, 2H), 8.11 
(ddd, 2H), 7.50 (td, 2H), 7.28 (dd, 2H), 3.66 (s, 3H). 13C NMR (DMSO-d6, 400 MHz): 153.5, 
151.6, 141.5, 121.2, 115.3 and 40.9. Anal. % calcd. for C11H11Cl2N3Pt: C 29.27, H 2.44, N 9.31. 
Found: C 28.85, H 2.50, N 8.87. TOF MS ES+: m/z [M+Na]+ = 473.99. 
 
Ptdpea, Yield 94.4 mg, (40.6 %). 1H NMR (DMSO-d6, 400 MHz): δ = 8.10 (dd, 2H), 7.31 
(dddd, 2H), 6.86 (brd, 2H), 6.64 (dddd, 2H), 4.00 (t, 2H), 1.03(t,3H). 13C NMR (DMSO-d6, 400 
MHz): 153.3, 151.8, 141.5, 121.6, 116.9, 45.1 and 13.7. Anal. % calcd. for C12H13Cl2N3Pt: C 
30.97, H2.79, N 9.03. Found: C 30.71, H 2.82, N 8.74. TOF MS ES+: m/z [M+Na]+ = 488.00 
Ptdppa, Yield 136.7 mg, (57.1 %). 1H NMR (DMSO-d6, 400 MHz): δ = 8.81 (dd, 2H), 8.09 
(dddd, 2H), 7.54 (dddd, 2H), 7.29 (dddd, 2H), 4.09 (t, 2H), 1.67 (m, 2H), 1.09 (t, 3H). 13C 
NMR (DMSO-d6, 400 MHz): 153.3, 151.7, 141.4, 121.6, 117.0, 51.9, 20.8 and 11.6. Anal. % 
calcd. for C13H15Cl2N3Pt: C 32.56, H 3.13, N 8.76. Found: C32.67, H 3.15, N 8.40. TOF MS ES+: 
m/z [M+Na]+ = 502.02. 
 
Ptdpba, Yield 256.3 mg, (57.4 %). 1H NMR (DMSO-d6, 400 MHz): δ = 8.81 (dd, 2H), 8.09 
(dddd, 2H), 7.55 (d, 2H), 7.28 (dddd, 2H), 4.11 (t, 2H), 1.64 (m, 4H), 0.90 (t, 3H). 13C NMR 
(DMSO-d6, 400 MHz): 153.3, 151.7, 151.4, 121.6, 116.9, 50.3, 29.6, 19.7 and 14.0. Anal. % 
calcd. for C14H17Cl2N3Pt: C 34.07, H 3.45, N 8.52. Found: C 34.37, H 3.47, N 8.51. TOF MS ES+: 
m/z [M+Na]+ = 516.03. 
 
ptdpha, Yield 108.6 mg, (41.7 %). 1H NMR (DMSO-d6, 400 MHz): δ = 7.84 (dddd, 2H), 7.07 
(dddd, 2H), 6.62 (brd, 2H), 6.39 (dddd, 2H), 3.68 (t, 2H), 1.20 (m, 2H), 0.83 (m, 6H), 0.40 (t, 
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3H). 13C NMR (DMSO-d6, 400 MHz): 153.3, 151.7, 141.4, 121.6, 116.9, 50.3, 31.1, 27.3, 26.5, 
26.2 and 26.0. Anal. % calcd. for C16H21Cl2N3Pt: C 36.85, H 4.03, N 8.06. Found: C 37.14, H 
4.03, N 7.59. TOF MS ES+: m/z [M+Na]+ = 544.06. 
 
4.2.4 Preparation of diaqua Pt(II) complexes  
Solutions of the aqua complexes were prepared by suspending an accurately weighed 
amount of the chloro complex in 0.1 M HClO4 and adding a stoichiometric amount of AgClO4 
(1.98 equiv) with respect to chloro complex. The mixture was then stirred in the dark at  
50 ˚C for 24 h. The white precipitate of silver chloride which formed was filtrated through a 
0.45-μm nylon membrane filter using a Millipore filtration unit. The clear, colourless filtrate 
was then made to the required concentration in a volumetric flask using a solution of 0.1 M 
HClO4. The use of the acidic solution at pH 1 was necessary to ensure that only the aqua 
complex, and not a mixture of the aqua and hydroxo complexes, was present in solution 
once the metathesis reaction was complete, and also, to ensure a constant ionic strength of 
0.1 M. This solution was used in the titration with NaOH solution to determine the pKa of 
the complexes whilst for kinetic investigations; the pH of the solution was maintained at 2 
based on the pKa study and the ionic strength was maintained at 0.1 M using NaClO4.  
 
4.2.5 Instrumentation and Measurements 
1H, 13C and 195Pt spectra were recorded on a Bruker Avance III 500 or Bruker Avance III 400 
at frequencies of 500 MHz or 400 MHz (1H) and 125 MHz/100 MHz using either a 5 mm 
BBOZ probe or a 5 mm TBIZ probe. All proton and carbon chemical shifts are reported 
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relative to the relevant solvent signals at 30 °C unless stated otherwise. Elemental 
compositions of the ligands and complexes were performed on a Thermo Scientific Flash 
2000. The pH of the aqueous solutions of the complexes were measured using a Jenway 
4330 Conductivity/pH meter equipped with a 4.5 µm diameter glass electrode. The 
electrode was calibrated at 25 ˚C using standard buffer solutions of pH 4.0, 7.0 and 10.0 
(Merck). The electrolyte of pH electrode was replaced with 3.0 M NaCl to prevent the 
precipitation of KClO4 during pH measurement. The mass spectral data of the ligands and 
complexes were acquired on a Waters Micromass LCT Premier spectrometer. Kinetic 
studies for fast reactions were monitored using an Applied Photophysics SX 20 stopped-
flow spectrophotometer coupled to an online data acquisition system. Slow reactions were 
monitored using a Varian UV-Visible Cary 100 spectrophotometer. The temperature of 
these instruments was controlled throughout all kinetic experiments to ± 0.02 ˚C. pKa and 
kinetic traces were graphically analysed using the software package, Origin 7.5.21  
 
4.2.6 pKa Determination 
In order to avoid formation of hydroxo species during kinetic studies it was important to 
determine the pH range within which the complexes exist in their aqua form. The measured 
pKa data are helpful in explaining the substitution lability of the aqua ligands in the metal 
complex as the pKa values of coordinated water serve as an experimental indicator for the 
electron density around the metal centre. A low pKa value is associated with the most 




To determine pKa values, the solution of the complex of known concentration was 
spectrophotometrically titrated with NaOH within the pH range of 1-10 at 25 ˚C. To avoid 
dilution effects due to the addition of the titrant, a large volume (150 mL) of the complex 
was used for the titration. To circumvent adding a large volume of NaOH to effect the 
change in pH within the pH range of 1-3, small granules of crushed NaOH pellets were 
added to the solution. Between a pH range of 4-10, various concentrations of NaOH 
solutions were used making sure that there was an even distribution of the UV-Vis spectra. 
To avoid contamination of the complex solution by chloride ions leaching from the pH 
electrode, it was necessary to take 0.6 mL aliquots from the complex solution, which was 
then transferred into narrow vials for the pH measurements. These were then discarded 
after each measurement. The reversibility of the titration was also tested using aqueous 
solutions of perchloric acid.  
 
4.2.7 Kinetic Measurements  
All kinetic measurements were performed under pseudo first-order conditions by making 
sure that the concentration of the nucleophile was at least 20-fold in excess to the 
concentration of Pt(II) complexes. This was to ensure that the reaction goes to completion. 
All the substitution reactions involving aqua complexes were studied at pH 2. Concentration 
dependence study of the complexes was performed at 25 °C. Reported rate constants in 
Table 4.4 represent an average value of at least three to five independent kinetic runs for 
each set of experimental conditions on UV-Visible and Stopped flow spectrophotometers 
respectively. The activation parameters, ΔH# and ΔS#, were obtained by studying the 
temperature dependence of the rate constant in the temperature range of 15-35 °C at an 
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interval of 5 °C with the nucleophile concentration held constant at 80 times the 
concentration of the metal complex.  
 
4.2.8 Computational Analysis 
Density functional theoretical (DFT) calculations were performed with the Gaussian 09 
programme suite.22 Geometrical optimizations were carried at B3LYP/LanL2DZ level of 
theory. B3LYP refers to a three parameter functional hybrid exchange of Becke23 with 
functional correlation gradient of Lee, Yang and Parr,24,25 whereas LanL2DZ refers to Los 
Alamos National Laboratory 2 Double ζ 26 basis set. The singlet states were used due to low 
electronic spin of Pt(II) complexes. The aqua complexes were each modelled at +2 with 
respect to their total charges. 
 
4.3 Results 
4.3.1 Acidity of the Aqua Complexes  
The acidities of the coordinated diaqua ligands on the Pt(II) complexes were determined 
through spectrophotometric titration. A typical plot of the UV-Visible spectra obtained 
during the course of the titration of the complex Ptdpba with NaOH is shown in Figure 4.2. 
Inset to the figure is the plot of absorbance versus pH at 290 nm for the Ptdpba. When the 
data points of the plot of absorbance versus pH were fitted on standard sigmoid equation 
using Origin 7.521 it revealed that two dissociation steps were involved. This was observed 
for each of the investigated complexes. The overall process can therefore be presented by 
the equilibrium reaction given in Scheme 4.1. The pKa values obtained are summarized in 
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Table 4.1 and as stated before for comparison purposes included in the table is the pKa 
value of Pt(bpy). The results show that by changing the length of the alkyl group attached 
to the spacing tertiary nitrogen of the bidentate chelate has insignificant influence on the 
deprotonation of the aqua molecules as the pKa values are similar in magnitude, true for 




























Scheme 4.1: Schematic presentation of the acid-dissociation equilibria of the investigated 
complexes. 
 
Table 4.1: Observed pKa values for the deprotonation of Pt-bound aqua ligands for each 
of the mononuclear Pt(II) complexes investigated. 
Complex Ptdpma Ptdpea Ptdppa Ptdpba Ptdpha Pt(bpy) 
pKa1 5.24 ± 0.07 5.27 ± 0.02 5.31 ± 0.03 5.36 ± 0.08 5.45 ± 0.12 4.80* 
pKa2 6.19 ± 0.04 6.29 ± 0.07 6.29 ± 0.02 6.31 ± 0.06 6.35 ± 0.11 6.32* 




Figure 4.2 UV-Visible spectra of the titration of Ptdpba with NaOH (pH range1-10). 
Inset: Plot of absorbance versus pH at 290 nm for the Ptdpba. 
 
It is also observed that deprotonation of the second coordinated water molecule to the 
dihydroxo species occurs at higher pH values than in the first step in all the five complexes. 
This results from a reduction of the overall charge to +1 after deprotonation of one 
coordinated water molecule. Hence, the Pt(II) centre of the aqua/hydroxo species is less 
electrophilic compared to that of the diaqua complex,27-30leading to higher pKa2 values. The 
lower pKa values of Pt(bpy) is ascribed to the rigid and planar π-acceptor pyridine moieties 
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cis to the aqua ligands which help to stabilize the electron density of the hydroxo ligands 
formed making the complex more electrophilic and acidic.  
 
4.3.2 Computational Studies 
The geometry optimized structures and the mapping of frontier molecular orbitals are 
presented in Table 4.2. The bidentate dpa ligand coordinates the metal centres via its two 
nitrogen donor atoms forming a six-membered chelating ring which exists in a boat 
conformation due to high flexibility of the nitrogen linker between the coordinative 
pyridines. Two aqua ligands complete the coordination spheres, resulting in a square-
planar geometry around the metal centre. The two heterocyclic rings of dpa form a dihedral 
angle in a range of 38˚-42˚. The basal angle around the Pt centre of all complexes with 
respect to cis pyridine rings lies between 113-119˚ (Figure 4.3 and Figure SI 4.28). The 
calculated bond lengths and angles (Table 4.3) fit well with the values given in literature 
for the chloro complexes of Pt(II) and Pd(II).10d  
 
Mappings of the frontier orbitals indicate that for all investigated complexes, the HOMOs 
are localized mainly on the platinum metal with significant contribution from the pyridine 
rings and the (CH2)n units of the alkyl chain. The LUMOs of these complexes are 
symmetrically delocalised on the Pt atom, pyridine nitrogens and on aqua groups. Because 
of the location of HOMO and LUMO, an electron-donating effect would be expected to 
increase electron density on the complex as a whole, raise the HOMO energy, and 
destabilize the LUMO. The individual energy levels of HOMO and LUMO increase with the 
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length of the aliphatic chain from Ptdpma to ptdpha. This trend can be explained by the 
increase in σ-donicity of the alkyl chain to the pyridyl side arms which increases with an 
increase in length of the alkyl chain. Literature shows that presence of electron donating 
groups in a system increases the energy of the molecular orbitals.31-34  
 
Included in Table 4.3 is global chemical reactivity descriptor for electrophilicity indices of 
the complexes calculated using a literature method.35 Electrophilicity values of the 
complexes (Table 4.3) follow the trend Ptdpha < Ptdpba < Ptdppa < Ptdpea < Ptdpma. 
Among the complexes, Ptdpha is the weakest electrophile whilst Ptdpma is the strongest 
electrophile. It is worth noting that the NBO charges of the Pt atom are of the same 





Figure 4.3: DFT-Optimized structures of Ptdpha showing dihedral angle, steric hindrance 




Table 4.2: Geometry optimized structures and DFT-calculated (B3LYP/LanL2DZ HOMOs 
and LUMOs for the investigated complexes. 
Complex  HOMO LUMO Planarity 
 
Ptdpma 
   
 
Ptdpea 







   
 
Ptdpha 
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Ptdpma Ptdpea Ptdppa Ptdpba Ptdpha 









-8.794 LUMO /eV 
HOMO/eV -12.913 -12.872 -12.793 -12.785 -12.723 
∆E /eV 3.819 3.971 3.931 3.952 3.929 
Reactivity descriptors 


































Dipole moment (debye) 2.678 3.648 4.803 5.209 6.469 
Bond Length (Å)      
Pt–O1 2.125(46) 2.128(58) 2.128(93) 2.126(98) 2.125(46) 
Pt–O2 
2.125(62) 2.128(66) 2.128(90) 2.126(23) 2.125(62) 




















177.949 177.812 177.953 178.514 178.605 
N1–Pt–N2 87.973 87.717 87.763 87.722 87.651 
O1–Pt–O2 87.506 86.878 86.835 87.623 87.396 




4.3.3 Kinetic Measurements 
Spectral changes resulting from mixing of the Pt(II) complex and nucleophile solutions 
were recorded over the wavelength range 200 to 600 nm to establish a suitable wavelength 
at which kinetic measurements could be performed. The selected wavelengths are 
summarized in Table S1 4.1. The substitution reactions of the aqua complexes by a series 
of neutral nucleophiles, viz. TU, DMTU, and TMTU were investigated as a function of 
concentration and temperature. All the reactions showed two independent substitution 
steps (Scheme 4.2). While the first step fitted on the stopped flow, the second step was too 
slow and was followed by conventional UV-Visible spectroscopy for only the two less 
sterically hindered nucleophiles TU and DMTU. The reactions with TMTU were too slow 
taking more than five days to go to completion. 
+ Nu + Nu + ligand
k2k1
R = methyl, ethyl, propyl, butyl and hexyl
Nu = Nucleophile


















Scheme 4.2: Proposed mechanism of aqua substitution from the investigated Pt(II) 
complexes and the thiourea nucleophiles at pH 2.0. 
 
The first substitution step was initiated by mixing equal volumes of a solution of the Pt(II) 
complex with a solution of the nucleophile directly in the stopped-flow instrument set at a 
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selected wavelength. An example of the kinetic trace is shown in Figure 4.4. Typical UV-
Visible spectra obtained for the second substitution step is shown in Figure 4.5 and inset to 
the Figure is the corresponding kinetic trace at 315 nm  














Figure 4.4: A typical kinetic trace for two step reaction between Ptdppa (0.25 mM) and 
TU (20 mM) recorded at 290 nm, T = 298 K, pH = 2.0, I = 0.1 M (NaClO4) on 






Figure 4.5: UV-Visible spectra recorded during the reaction of 0.25 mM Ptdppa with  
30 mM thiourea at 25 °C and pH 2 (I = 0.1 M, NaClO4). Inset: Kinetic trace 
recorded at 315 nm. 
 
In both steps, the kinetic traces for the ligand substitutions gave excellent fits to a single 
exponential function to generate the pseudo first-order rate constants, 2 or obs1k  for the first 
and second substitution steps respectively at specific nucleophile concentrations and 
temperature. The second-order rate constants, 1k  and 2k  of the reactions (where 1k = rate 
constant for the first step and 2k = rate constant for the second step) were obtained from 
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the linear regression of the plot of 2 or obs1k  versus nucleophile concentration using origin 
7.5®.21 
 
Representative plots for each of the investigated nucleophiles show a linear dependence on 
the concentration of the incoming nucleophile and is shown in Figure 4.6 (also Figures SI 
4.19-4.21 and SI 4.25). The linear regression plots have zero intercepts which suggests 
that the mechanistic pathway is independent of the solvent effect.  







































        (b) 
Figure 4.6: Concentration dependence of 2 or obs1k  for the substitution of aqua from 
Ptdpha (0.25 mM) by thiourea nucleophiles for (a) the first and (b) the 
second substitution steps at pH 2, I = 0.1 M NaClO4 and 25 ∘C. 
 
The proposed equations for the two substitution steps can be represented by Equation 4.1. 
][21 Nuor2 or obs1 kk =        (4.1) 
The activation parameters; the enthalpy of activation, ∆H#, and entropy of activation, ∆S#, of 
each substitution step were determined by studying the temperature dependence of the 
rate constants, 1k  and 2k  at a fixed nucleophile concentration. Typical plots are shown in 
Figure 4.7 (also Figures SI 4.22-4.24) and the corresponding values were calculated using 
the Eyring equation.36 A summary of rate constants and activation parameters for the first 










































Figure 4.7: Eyring plots for the determination of the thermal activation parameters for 
(a) the first and (b) the second substitution steps of 0.25 mM Ptdppa for the 
nucleophiles studied at pH 2 (I = 0.1 M NaClO4)  
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Table 4.4: Summary of second order rate constants and activation parameters for the first and second substitution steps 
 



















38.7 ± 0.6 
48.8 ± 0.5 
22.8 ± 0.4 
106 ± 3 
     2.4 ± 0.1 
- 
     41± 0.5 
    40 ± 0.5 
40 ± 1 
27 ± 1 
    36 ± 0.5 
- 
-115 ± 2 
-115 ± 2 
-122 ± 4 
-193 ± 3 







36.8 ± 0.7 
28.5 ± 0.6 
16.7 ± 0.2 
8.6 ± 0.3 
2.2 ± 0.1 
- 
39 ± 2 
42 ± 1 
38 ± 1 
37 ± 2 
46 ± 1 
-133 ± 6 
-122 ± 3 
-142 ± 3 
-127 ± 6 







23.7 ± 0.3 
18.9 ± 0.4 
  7.7 ± 0.1 
7.4 ± 0.4 
1.4 ± 0.1 
- 
41 ± 1 
43 ± 1 
40 ± 2 
24 ± 2 
    25 ± 0.6 
- 
-119 ± 3 
-115 ± 3 
-132 ± 6 
-185 ± 6 







20.6 ± 0.3 
17.0 ± 0.1 
   7.4 ± 0.2 
5.0 ± 0.2 
   1.2 ± 0.05 
- 
41 ± 2 
44 ± 1 
39 ± 2 
40 ± 2 
37 ± 2 
- 
-121 ± 6 
-113 ± 3 
-137 ± 6 
-125 ± 6 







16.0 ± 0.1 
14.9 ± 0.2 
  6.2 ± 0.1 
4.3 ± 0.1 
0.7 ± 0.01 
- 
44 ± 1 
   47 ± 0.4 
79 ± 3 
22 ± 1 
39 ± 1 
- 
-113 ± 3 
-105 ± 1 
-120 ± 9 
-157 ± 3 
-169 ± 3 
- 
Pt(bpy)a TU 5080 ± 275 1119 ±22 45 ± 2 34 ± 2 -24 ± 7 -73 ± 5 
aData extracted from reference 15d. 
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To further understand the kinetics of the second and slower step of the reaction, the ligand 
substitutions of Ptdppa-Cl was followed using 1H and 195Pt NMR. An array of the 1H NMR 
spectra (showing only the aromatic resonances) for the reaction between Ptdppa-Cl and 
excess TU (six equivalents) is shown in Figure 4.8. The pyridyl protons were chosen to 
monitor the progress of the reaction as they are in a close proximity with the N-donor atom 
bonded to the metal centre. The numbering scheme employed for the pyridyl protons is 











Scheme 4.3: The numbering scheme employed for the pyridyl protons of Ptdppa-Cl2 
 
Figure 4.8: 1H NMR spectra of Ptdppa-Cl2 acquired during the reaction with TU 6 equiv. 




The resonances of the unreacted Ptdppa-Cl2 protons labelled H5, H4, H3 and H2 appear at  
δ = 8.82, 8.10, 7.55 and 7.28 ppm respectively with the 195Pt NMR peak at δ = -2178.9 ppm 
(Figure 4.9). The 1H and 195Pt NMR spectra show that within the time scale of the reaction 
only two main products had been formed. These are identified as uncoordinated dppa 
ligand with its aromatic protons appearing at δ = 8.29, 7.62, 7.11 and 6.93 ppm for H5’, H4’, 
H3’ and H2’ respectively and the 195Pt peak at δ = -3914.2 ppm corresponding to Pt(TU)4. No 
intermediate peaks were observed in the 195Pt NMR spectra during the course of reaction 
thus, the coordinated aqua ligands are simultaneously substituted from Pt(II) centre in the 
first step. The disappearance of the original 1H and 195Pt NMR peaks of Ptdppa-Cl2 and the 
appearance of the 195Pt NMR peak at δ = 3914.2 ppm corresponding to Pt(TU)4 all support 
the proposed reaction given in Scheme 4.2. 
 
Figure 4.9: 195Pt NMR spectra of Ptdppa-Cl2 acquired during the reaction with TU  





As stated before all substitution reactions were characterized by two steps. The first step 
involves simultaneous displacement of the aqua ligands and the second step involved 
dechelation of the dipyridylalkylamine ligand following the coordination of further thiourea 
nucleophiles to the Pt(II) centre. This conclusion was arrived at after monitoring the 
reaction between Ptdppa-Cl2 and TU (excess) by 1H and 195Pt NMR spectroscopy.  
 
It is well known from the literature that 195Pt NMR is effective in identifying the species in 
the solution. The 195Pt chemical shifts are influenced by all the ligands in the coordination 
sphere of the Pt atom and are highly sensitive to the nature of the binding atoms.37,38 The σ-
bond between the ligand and the metal (L⤍M) reduces the electron density on the ligand 
and increases it on the Pt atom. If there is a back-donation of π electrons (M⤍L), the 
electron density is then reduced on the Pt atom and is increased on the ligand. In lieu of 
most ligands, π-bonding is not very important, and a deshielding effect is observed on the 
ligand. For a series of Pt complexes, the resonance is shifted toward higher fields (more 
negative) when the donor atom varies from chlorine, nitrogen and sulfur in the following 
order Cl < N < S. Platinum complexes have chemical shifts of [PtN3Cl] at δ = -1700 to -2369 
ppm,38,39, [PtN2Cl2] at δ = -1900 to -2400 ppm,38 [PtN3S] at δ = -2800 to-3200 ppm,39,40 
[PtN2S2] at δ = -3100 to -3500 ppm41 and [PtS4] at δ = -3800 to -4800 ppm38 while a value 
near δ = -5900 ppm is indicative of five coordinated sulfurs.42 The peak of the unreacted 
Ptdppa-Cl2 at δ = -2178.9 and a new peak at δ = -3914.2 ppm are therefore, mainly due to 
[PtN2Cl2] and [PtS4] after decoordination of dppa ligand. The assignment of these peaks in 
195Pt NMR spectra to [PtN2Cl2] and [PtS4] coordination spheres is in agreement with that 
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reported in literature.38,42 Furthermore, taking the solvent used into account, the chemical 
shifts of the aromatic protons in spectrum resulting after addition of TU (excess) to the 
Ptdppa-Cl2 correspond well with those of the dppa free ligand (See Figure SI 4.26).  
 
Based on the 1H NMR spectroscopy together with 195Pt NMR results all support the 
proposed reaction Scheme 4.2. Therefore it is reasonable to conclude that the presence of 
strong labilizing thiourea nucleophiles at the Pt(II) centre enhances ring opening of the 
bidentate ligand attached to the metal centre leading to metal-ligand dissociation upon 
exposure to excess TU. Results on ring opening influenced by the strong labilizing effect of 
thiourea nucleophiles have been reported by Jaganyi et al.28,43 
 
Taking the simultaneous substitution reaction of the aqua molecules with TU as a reference, 
the rate constant of the complexes (Table 4.4) decreases in the order of 38.7 > 36.8 > 23.7 
> 20.6 > 16.0 M-1 s-1 for Ptdpma, Ptdpea, ptdppa, ptdpba and Ptdpha respectively. The 
difference in reactivity can be ascribed by the steric hindrance and electronic effect of the 
pendant alkyl chain bonded on the tertiary nitrogen joining the cis pyridine rings. In all the 
five complexes, the pendant alkyl chain on the tertiary nitrogen is sticking out of the plane 
blocking the approach of the nucleophile from either the top or bottom of the square planar 
geometry depending on its length. In Ptdpma and Ptdpea, the chain is not long enough to 
block the entry of the nucleophile from both sides so the nucleophile can easily attack the 
Pt(II) centre from either side resulting into higher rate of substitution reaction. However, 
for Ptdppa, PtPtdpba and Ptdpha the aliphatic chain is bending downwards and so blocks 
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the approach of the nucleophile from both sides of the square planar Pt(II) contributing to 
the lowering of reaction rate.  
 
The individual HOMO and LUMO energies increase with an increase in alkyl chain length 
resulting into destabilization of the energies of both the HOMO and LUMO.44 This affects 
electrophilicity of the complexes45 as revealed in Table 4.3 that the electrophilicity index 
decreases with an increase in σ-donicity of the aliphatic chain. The electronic effect of the 
alkyl chain to the tertiary nitrogen and to the pyridine nitrogen’s is supported by their 
dipole moments and NBO charges shown in Table 4.3. The tertiary nitrogen becomes more 
negative with increase in alkyl chain length and so the pyridine nitrogen’s. This causes the 
accumulation of the electron density into the LUMO type of the pyridyl rings making them 
weak π-acceptors hence less reactive Pt(II) centre towards substitution reaction. The 
decrease in reactivity of the complexes on moving from Ptdpma to Ptdpha in addition to 
the steric hindrance is also controlled by the σ-donation of electron density to the complex 
brought by the alkyl group through tertiary nitrogens which then destabilizes the transition 
state resulting into slow substitution reactions. On the other hand, slight changes in 
reactivity of the complexes with the increase in aliphatic chain length (from Ptdppa to 
Ptdpha) suggest that the bendiness of the chain reduces the sigma donation. The apparent 
increase in dipole moments by 1 debye with subsequent addition of -(CH2)n- fragment from 
Ptdpma to Ptdpha except from Ptdppa to Ptdpba where the increase is only 0.4 debye is 





A comparison also reveals that dpa Pt(II) complexes are generally less reactive towards 
thiourea nucleophile by two orders of magnitude compared to bipyridine Pt(II) complex, 
Pt(bpy) reported preveously.15d This is because dpa is a less π-acceptor ligand than 
bipyridine (bpy).47 In addition, dpa coordinates with six-membered chelate rings instead of 
five-membered rings for bpy thus Pt(bpy) complex is rigid and planar with both pyridine 
moieties situated within the plane resulting in a very efficient π-back donation of the 
incoming electron density from the nucleophile to the pyridine chelate.15d This stabilizes 
the five-coordinate transition state relative to the ground state, since the ground state 
cannot benefit much from the π-back donation given that the 6pz orbital of the Pt centre is 
empty and hence enhancement of the reaction rate. On contrary, the bidentate chelate 
system in dpa Pt(II) complexes investigated in this study is more flexible adopting tilted 
pyridyl ring planes which then thwarts the flow of π-electrons around the ring rendering 
poor π-acceptor ability of the ligand and steric retardation on the metal centre towards the 
approach of the nucleophile. 
 
The slower second substitution step can be ascribed to substitution of the labilised Pt-
pyridinic N bonds trans positions to two TU molecules, as a result of the strong trans effect 
of S-donor nucleophiles following their coordination to the soft Pt(II) centre. Having a 
closer look on this second substitution step, it is forty times slower than the first step in all 
the investigated complexes. The presence of the two thiourea groups after the first 
substitution step makes the Pt(II) centre more crowded and sterically hindered. In addition 
due to the σ-donation of the thiourea towards the Pt(II) centre makes it difficult for another 
nucleophile to attack. This accounts for the observed slow rate of reaction in comparison to 
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the aqua substitution noting also that the leaving groups are different. This same reason 
explains why the second substitution reaction using the most sterically hindered 
tetramethyl thiourea (TMTU) nucleophile could not be followed. 
Generally, the substitution of coordinated aqua ligands by the more sterically hindered 
nucleophiles DMTU and TMTU shows a clear dependence on the steric bulk of the 
nucleophiles.28,43,48-49 For example, the values of the rate constants for the first substitution 
step of Ptdpea decrease in the order TU (36.8) > DMTU (28.5) > TMTU (16.7). The most 
sterically hindered nucleophile TMTU shows the lowest reactivity reflecting the steric 
effects characteristic of a mechanism involving bond making in the transition state. 
However, the first substitution step for Ptdpma shows that DMTU reacts faster than TU. 
This can be explained by the increase in basicity of its sulfur donor atom caused by the σ-
donation of electrons by the two methyl group relative to that of TU which outweighs any 
steric contribution.50 
 
For all investigated complexes, the enthalpies of activation, (∆Η#), are small and positive 
whereas activation entropies, (∆S#) are large and negative. This confirms the associative 
mode of activation for all investigated complexes and substitution steps.51  
 
4.5 Conclusion 
The novel dpa Pt(II) complexes (Ptdppa and Ptdpha) and Ptdpma, Ptdpea and Ptdpba 
were synthesized and the kinetics of ligand substitution with thiourea nucleophiles were 
studied. In all complexes, two substitution steps were observed corresponding to the 
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simultaneous displacement of the aqua ligands and dechelation of the dpa ligand by 
thiourea nucleophiles. For both substitution steps, it was found that the reactivity of the 
metal centre decrease with the increase in length of aliphatic chain attached on the tertiary 
nitrogen bridging the cis coordinated pyridyl units. The trend in reactivity is attributed to 
the steric hindrance of the alkyl chain which blocks the attack of the nucleophile from either 
the top or bottom side of the Pt(II) centre.  
 
In addition, the σ-donor effect of the pendant alkyl chain towards the tertiary bridging 
nitrogen is felt in the cis pyridine rings resulting into the decrease in their π-acceptor 
ability. The decrease in reactivity of the Pt(II) complexes with the increase in length of the 
alkyl chain is also supported by the dipole moments and the calculated electrophilicity 
indices. The decrease in enthalpy of activation, (∆Η#) with an increase in the reaction rate 
and the more negative entropy of activation, (∆S#) is an indication of the low energy 
transition state compared to the reactant state. This enthalpies and entropies of activation 
confirm an associative mode of activation common in many Pt(II) complexes. 
 
Furthermore, the systematic tuning of the 2,2'-dipyridylalkylamine chelate ligands as 
shown in this work represents the possibility of having Pt(II) complexes with different 
steric and electronic behaviour which might improve the cellular activity of the Pt(II) 
compared to cisplatin through increased cellular uptake brought by the surfactant effect of 
the alkyl chain. Possible concern is the likelihood of disintegration of these complexes if 
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4.7 Supporting Information (SI)  
Representative NMR, mass spectra and pH titration spectra, summary of wavelengths used 
for kinetics, concentration dependence and Eyring plots and HOMO-LUMO energy diagram 








































Figure SI 4.2: 1H NMR spectrum for Ptdpma in DMSO. 
 
























Figure SI 4.4: 1H NMR spectrum for Ptdpea in DMSO. 
 









































Figure SI 4.7: 195Pt NMR spectrum for Ptdppa in DMSO. 
 






































Figure SI 4.10: 195Pt NMR spectrum for Ptdpba in DMSO. 
 









































Figure SI 4.14: Mass spectrum for Ptdpha in DMSO. 
 
Table SI 4.1. Summary of the selected wavelength used for kinetics studies for the first  
and second substitution steps. 
Complex  Nucleophiles  Wavelength, (nm) 
   
TU 
 1st step 2nd step 










  TU  290 340 
Ptdpea  DMTU  286 345 













TMTU  355 355 
  TU  290 310 
Ptdpba  DMTU  287 335 



















Figure SI 4.15: UV-Vis spectra of the Ptdpma diaqua complex recorded as a function 
of pH in the range 1 to 10. Inset: Plot of absorbance versus pH at 280 





Figure SI 4.16: UV-Vis spectra of the Ptdpea diaqua complex recorded as a function of 
pH in the range 1 to 10. Inset: Plot of absorbance versus pH at 290 nm 





Figure SI 4.17: UV-Vis spectra of the Ptdppa diaqua complex recorded as a function of 
pH in the range 1 to 10. Inset: Plot of absorbance versus pH at 290 nm 





Figure SI 4.18: UV-Vis spectra of the Ptdpha diaqua complex recorded as a function of 










Table SI 4.2: Average observed rate constants, obsk , s-1, for the first displacement of the 
aqua ligands in Ptdpma, Ptdpea, Ptdppa, Ptdpba and Ptdpha by thiourea, 
(TU) nucleophile, T = 298 K, pH = 2, I = 0.1 M NaClO4 





















0.005 0.184 0.0018 0.063 0.005 0.13 0.005 0.112 0.005 0.081 
0.0075 0.291 0.0027 0.094 0.0075 0.177 0.0075 0.151 0.0075 0.114 
0.01 0.397 0.0036 0.134 0.01 0.230 0.01 0.205 0.01 0.159 
0.0125 0.501 0.0045 0.159 0.0125 0.294 0.0125 0.250 0.0125 0.200 




























Figure SI 4.19: Dependence of obsk  on the entering TU nucleophile for the first 
displacement of the aqua ligands in Ptdpma, Ptdpea, Ptdppa, Ptdpba 











Table SI 4.3: obsk , s-1, for the first displacement of the aqua ligands in Ptdpma, Ptdpea, 
Ptdppa, Ptdpba and Ptdpha by dimethylthiourea, (DMTU) nucleophile, T = 
298 K, pH = 2, I = 0.1 M NaClO4. 
 Ptdpma Ptdpea Ptdppa Ptdpba Ptdpha 
[DMTU] /M obsk , s-1 obsk , s-1 obsk , s-1 obsk , s-1 obsk , s-1 
0.005 0.246 0.045 0.1033 0.09451 0.06997 
0.0075 0.347 0.0756 0.13738 0.12352 0.10825 
0.01 0.493 0.105 0.19152 0.17358 0.14894 
0.0125 0.604 0.123 0.22413 0.20868 0.18283 
0.015 0.744 0.160 0.2899 0.25669 0.23098 
 


















Figure SI 4.20: Dependence of obsk  on the entering DMTU nucleophile for the first 
displacement of the aqua ligands in Ptdpma, Ptdpea, Ptdppa, Ptdpba and 





Table SI 4.4: Average obsk , s-1, for the first displacement of the aqua ligands in Ptdpma, 
Ptdpea, Ptdppa, Ptdpba and Ptdpha by tetramethylthiourea, (TMTU) 
nucleophile, T = 298 K, pH = 2, I = 0.1 M NaClO4 





















0.005 0.122 0.0018 0.0323 0.005 0.038 0.005 0.043 0.005 0.026 
0.0075 0.179 0.0027 0.044 0.0075 0.055 0.0075 0.054 0.0075 0.044 
0.01 0.233 0.0036 0.06 0.01 0.075 0.01 0.0714 0.01 0.062 
0.0125 0.2913 0.0045 0.078 0.0125 0.099 0.0125 0.0954 0.0125 0.08 

























Figure SI 4.21: Dependence of obsk  on the entering DMTU nucleophile for the first 
displacement of the aqua ligands in Ptdpma, Ptdpea, Ptdppa, Ptdpba and 
Ptdpha by tetramethylthiourea, (TMTU) nucleophile T = 298 K, pH = 2, I = 











Table SI 4.5: Temperature dependence of rate constants, 1k /M-1 s-1, for the first 
displacement of the aqua ligands in Ptdpma, Ptdpea, Ptdppa, Ptdpba and 
Ptdpha by thiourea, (TU) nucleophile, pH = 2, I = 0.1 M NaClO4, T = 15-35 
°C. 






































0.00347 -7.18971 -8.27378 -7.69654 -7.79215 -8.10685 
0.00341 -6.9157 -8.00189 -7.43602 -7.54474 -7.80615 
0.00336 -6.62102 -7.70772 -7.16532 -7.28011 -7.53432 
0.0033 -6.35882 -7.41791 -6.87608 -6.97216 -7.22683 

























Figure SI 4.22: Plots of Tln
1k  versus T
1  for the first displacement of the aqua ligands in 
Ptdpma, Ptdpea, Ptdppa, Ptdpba and Ptdpha by thiourea, (TU) 











Table SI 4.6: Temperature dependence of rate constants, 1k /M-1 s-1, for the first 
displacement of the aqua ligand in Ptdpma, Ptdpea, Ptdppa, Ptdpba and 
Ptdpha by dimethyl thiourea, (DMTU) nucleophile, pH = 2, I = 0.1 M NaClO4, T 
= 15-35 °C. 






































0.00347 -6.95353 -8.5031 -7.96535 -8.03256 -8.23998 
0.00341 -6.66519 -8.2501 -7.68406 -7.74874 -7.92468 
0.00336 -6.40437 -7.95458 -7.34986 -7.44822 -7.60128 
0.0033 -6.12586 -7.66593 -7.07246 -7.1475 -7.28631 


























Figure SI 4.23: Plots of Tln
1k  versus T
1  for the first displacement of the aqua ligand in 
Ptdpma, Ptdpea, Ptdppa, Ptdpba and Ptdpha by dimethyl thiourea, 














Table SI 4.7: Temperature dependence of rate constants, 1k /M-1 s-1, for the first 
displacement of the aqua ligands in Ptdpma, Ptdpea, Ptdppa, Ptdpba and 
Ptdpha by tetramethylthiourea, (TMTU) nucleophile, pH = 2, I = 0.1 M 
NaClO4, T = 15-35 °C. 






































0.00347 -7.67758 -9.1465 -8.79057 -8.95172 -9.78952 
0.00341 -7.44401 -8.83987 -8.57136 -8.61552 -9.08402 
0.00336 -7.15542 -8.58815 -8.29271 -8.33837 -8.4739 
0.0033 -6.89348 -8.3702 -7.99826 -8.06888 -8.03179 

































1  for the first displacement of the aqua ligands in 
Ptdpma, Ptdpea, Ptdppa, Ptdpba and Ptdpha by tetramethylthiourea, 









Table SI 4.8: Average obs2k /s-1, for the second displacement of the aqua ligands in 
Ptdpma, Ptdpea, Ptdppa, Ptdpba and Ptdpha by thiourea, (TU) 
nucleophile, T = 298 K, pH = 2, I = 0.1 M NaClO4. 









0.005 0.00485 0.0027 3.643E-5 9.813E-5 1.989E-4 7.987E-5 
0.0075 0.00772 0.0036 6.139E-5 2.083E-4 3.616E-4 1.719E-4 
0.01 0.01018 0.0045 9.251E-5 3.978E-4 5.396E-4 3.547E-4 
0.0125 0.01378 0.0054 1.344E-4 5.531E-4 7.603E-4 4.895E-4 













Table SI 4.9: Average obs2k , s-1, for the second displacement of the aqua ligands in 
Ptdpma, Ptdpea, Ptdppa, Ptdpba and Ptdpha by dimethyl thiourea, 
(DMTU) nucleophile, T = 298 K, pH = 2, I = 0.1 M NaClO4.  












0.005 7.136E-5 0.0027 1.903E-5 7.628E-5 7.136E-5 6.199E-5 
0.0075 1.306E-4 0.0036 2.472E-5 1.382E-4 9.906E-5 9.228E-5 
0.01 1.896E-4 0.0045 3.213E-5 1.932E-4 1.296E-4 1.214E-4 
0.0125 2.377E-4 0.0054 3.919E-5 2.650E-4 1.777E-4 1.538E-4 

























Figure SI 4.25: Plots of obs2k  versus DMTU][  for the second displacement of the aqua 
ligands in Ptdpma, Ptdpea, Ptdppa, Ptdpba and Ptdpha by 
dimethylmethylthiourea, (DMTU) nucleophile, pH = 2, I = 0.1 M NaClO4 T = 





Figure SI 4.26: 1H NMR spectrum showing the aromatic protons of PtdppaCl2 with excess 


























   
Ptdpma     Ptdpea 
   
Ptdppa       Ptdpba 
 
Figure SI 4.28: Basal angles of Pt centre with respect to cis pyridine rings 
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A Kinetic Study of Novel Dinuclear Pt(II) Complexes Containing Four Non-Coplanar 
Pyridine Ligands 
Abstract  
Substitution reaction of aqua ligands of azine-bridged dinuclear platinum(II) complexes of 
the type [{cis-Pt(py)2(OH2)}2(μ-pzn)](ClO4)4 (where pzn = pyrazine (Pt-PZN), 2,3-
dimethylpyrazine (Pt-2,3PZN), 2,5-dimethylpyrazine (Pt-2,5PZN) and 2,6-
dimethylpyrazine (Pt-2,6PZN) by thiourea nucleophiles was investigated under pseudo 
first-order conditions as a function of concentration and temperature using the stopped-
flow technique. The experimental results are discussed in reference to structures obtained 
by DFT (B3LYP/LanL2Dz) calculations. The reactivity of the complexes follows the trend 
Pt-PZN > Pt2,6PZN > Pt-2,5PZN > Pt-2,3PZN and Pt-PZN > Pt2,5PZN > Pt-2,3PZN > Pt-
2,6PZN for the first and second substitution steps respectively. The results are well 
supported by the pKa values as well as the calculated data from density functional theory 
(DFT). The trend in reactivity observed in this study can be explained in terms of electronic 
effects and steric hindrance imposed by the methyl groups introduced into the bridging 
ligand. Compared to [{cis/trans-Pt(NH3)2(OH2)}2(μ-pzn)](ClO4)4, the complexes in this 
series react faster by a factor of 10 or 23 respectively due to the presence of pyridine rings 
which forces the structural geometry to allow π-backbonding to take place where the 
electrons from the metal centres are accepted to the empty π*-orbitals of the pyridine sub 
units. The reactivity of the nucleophile is steric dependent with TMTU reacting three times 
slower than TU. In all complexes and for both substitution steps the mode of activation 




In order to understand how dinuclear Pt(II) complexes interact with the biological 
molecules in the body, it has become increasingly important to understand the mechanism 
of their ligand substitution reactions using model molecules which mimic bionucleophiles 
such as thiol, certain groups of enzymes, peptides and protein molecules present in the 
body. Through suitable kinetic investigations of Pt(II) complexes results obtained may 
contribute to a better understanding of the precise rate of important biochemical 
transformations as well as the underlying mechanism for those complexes. Moreover, by 
monitoring the substitution reactions with sulfur-donors, more information can be gained 
on the possible modes of interaction of Pt(II) complexes with in vivo targets and their 
subsequent application in the study of their anti-tumour properties. 
 
Because of this kinetics of ligand substitution of dinuclear Pt(II) complexes with flexible and 
rigid linkers has been reported.1 Substitutional reactivity of the metal centres has been 
shown to depend on the length and nature of the bridging ligand.1 For example, when a 
straight aliphatic chain is used in dinuclear complexes with monodentate ammine1h and 
bis(2-pyridylmethyl)amine1a,i-l carrier ligand around the Pt centres, the reactivity increases 
with the increase in chain length until it reaches the point where it is independent of the 
chain length. The increase in reactivity as the chain length increases was ascribed to the 
decrease in charge addition of the Pt atoms caused by a combination of increased 
electrostatic interactions with a concomitant increase in the σ-donor capacity towards each 
Pt atom.1a,b A similar trend in reactivity was observed by van Eldik and co-workers1i-l when 
anionic and biological relevant nucleophiles were used to study the ligand substitution 
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reactions in alkanediamine-bridged Pt(II) complexes with a bis(2-pyridylmethyl)amine 
chelate framework around each Pt atom. The trend in reactivity is the same in all cases as 
the one reported in the study by Jaganyi et al1h for the dinuclear complexes with 
monodentate amine ligands around the Pt(II) centres. In addition, the decrease in reactivity 
with increase in alkanediamine chain was observed for dinuclear complexes with the linker 
on cis position to the leaving group.2 The retardation of the rate of substitution on 
increasing the alkanediamine chain is attributed to the strong σ-donor ability of the -(CH2)n- 
moiety that is in the cis-position with respect to the leaving group. This causes 
accumulation of the electron density to the metal centre making it less electrophilic.2 On the 
other hand when rigid and semi rigid ligands are used to link Pt(II) centres, the reactivity of 
the complex depends on the ability of the linker to reduce electron from the metal centre 
through π-back bonding.1e,g,3 
 
The substitution results obtained for dinuclear Pt(II) complexes edify that the reactivities of 
these complexes may be manipulated by the geometry of the complex, especially with 
respect to the relationship of leaving groups to diamine bridge, and the nature of the 
diamine bridge itself as well as the other ligands in the Pt coordination sphere. It has been 
reported that the DNA binding properties of Pt(II) complexes differ dramatically when the 
ligand coordinated to the Pt centre is varied from NH3 to pyridine.4 The current study is an 
expansion of an earlier study from our group on azine bridged dinuclear Pt(II) complexes 
with NH3 ligands cis or trans to each other1g,3 and is intended to resolve the thermodynamic 
and kinetic properties of the complexes as a function of pyridine ligands bonded to Pt 
centre. I am particularly interested to know if the pyridine rings will enter into electronic 
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communication with the Pt(II) orbitals through π-backbonding and how will this affect the 
reactivity of the complexes taking into account the steric effect imposed by the methyl 
groups on the pyrazine linker. For this reason, I set out to synthesize and study the kinetics 
of ligand substitution of novel cationic dinuclear Pt(II) complexes bearing two pyridine 
rings at each Pt centre (Figure 5.1). The choice of the pyridine ligand and azine as a linker 
was due to the interesting cytotoxic activity of their mononuclear and dinuclear Pt(II) 
complexes.4,5  
Pt-PZN Pt-2,6 PZN Pt-2,5 PZN Pt-2,3 PZN
OH2H2OH2O OH2





























5.2.1 Chemicals and Reagents.  
Pyrazine (99%), 2,3-dimethylpyrazine (99%), 2,5-dimethylpyrazine (99%), 2,6-
dimethylpyrazine (99%), NaClO4·H2O (98%), HClO4 (70%), AgClO4 (99.98%) and pyridine 
(99%) were obtained from Aldrich and were used without further purification. Potassium 
tetrachloroplatinate [K2(PtCl4)] (99.99%) was purchased from Strem Chemicals. The 
nucleophiles; thiourea, TU (99%), 1,3-dimethyl-2-thiourea, DMTU (99%), 1,1,3,3-
tetramethyl-2-thiourea, TMTU (98%) used in the kinetic measurements were obtained 
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from Aldrich. Ultrapure water (PureLab Systems) was used in all experiments. All other 
reagents used were of analytical grade quality. 
 
5.2.2 Synthesis of the Complexes 
Four dinuclear Pt(II) complexes with the formulae [trans-{PtCl(Py)2}2-μ-pzn] (ClO4)2 (Pt-
PZN) (pzn = pyrazine), [trans -{PtCl(Py)2}2-μ-2,3-pzn](ClO4)2 (Pt-2,3PZN) (2,3pzn = 2,3-
dimethylpyrazine), [trans -{PtCl(Py)2}2-μ-2,5-pzn](ClO4)2 (Pt-2,5PZN) (2,5pzn = 2,5-
dimethylpyrazine) and [trans -{PtCl(Py)2}2-μ-2,6-pzn](ClO4)2 (Pt-2,6PZN) (2,6pzn = 2,6-
dimethylpyrazine) were prepared from [trans-{PtCl(Py)2(DMF)}]ClO4.  
 
5.2.3 Synthesis of [trans-PtCl2Py2] 
The mononuclear starting compound of the general formula [trans-PtCl2(Py)2] was 
prepared according to literature procedure.6 To a solution of K2PtCl4 (1.62 g, 3.89 mmol) in 
100 mL of water was added pyridine (1.25 mL, 15.58 mmol) and the mixture was heated at 
reflux temperature (115 ∘C) until the yellow precipitate which formed dissolved to give a 
clear solution. HCl (2.0 M, 100 mL) was added to the hot solution and the mixture heated at 
reflux until the solution turned to yellow. On reducing the volume of the solution to ca 10 
mL, a light yellow solid precipitated. The solid was filtered off and washed with water and 
acetone. The crude product was recrystallized from CHCl3/ether.  
 
trans-[PtCl2Py2] Light yellow powder, yield 1.44 g, (89 %). 1H NMR (CDCl3, 400 MHz,): δ = 
8.92 (d, 4H), 7.79 (t, 2H), 7.32 (t, 4H). 13C NMR (CDCl3, 400 MHz,): 153.7, 138.3 and 125.2. 
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Anal. Calcd. for C10H10N2PtCl2: C 28.30, H 2.36, N 6.60. Found C 28.27, H 2.36, N 6.54. TOF 
MS ES+: m/z, [M+Na]+ = 446.97. 
 
5.2.4 Synthesis of [trans-{PtCl(Py)2(DMF)}]ClO4 
The title compound was prepared following the literature method.7,8 To a solution of known 
amount of trans-[PtCl2(Py)2] in 10 mL of DMF was added one equivalent of AgClO4. The 
solution was stirred in the dark overnight at room temperature. After cooling to 5 ˚C the 
precipitated AgCl was filtered off and a yellow filtrate retained. 
 
5.2.5 Synthesis of Dinuclear Pt(II) Complexes 
The synthesis of the new tetra pyridyl coordinated dinuclear compounds was adopted from 
a previously published method8 starting with [trans-{PtCl(Py)2(DMF)}]ClO4 and pyrazine 
derivatives as the bridging ligand with some minor modifications. To a filtrate of [trans-
{PtCl(Py)2(DMF)}]ClO4 was added dropwise a solution of the pyrazine derivatives (half 
equivalent that of the metal complex) in 2 mL of DMF. The mixture was stirred overnight at 
30-40 °C in the dark. The solution was then cooled and concentrated on a rotary evaporator 
at a reduced pressure to a volume of approximately 2 mL. The off-yellow compounds which 
precipitated out after addition of methanol (20 mL) was filtered and repeatedly 
recrystallized in minimal H2O/ethanol. All complexes were prepared as perchlorate salts 
and were characterized by 1H NMR and elemental analysis. Characterization data were in 
complete agreement with the proposed structures.  
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Pt-PZN Light yellow powder, yield 76.60 mg, (35 %). 1H NMR (DMSO-d6, 400 MHz,): δ = 
8.95 (d, 2H), 8.79 (d, 8H), 8.02 (t, 4H), 7.73 (d, 2H), 7.53 (dd, 8H). Anal. Calcd. for 
C24H24N6O8Pt2Cl4: C 27.27, H 2.65, N 7.95. Found C 27.57, H 2.46, N 7.64.  
 
Pt-2,3PZN Light yellow powder, yield 74.40 mg, (33 %). 1H NMR (DMSO-d6, 400 MHz,): δ = 
8.97 (d, 8H), 8.94 (d, 2H), 8.22 (t, 4H), 7.76 (dd, 8H), 2.35 (s, 6H). Anal. Calcd. for 
C26H28N6O8Pt2Cl4: C 28.78, H 2.58, N 7.75. Found C 28.21, H 2.76, N 7.53.  
Pt-2,5 PZN Light yellow powder, yield 67.64 mg, (30 %). 1H NMR (DMSO-d6, 400 MHz,): δ = 
8.95 (d, 8H), 8.39 (s, 2H), 8.19 (t, 4H), 7.74 (dd, 8H), 2.43 (s, 6H). Anal. Calcd. for 
C26H28N6O8Pt2Cl4: C 28.78 H 2.58, N 7.75. Found C 28.66, H 2.49, N 7.56.  
Pt-2,6 PZN Light yellow powder, yield 67.64 mg, (30 %). 1H NMR (DMSO-d6, 400 MHz,): δ = 
8.74 (s, 2H), 8.96 (d, 8H), 7.81 (t, 4H), 7.32 (dd, 8H), 2.61 (s, 6H). Anal. Calcd. for 
C26H28N6O8Pt2Cl4: C 28.78, H 2.58, N 7.75. Found C 29.07, H 2.61, N 7.67.  
 
5.2.6 Preparation of Aqueous Complex Solutions 
The desired solutions of the diaqua complexes were prepared by reacting a known amount 
of chloro Pt(II) complex with AgClO4 in a ratio of 1:1.98 molar ratio of the chloro complexes 
to silver perchlorate in 0.1 M HClO4 acid. The mixture was vigorously stirred in the dark at 
50 °C for 24 h. After cooling in ice cold water, the precipitated AgCl was filtered off through 
a 0.45-μm nylon membrane filter using a Millipore filtration apparatus. The resulting 
aqueous solution was brought to a final complex concentration of, 3.4 x 10-4, 2.15 x 10-4, 
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4.37 x 10-4 and 5.78 x 10-4 M for Pt-PZN, Pt-2,3PZN, Pt-2,5PZN and Pt-2,6PZN, using 0.1M 
HClO4 acid respectively.  
 
5.2.7 Instrumentation and Measurements 
NMR spectra were recorded on a Bruker Avance III 500 at frequencies of 500 MHz using 
either a 5 mm BBOZ probe or a 5 mm TBIZ probe. All proton chemical shifts are quoted 
relative to the relevant solvent signals at 30 °C unless stated otherwise. Elemental 
compositions of the complexes were determined from a Carlo Erba Elemental Analyzer 
1106. The pH of the aqueous solutions of the complexes were measured using a Jenway 
4330 Conductivity/pH meter equipped with a Micro 4.5 diameter glass electrode. The 
electrode was calibrated at 25 °C using standard buffer solutions of pH 4.0, 7.0 and 10.0 
(Merck). The pH electrode was filled with 3.0 M NaCl and not KCl to prevent precipitation of 
KClO4. An Applied photophysics SX 20 stopped-flow spectrophotometer thermostated to 
within ± 0.1 °C was used for the kinetic measurements. pKa and kinetic traces were 
graphically analysed using the software package, Origin 7.5.9  
 
5.2.8 Computational Methods 
The geometry optimizations of the complexes Pt-PZN, Pt-2,3PZN, Pt-2,5PZN and Pt-
2,6PZN were carried out in the gas phase at the level of DFT-B3LYP10 with LanL2DZ basis 
sets11 using a Gaussian 09 program suite.12 B3LYP relates to the hybrid functional Becke’s 
three-parameter formulation, which has been proven to be superior to traditional 
functionals. LANL2DZ is double-zeta basis set containing effective core potential (ECP) 
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representations of electrons near the nuclei for transition metal complexes.13 The 
complexes were optimized in their diaqua form as cations of total charge of +4. 
 
5.2.9 pKa Titrations of the Diaqua Complexes.  
Spectrophotometric pH titrations of the aqua complex solutions were performed using 
NaOH as the base in the pH range of 1–10 at 25 ˚C. In order to avoid absorbance corrections 
due to dilution, a large volume (150 mL) of the metal complex solution was used during the 
titration. Adjustments in pH were made by stepwise additions of crushed solid NaOH pellets 
in the pH range 1-3 while micropipette dropwise additions of NaOH solutions of different 
concentrations (1.0, 0.5, 0.1 and 0.01 M) or conc. HClO4 (for reversibility of the pH) were 
added to the solution in the pH range of 4-10 until the desired pH was attained prior to 
withdrawal of 1.0 mL aliquot from the solution for pH measurement and 2 mL aliquots for 
monitoring the absorbance spectrophotometrically. The 1 mL aliquot after each pH 
measurement was discarded to avoid in situ contamination of the complex solution by 
chloride ions leaching from the pH electrode.  
 
5.2.10 Kinetic Measurements  
The kinetics of the substitution of coordinated aqua ligands of the complexes Pt-PZN, Pt-
2,3PZN, Pt-2,5PZN and Pt-2,6PZN were monitored under pseudo first-order conditions 
with at least a 20-fold excess of the nucleophile concentration over the dinuclear complex at 
pH 2 in order to force the reactions to go to completion The reactions were initiated by 
mixing of equal volumes of a solution of the Pt(II) complex with a solution of the 
nucleophile directly in the stopped-flow instrument at suitable wavelengths predetermined 
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from UV-Vis spectrophotometer (Table SI 5.1). Observed rate constants, obs1k  and 2 obsk  
were calculated by a double exponential fit to the kinetic traces. The reported obs1k  and 
2 obsk  are mean values of at least five independent kinetic runs on the stopped-flow 
spectrophotometer. The second-order rate constants, 1k  and 2k  were obtained by a fit of a 
straight line to the plot of obs1k  and 2 obsk  versus concentration of nucleophile, [Nu] using a 
standard least-squares minimizing procedure by Origin 7.5® software package.9 The 
temperature dependencies of the rate constants in the range of 15-35 °C at a 5 °C interval 
allowed for the calculation of the enthalpies and entropies of activation, ΔH≠ and ΔS≠, with 
the nucleophile concentration held constant at 60 times the concentration of the metal 
complex. The respective values were obtained by a linear fit of the natural logarithm of the 












 using Eyring equation.14 
 
5.3 Results 
5.3.1 Computational Analysis  
In this study, one of the most important structural parameter is the presence of two 
pyridine moieties trans to each other and cis to leaving group at each Pt(II) centre. 
Computational calculations were performed in order to gain an in-depth understanding of 
the structural as well as the electronic differences that exist in the complexes compared to 
those reported in previous studies.1g,3 Geometry optimized structures and the HOMO/LUMO 




It is important to mention that the complexes were synthesized and drawn as trans but at 
the end of the calculation the pyridine rings had twisted to the equatorial plane adopting 
the cis geometry in relation to the second pyridine ring. The calculations also show that the 
square planarity around the Pt centres is maintained and the pyrazine ligand plus the 
twisted pyridine rings all lie on the same plane with the Pt(II) centres creating an 
environment for electronic communication through π-backbonding between them to take 
place.  
 
For all complexes investigated, the HOMO orbitals are concentrated on the horizontal 
pyridyl π-acceptor carrier ligands and the LUMO is centred primarily on the pyrazine 
bridging ligand and partly on the dxy orbital of the Pt centre. A general increase in the 
energy gap, ΔE (HOMO–LUMO), of the frontier orbitals and decrease in NBO charges 
dependent on the position of the methyl group is observed upon introducing electron-
donating methyl group to the pyrazine moiety. This is linked with the increase in electron 
density at the metal centre which results in destabilization and minimum interactions of the 
molecular orbitals. Because of the outcome of twisting the pyridine rings to the equatorial 
plane as revealed in Table 5.1, the thermodynamic and kinetic data in this paper are 
discussed in line with the geometry optimized structures. Included in the Table 5.2 are 
DFT-based reactivity descriptors such as chemical hardness and electrophilicity index 
which were calculated from their energies of HOMO and LUMO15 to elucidate the observed 
reactivity trend of the complexes. From Table 5.2, the chemical hardness decreases in the 
order Pt-2,3PZN > Pt-2,5PZN > Pt-2,6PZN > Pt-PZN and tallies well with the reactivity 
trend observed where Pt-PZN is more reactive than Pt-2,3PZN. It is worth noting that the 
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values of chemical potential (Table 5.2) which describes the escaping tendency of electrons 
from an equilibrium system are all of the same magnitude and negative because the 
electron acceptance by the complexes is accompanied by a decrease in energy. The 
electrophilicity trend which measures the capacity of a complex as a whole to accept 
electrons (Table 5.2) is Pt-2,3PZN < Pt-2,5PZN < Pt-2,6PZN < Pt-PZN. A good electrophile 
is characterized by a high value of electrophilicity index, therefore, Pt-PZN is the most 




Table 5.1: Geometry optimized structures and DFT-calculated (B3LYP/LACVP+**) 
HOMO and LUMO for the investigated complexes. 











































-13.54 LUMO /eV 
HOMO/eV -17.26 -17.30 -17.16 -17.16 
∆E /eV 3.16 3.47 3.52 3.62 








Pt2 0.756 0.690 0.702 0.694 
Chemical hardness (eV) 1.58 1.73 1.76 1.81 
Chemical potential (eV) 

















Pt1–N1 2.105 2.128 2.114 2.119 
Pt2–N2 2.105 2.105 2.116 2.119 
Pt1–OH1 2.139 2.139 2.137 2.136 
Pt2–OH2 2.139 2.134 2.136 2.136 


















Point group symmetry C2 C1 C1 Cs 







5.3.2 Acidity of the Aqua Complexes  
Figure 5.2 (also Figures SI 5.8-5.10) shows an example of the spectral changes observed 
during the pH titration of Pt-2,6PZN with NaOH. The pKa values of the coordinated aqua 
ligands were calculated from the pH profiles and an example of which is shown as an inset 
in Figure 5.2. When the data were fitted to separate single sigmoidal functions using Origin 
7.5® software9, pKa values for the deprotonation of the protons of the coordinated aqua 
ligands were obtained. Their values are summarised in Table 5.3. Included for comparison 
purposes in Table 5.3 are the pKa values of the analogous dinuclear Pt(II) complexes 
having cis NH3 ligands at each metal centre. The overall titration process can be presented 























Figure 5.2: UV-Vis spectra of the Pt-2,6PZN diaqua complex recorded as a function of pH 
in the range 1-10 at 25 ᵒC. Inset: Plot of absorbance versus pH at 300 nm. 
 
Results in Table 5.3 clearly show a correlation between the pKa values and electronic as 
well as steric demands of the pyrazine ligand linking the two Pt(II) centres. The pKa1 values 
of the deprotonation of the first coordinated aqua ligand increase in the order of 3.14 < 3.35 
≈ 3.37< 3.59 for Pt-PZN, Pt-2,3PZN, Pt-2,5PZN and Pt-2,6PZN respectively. The trend in 
pKa values is associated with the electronic effect of methyl substituents on the pyrazine 
moiety which through inductive effect results in the Pt–OH2 bond being longer and 
consequently high pKa values of the resultant complex. The second deprotonation step 
(Table 5.3) in all complexes occurs at higher pH values than the first one and this is 
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attributed to the decrease in overall charge from +4 to +3 of the complexes upon formation 
of the hydroxo species. Interestingly, the pKa values for the first deprotonation step 
obtained in this study are slightly lower than those obtained for the analogous dinulear 
complexes with sp3-hybridized ammine unit (NH3) on trans and cis position to the leaving 
group.1g,3 This may be attributed to the effect of the introduced pyridine rings which help to 
stabilize the electron density on the Pt(II) centre and the hydroxo ligand as the pyridine is a 
better π-acceptor compared to NH3.16 
 
Table 5.3: The pKa values for the deprotonation of Pt-bound aqua ligands in the 
dinuclear Pt(II) complexes. 
Complex Pt-PZN Pt-2,6PZN Pt-2,5PZN Pt-2,3PZN 
pKa1 
 
3.14 ± 0.03 
 3.32 ± 0.06a 
3.59 ± 0.03 
  3.48 ± 0.51a 
3.37 ± 0.01 
  3.96 ± 0.12a 
3.35 ± 0.01 




5.93 ± 0.04 
 5.64 ± 0.09a 
2.79 
6.12 ± 0.05 
  6.88 ± 0.04a 
2.84 
6.15 ± 0.02 
  6.13 ± 0.05a 
2.78 
6.43 ± 0.03 
  6.01 ± 0.18a 
2.77 
 apKa values extracted from reference 3. 
 
5.3.3 Kinetics Measurements  
As already mentioned, all the kinetic measurements were done under pseudo first-order 
conditions with respect to the nucleophile in order to force the reactions to go to 
completion. The substitution reactions of the complexes with thiourea nucleophiles (TU, 
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DMTU, TMTU) were carried out at pH 2 and they were characterized by two reaction steps 
(Scheme 5.2).  
L L
Charges of the complexes are omitted for clarity
L
k1 k2
where, L = bridge = pzn, 2, 3-pzn, 2, 5-pzn, and 2, 6-pzn














Pt Pt PtPt PtPt
 
Scheme 5.2: The general reaction scheme for the reactions between the Pt(II) complexes 
and the thiourea nucleophiles at pH 2. 
 
Both substitution steps are irreversible and the overall reaction can be summarized by the 
rate law given by Equation 5.1. 
[ ]Nu1/21/2obs kk =      (5.1) 
The kinetic traces of the ligand substitution reaction for all complexes investigated gave 
excellent fits to a double exponential decay to generate the pseudo first-order rate 
constants, 1 obsk  and obs2k  at specific nucleophile concentration and temperature for the first 
and second substitution step respectively. An example of the kinetic trace obtained for the 





Figure 5.3: Typical double exponential fit for a two step reaction between Pt-2,3PZN (0.2 
mM) and TU (1.2 mM) recorded at 295 nm, T = 298 K, pH = 2.0, I = 0.1 M 
(NaClO4) on the stopped-flow spectrophotometer. t1 and t2 are time values 
from which obs1k  and obs2k  are obtained. 
 
The rate constants, 1k  and 2k  were obtained from the slope of the plot of obs1k  or obs2k  
against nucleophile concentrations at 25 °C and are summarized in Table 5.4. 
Representative plots for the first and second substitution step for Pt-PZN with the three 
investigated nucleophiles are shown in Figure 5.4 (also Figures SI 6.13, 6.15 and 6.17). 
The dependence of rate constant on temperature was studied at a temperature range  
15-35 ˚C. Typical Eyring plots are shown in Figure 5.5 (also Figures SI 6.14, 6.16 and 











































Figure 5.4: Plots of 1/2 obsk  versus nucleophile concentration for the (a) first and (b) second 











































Figure 5.5: Eyring plots for the determination of the thermal activation parameters for the 
(a) first and (b) second substitution steps of 0.22 mM Pt-PZN for all three 
nucleophiles studied at pH 2 (I = 0.1 M NaClO4). 
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Table 5.4: Summary of rate constants and activation parameters of the investigated complexes for the first  
and second substitution steps.  






J K-1 mol-1 
∆ S≠2/ 












427.7 ± 8.2 
393.3 ± 5.5 
102.4 ± 3.1 
72.5 ± 1.1 
45.4 ± 1.0 
24.6 ± 0.5 
27 ± 1 
41 ± 2 
49 ± 2 
41 ± 1 
42 ± 2 
47 ± 1 
-142 ± 4 
 -96 ± 6 
 -79 ± 6 
-114 ± 3 
-177 ± 7 









338.7 ± 6.5 
200.6 ± 4.1 
146.1 ± 3.3 
16.2 ± 0.3 
5.6 ± 0.1 
3.3 ± 0.05 
40 ± 1 
43 ± 2 
48 ± 1 
38 ± 2 
46 ± 2 
47 ± 2 
-122 ± 3 
-108 ± 6 
-100 ± 4 
-132 ± 6 
-104 ± 6 









314.0 ± 1.4 
304.7 ± 6.1 
102.2 ± 0.9 
43.4 ± 0.6 
38.4 ± 0.6 
27.3 ± 0.3 
27 ± 1 
26 ± 1 
39 ± 1 
37 ± 2 
37 ± 2 
43 ± 2 
-151 ± 3 
-154 ± 3 
-119 ± 3 
-139 ± 6 
-139 ± 6 










247.8 ± 6.1 
185.5 ± 4.6 
136.1 ± 2.7 
29.7 ± 0.7 
24.1 ± 0.7 
18.6 ± 0.6 
31 ± 1 
30 ± 2 
43 ± 1 
30 ± 1 
47 ± 3 
33 ± 2 
-102 ± 3 
-124 ± 6 
-118 ± 3 
-166 ± 3 
-120 ± 9 




Previous studies have shown that there is relationship between pKa values and 
electrophilicity of the metal centre.1i,k,17,18 It has also been reported that, electron-
withdrawing π-acceptor effect tends to stabilize the electron-rich hydroxo species in 
comparison to the aqua species resulting in lower pKa values.1k,17,18 Alternatively, if the σ-
donor capacity of the ligand trans to the aqua moiety is enhanced, then a higher pKa value is 
obtained.19 In this study the pKa results obtained show that the introduction of methyl 
groups to the pyrazine moiety as in Pt-2,3PZN, Pt-2,5PZN and Pt-2,6PZN decreases the 
electrophilicity of the metal centre through electron donation via the pyrazine ring. This 
result into a moderate increase in pKa values for these complexes compared to Pt-PZN. One 
can see that the position of the methyl groups in the pyrazine moiety of Pt-2,3PZN and Pt-
2,5PZN gave equal distribution of the charges at each Pt(II) centre explaining why these 
two complexes have pKa values that are approximately the same. However, donation of 
charge from methyl groups of Pt-2,6PZN is not symmetrical resulting into Pt1 being more 
electrophilic compared to Pt2. This is in line with the huge difference in pKa values observed 
for this complex when compared with other complexes in this study. The trend in the pKa 
values are well supported by the DFT NBO calculated charges and the reactivity descriptors 
(Table 5.3) where the second Pt centre is less positive compared to other Pt centres in the 
complexes investigated. 
 
Comparing the current pKa findings with those of related cis-complexes3 [cis-
{Pt(NH3)2(OH2)}2-μ-pzn]4+(Table 5.3), pKa values obtained in this study were slightly lower. 
This can only mean that by addition of pyridine units as monodentate ligands the electron 
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density on the Pt(II) centre and the hydroxo ligand is slightly stabilized by the poor σ-donor 
pyridine rings16 compared to NH3 which is a strong σ-donor and increases the electron 
density on the metal centre. Moreover, the mapping of the frontier orbitals confirmed 
enhancement of electronic communication between the metal and ligand as Pt(II) centre is 
free in electrons. Further observation also shows that deprotonation of the second 
coordinated aqua molecule to the dihydroxo species occurs at higher pH values than in the 
first step in all the four complexes. This is ascribed to reduction of the overall charge from 
+4 to +3 following deprotonation of the first coordinated aqua molecule in all the dinuclear 
complexes causing a decrease in acidity and electrophilicity of the second Pt(II) centre. This 
increase in pKa value due to the change in overall charge of the complex has also been 
observed and reported in previous studies.1,2,3  
 
Substitution reactions of the series of dinuclear Pt(II) complexes with thiourea nucleophiles 
was monitored at pH 2 where all the complexes exists in their diaqua form and protonation 
of thiourea can be ruled out.20 Two substitution steps were observed for all dinuclear Pt(II) 
complexes studied indicating that there is electronic communication between the two Pt 
centres resulting in each having different kinetic properties. The smallness and rigidness of 
the azine linker enhances metal-metal electronic communication by electrostatic charge 
transfer from the metal centre to the lowest unoccupied molecular orbitals of the bridging 
ligand, making the Pt(II) centre more electrophilic.21 It is worth mentioning that as 
previously reported,1g,3 the reactivity of the complexes reported is also dependent on the 




The first substitution step is assigned to the replacement of one aqua ligand with the 
thiourea nucleophiles (TU, DMTU, TMTU) whilst the second step is the substitution of the 
second aqua ligand. Since other dinuclear Pt(II) complexes studied in our group3 were 
involving dechelation or dissociation of the linker, ligand substitutions of Pt-2,5PZN-Cl2 
was followed using 1H NMR to evaluate the possibility of dechelation. An array of the 
1HNMR spectra (showing only the aromatic resonances) for the reaction between Pt-
2,5PZN-Cl2 and excess thiourea (6 equivalents) is shown in Figure 5.6. The pyridyl protons 
were chosen to monitor the progress of the reaction as they are in close vicinity with the N-
donor atom bonded to the metal centre and hence to the incoming TU. The numbering 
scheme employed for the pyridyl protons is shown in the structure of the Pt-2,5PZN-Cl2 
complex in Scheme 5.3. From Figure 5.6, the H2 and H2’ resonances of the pyridine in Pt-
2,5PZN-Cl2 complex which appear at δ = 8.89 ppm are shifted downfield to δ = 9.07 ppm 
upon coordination of TU-six equivalent while the electronic environments of the other 
pyridyl and the pyrazine protons are not affected to a great extent by the coordination of 
thiourea. It is worth mentioning that no extra sets of resonances in support of a dechelation 

















Figure 5.6: 1H NMR spectra of Pt-2,5PZN-Cl2 acquired during the reaction with 6 
equivalent TU at 30 °C. The first spectrum labelled t = 0 is for the unreacted 
Pt(II) chloro complex and the rest are after the reaction with 6 equivalent TU 
at a specified time.  
 
Taking the first substitution with thiourea as a reference, the reactivity of the dinuclear 
Pt(II) complexes decreases in the order 427.7 > 338.6 ≃ 314.0 > 247.8 M-1 s-1 for Pt-PZN, 
Pt2,6PZN, Pt-2,3PZN and Pt-2,5PZN, respectively. The trend in reactivity observed in this 
study can be explained in terms of electronic effect and steric hindrance imposed by the 
methyl groups introduced into the bridging ligand as reported in previous studies.1g,3 The 
higher lability of the Pt-PZN complex is ascribed to less steric hindrance and the decrease 
in electron density on the platinum centre caused by the π-acceptor ability of the pyrazine 
ligand and the twisted pyridine rings. This makes the metal centres in Pt-PZN more 
electrophilic and favour the rapid binding of the entering nucleophile. The high reactivity of 
Pt-PZN is supported by the observed lower pKa values, narrow HOMO-LUMO gap, small 
value of chemical hardness and large values of electrophilicity index and NBO charges. The 
decrease in reactivity of the Pt-2,6PZN, Pt-2,3PZN and Pt-2,5PZN compared to Pt-PZN can 
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be ascribed to the increased σ-inductive effect due to the additional methyl groups on the 
bridging pyrazine ligand. Previous studies have shown that methyl groups and other 
electron-donating groups collectively lead to a reduction in the rate of ligand substitution, 
by reducing the positive charge density on the platinum atom, thus lowering the 
electrophilicity of the metal centre.1g,2,3,22-24 The introduced methyl groups also impose the 
steric hindrance which restrict the path of the incoming nucleophile to one or both sides of 
the square planar of the platinum(II) centres.  
 
The second-order rate constant of Pt-PZN is greater than that of Pt-2,6PZN by a factor of 
ca. 1.3. These two complexes differ from each other due to the fact that one of the platinum 
centre in Pt-2,6PZN is crowded with methyl groups making it less electrophilic compared 
to the second metal centre as supported by DFT calculated NBO charges. From the NBO 
charges in Table 5.2, the electrophilicity of the unshielded metal centre of Pt-2,6PZN is of 
the same magnitude with that of Pt-PZN. This explains why the reactivity of the first 
substitution step in Pt-2,6PZN is close to that of Pt-PZN and higher than that of Pt-2,5PZN 
and Pt-2,3PZN. In addition, the determined pKa values and the observed HOMO-LUMO gap 
for Pt-2,6PZN confirms the difference in electrophilicity between the two Pt(II) centres.  
 
In the case of Pt-2,3PZN and Pt-2,5PZN, the positioning of the methyl groups in ortho and 
para position of the pyrazine makes the two complexes symmetrical as the charges are 
equally distributed between the two Pt(II) centres. Due to this fact one expects the 
reactivity of these two complexes to be similar in magnitude. Surprisingly, this was not the 
case showing that the position of the methyl groups influences the twisting of the pyridine 
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rings which in turn influences the extend of π-backbonding. The steric effect brought by the 
methyl groups in Pt-2,3PZN causes the twisting of the complex to the extent that the two Pt 
centres lie on a different plane by 9.1ᵒ (Figure SI 5.20) which interferes with the electronic 
communication and slowing down of the reactivity.  
 
The second substitution step was significantly slower than the first in all the investigated 
complexes. This is possibly due to change in the electronic communication between the two 
platinum atoms. The order of reactivity for the second substitution step with TU is Pt-PZN > 
Pt-2,5PZN > Pt-2,3PZN > Pt-2,6PZN. The same trend in reactivity is also observed for 
other nucleophiles, DMTU and TMTU. As for the first substitution step, this is caused by the 
increased σ-inductive effect of methyl groups on the bridging pyrazine ligand which in turn 
increases its σ-donation to the metal centre (reducing its π-acceptability) resulting into a 
less positive metal centre. With this effect, the incoming nucleophile is repelled by the 
increased amount of electron density around the metal centre, leading to a less stable five-
coordinate transition-state and reduced rate of substitution. In case of Pt-2,6PZN there is 
additional steric effect which blocks entry of the incoming nucleophile on both sides of the 
hindered Pt(II) centre as supported by the reduced NBO charges of the second metal centre. 
 
When the reactivity of the Pt-pzn derivatives for both substitution steps is compared with 
[cis-{Pt(NH3)2(OH2)}2-μ-pzn]4+ and then to [trans-{Pt(NH3)2(OH2)}2-μ-pzn]4+, its second-
order rate constants are higher by a factor of 10 and 23 respectively.1g,3 This indicates that 
the structure containing pyridyl units labilizes the aqua ligands more than their cis and 
trans-counterparts with NH3 as the ligand. The introduction of pyridine groups into the 
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[{Pt(NH3)2(OH2)}2-μ-pzn]4+ complex changes the structural geometry of the complex in 
such a way that a significant increase in π-acceptor abilities of the ligands is induced. The 
net outcome is a significant increase in the electrophilicity of the complex as a whole and 
the metal centre as reflected by a more positive charge on the Pt(II) centres, high 
electrophilicity indices and lower pKa values for the deprotonation of the aqua ligands. This 
increases the rate of substitution of the coordinated aqua ligands. In addition, from Table 
5.1, the HOMO in all dinuclear complexes is distributed on the pyridine ligand and the 
LUMO is highly populated on the pyrazine bridging ligand. The HOMO orbital of the 
previously studied pyrazine bridged dinuclear Pt(II) complexes1g,3 was located at the metal 
centres as the NH3 is a more of σ-donor than pyridine making the Pt(II) centres less 
electrophilic compared to the current Pt(II) complexes investigated. 
 
The dependence on the rate of substitution of the aqua on the steric hindrance of the 
incoming nucleophiles is clearly evident from results shown in Table 5.4. Substitutions 
involving TMTU gave the slowest rates, whereas those with TU reacted significantly faster. 
This reactivity trend is in line with the steric size of TMTU nucleophile relative to the other 
two, TU and DMTU.18b,25-26 The activation parameters in Table 5.4 show that the entropies 
of activation are large and negative. This indicates that the transition state is highly ordered 
and more compact than either the reactant or product species. In addition, the enthalpies of 
activation are relatively low, showing the ease with which the new bond can form due to 
the electrophilicity of the metal centre. These activation parameter results are consistent 
with substitution reactions for square-planar Pt(II) complexes which are known to proceed 




Novel dinuclear Pt(II) complexes were synthesized and their kinetic substitution reactions 
undertaken. It was found that the use of pyridine ligands instead of NH3 on 
Pt(NH3)2(OH2)}2-μ-pzn]4+ complexes increases the substitution rates of diaqua complexes 
by a factor of 10 and 23 for the trans and cis complexes respectively during which an 
associative mode of substitution is retained. This is because pyridine enhances the π-
backbonding by accepting the electrons from the metal centres to the empty π*-orbitals of 
the pyridine sub units. This is made possible due to the geometry configuration that results 
in pyridine rings, pyrazine and Pt centre being on the same plane. This situation results in 
lower pKa values, increase in electrophilicity of the Pt(II) centre and an increase in 
reactivity of the metal centre as supported by DFT calculations. The trend in these azine 
bridged Pt(II) complexes remain the same as those reported containing NH3 ligands.1g,3 
Electron-donating groups such as methyl as used in this study donate electrons in the 
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5.7 Supporting Information (SI)  
The available SI includes a number of NMR and mass spectra, wavelengths for kinetic 
measurements, pH titration spectra, concentration dependence and Eyring plots for 
determination of second order rate constants and activation parameters respectively, 





















Figure SI 5.2: 13C NMR spectrum of trans-[PtCl2Py2] 
 


















































































Figure SI 5.8: UV-Vis spectra of the Pt-2,3PZN diaqua complex recorded as a 
function of pH in the range of 1 to 10 at 25 °C. Inset: Plot of absorbance 







Figure SI 5.9: UV-Vis spectra of the Pt-2,5PZN diaqua complex recorded as a 
function of pH in the range of 1 to 10 at 25 °C. Inset: Plot of absorbance 







Figure SI 5.10: UV-Vis spectra of the Pt-PZN diaqua complex recorded as a function of 
pH in the range of 1 to 10 at 25 °C. Inset: Plot of absorbance versus pH 
at 300 nm. 
Table S1 5.1: Summary of the wavelengths (nm) used for monitoring the kinetic reactions 
between a series of Pt(II) complexes and thiourea nucleophiles.  








 TU 295 
Pt-2,3PZN DMTU 296 









 TU 295 
Pt-2,6PZN DMTU 300 





Table SI 5.2: Average observed rate constants, obs1/2k  (s-1), for the first and second 
displacement of the aqua ligands in Pt-PZN, by thiourea nucleophiles,  
T = 298 K, pH = 2, I = 0.1 M NaClO4 
obs1k  (s-1) obs2k  (s-1) 
[NU] /M TU DMTU TMTU TU DMTU TMTU 
0.0034 1.50331 1.38221 0.44642 0.27128 0.14384 0.0917 
0.0068 2.86203 2.6906 0.78597 0.50164 0.27428 0.16978 
0.0102 4.1375 4.18243 1.09161 0.74936 0.45012 0.23902 
0.0136 5.63436 5.14312 1.361 0.94356 0.60564 0.3198 
0.017 7.55946 6.73364 1.68249 1.25218 0.8032 0.43498 
 
 




































Figure SI 5.11: Dependence of the obs1/2k  on the entering nucleophile concentration 
for the (a) first and (b) second displacement of the aqua ligands in  




Table SI 5.3: Temperature dependence of obs1/2k  (s-1) for the displacement of aqua ligands 
in Pt-PZN by thiourea nucleophiles at 60-fold excess over [Pt], pH = 2,  
I = 0.1 M NaClO4. 
Parameter 
/T)ln( 1k  /T)ln( 2k  
Nucleophile Nucleophile 
T
1 , (K-1) TU DMTU TMTU TU DMTU TMTU 
0.00347 -4.57338 -5.04894 -6.45389 -7.18388 -8.46313 -8.46313 
0.00341 -4.36579 -4.68733 -5.98511 -6.94618 -8.17877 -8.17877 
0.00336 -4.13094 -4.38711 -5.67243 -6.67878 -7.82144 -7.82144 
0.0033 -3.9465 -4.17314 -5.37874 -6.35838 -7.52332 -7.52332 
0.00325 -3.70683 -3.90795 -5.08522 -6.07485 -7.1903 -7.1903 
 

































(a) (b)  
Figure SI 5.12: Eyring plots of the reaction between Pt-PZN and thiourea 





Table SI 5.4: Average obs1/2k  (s-1), for the first and second displacement of the aqua ligands 
in Pt-2,3PZN, by thiourea nucleophiles, T = 298 K, pH = 2, I = 0.1 M NaClO4. 
obs1k  (s-1) obs2k  (s-1) 
[NU] /M TU DMTU TMTU TU DMTU TMTU 
0.002 0.534 0.43624 0.28936 0.064 0.05277 0.03462 
0.004 1.14128 0.8248 0.58784 0.12941 0.11324 0.08709 
0.006 1.5562 1.192 0.8546 0.19044 0.15588 0.1237 
0.009 2.1312 1.61432 1.245 0.25355 0.2115 0.1657 
0.011 2.708 1.99956 1.43976 0.32963 0.25562 0.19445 
 
 





































Figure SI 5.13: Dependence of the obs1/2k  on the entering nucleophile concentration 
for the (a) first and (b) second displacement of the aqua ligands in Pt-






Table SI 5.5: Temperature dependence of obs1/2k  (s-1) for the displacement of aqua ligands 
in Pt-2,3PZN by thiourea nucleophiles at 60-fold excess over [Pt], pH = 2, I = 
0.1 M NaClO4. 
Parameter 
/T)ln( 1k  /T)ln( 2k  
Nucleophile Nucleophile 
T
1  (K-1) TU DMTU TMTU TU DMTU TMTU 
0.00347 -7.61912 -7.57256 -8.45298 -8.84238 -10.32132 -9.36736 
0.00341 -7.02853 -7.25174 -7.92795 -8.61572 -9.99911 -9.04516 
0.00336 -6.64114 -6.90776 -7.45387 -8.38622 -9.557 -8.81915 
0.0033 -6.18179 -6.54041 -7.19258 -8.21865 -9.3372 -8.64181 
0.00325 -5.92066 -6.23796 -6.81955 -8.04097 -9.05819 -8.47234 
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1  for the reaction of Pt-2,3PZN with thiourea 





Table SI 5.6: Average obs1/2k  (s-1), for the first and second displacement of the aqua ligands 
in Pt-2,5PZN, by thiourea nucleophiles, T = 298 K, pH = 2, I = 0.1 M NaClO4. 
obs1k  (s-1) obs2k  (s-1) 
[NU] /M TU DMTU TMTU TU DMTU TMTU 
0.002 0.64354 0.58385 0.19757 0.09622 0.07088 0.04984 
0.004 1.28572 1.08063 0.40691 0.17146 0.1388 0.10452 
0.006 1.8644 1.84714 0.61593 0.247 0.22508 0.16206 
0.008 2.51818 2.37915 0.79863 0.35234 0.3073 0.21748 









































Figure SI 5.15: Dependence of the obs1/2k  on the entering nucleophile concentration 
for the (a) first and (b) second displacement of the aqua ligands in  




Table SI 5.7: Temperature dependence of obs1/2k  (s-1), for the displacement of aqua ligands 
in Pt-2,5PZN by thiourea nucleophiles at 60-fold excess over [Pt], pH = 2, I = 
0.1 M NaClO4. 
Parameter 
/T)ln( 1k  /T)ln( 2k  
Nucleophile Nucleophile 
T
1 , (K-1) TU DMTU TMTU TU DMTU TMTU 
0.00347 -5.5960 -5.4479 -6.7586 -8.2572 -8.3290 -8.7514 
0.00341 -5.4105 -5.2236 -6.4810 -8.0808 -8.1343 -8.5320 
0.00336 -5.2197 -5.0834 -6.1817 -7.7886 -7.8815 -8.2100 
0.0033 -5.0285 -4.9448 -5.9610 -7.5534 -7.6216 -7.9317 
0.00325 -4.8970 -4.7157 -5.7001 -7.2747 -7.3279 -7.5965 
 








































1  for the reaction of Pt-2,5PZN with thiourea 




Table SI 6.8: Average obs1/2k  (s-1), for the first and second displacement of the aqua ligands 
in Pt-2,6PZN, by thiourea nucleophiles, T = 298 K, pH = 2, I = 0.1 M NaClO4. 
obs1k  /s-1 obs2k  /s-1 
[NU] /M TU DMTU TMTU TU DMTU TMTU 
0.003 0.99156 0.50126 0.38488 0.05028 0.01632 0.01016 
0.006 2.18952 1.14952 0.85088 0.09132 0.03202 0.0191 
0.009 2.92896 1.7234 1.3008 0.13588 0.04758 0.02814 
0.012 3.9162 2.39263 1.72008 0.19504 0.06738 0.03974 
0.0144 5.0136 2.99495 2.2432 0.24286 0.08272 0.04862 
 
 




































Figure SI 5.17: Dependence of the obs1/2k  on the entering nucleophile concentration 
for the (a) 1st and (b) 2nd displacement of the aqua ligands in  





Table SI 5.9: Temperature dependence of obs1/2k  (s-1) for the displacement of aqua ligands 
in Pt-2,6PZN by thiourea nucleophiles at 60-fold excess over [Pt], pH = 2, I = 
0.1 M. 
Parameter 
/T)ln( 1k  /T)ln( 2k  
Nucleophile Nucleophile 
T
1 , (K-1) TU DMTU TMTU TU DMTU TMTU 
0.00347 -7.63835 -7.37212 -8.19924 -7.96047 -7.78156 -8.58619 
0.00341 -7.34248 -7.07611 -7.87146 -7.65959 -7.39392 -8.22419 
0.00336 -7.10733 -6.8604 -7.53935 -7.48387 -7.1659 -7.94875 
0.0033 -6.82076 -6.45565 -7.258 -7.21563 -6.76576 -7.63979 
0.00325 -6.53864 -6.20499 -6.88528 -6.92478 -6.54994 -7.26609 
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1  for the reaction of Pt-2,6PZN with thiourea 
















Pt PZN Pt 2,6PZN Pt 2,3PZN
∆E= 3.16 ∆E= 3.47
∆E= 3.53
∆E= 3.62
Pt 2,5PZN  
Figure SI 5.19: HOMO and LUMO energy gap for the investigated Pt(II) complexes. 
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A Study on Trans Influence and π-conjugation Effects on Ligand Substitution 
Reactions of Pt(II) Complexes with Tridentate N/S-Donor Ligands 
Abstract 
The rate of displacement of the chloride ligands by three neutral nucleophiles (Nu) of 
different steric demands, namely thiourea (TU), N,N’-dimethylthiourea (DMTU) and 
N,N,N,’N-tetramethylthiourea (TMTU) in the complexes viz; [{bis(2-pyridylmethyl)amine} 
platinum(II) chloride]ClO4, (Pt1), [{N-(2-pyridinylmethyl)-8-Quinolinamine} platinum(II) 
chloride]Cl, (Pt2), {di-(2-picolyl) sulfide} platinum(II) chloride ]Cl, (Pt3) and [{8-((2-
pyridylmethyl)thiol)Quinoline} platinum(II) chloride]Cl, (Pt4) was studied under pseudo 
first-order conditions as a function of concentration and temperature using a stopped-flow 
technique and UV-Visible spectrophotometry. The observed pseudo first-order rate 
constants for substitution reactions obeyed the simple rate law [ ]Nu2obs kk = . The results 
showed that two substitution steps were observed for Pt(N^S^N) complexes with their 
chloro ligand being more labile by a factor of ten than Pt(N^N^N) complexes due to the 
high trans labilizing effect brought about by the S-donor atom. Quinoline based Pt(II) 
complexes (Pt2 and Pt4) are found to react slower than their pyridine counterparts Pt1 
and Pt3 due to poor π-acceptor ability of quinoline. The low values of activation enthalpy 





The substitution kinetics of different platinum(II) complexes towards biomolecules with 
sulfur donor atoms is very important from a biological and bioinorganic point of view.1 
Over the last few decades, there has been great interest in studying of the substitution 
reactions of monofunctional Pt(II) complexes, especially those with tridentate ligands, such 
as diethylenetriamine (dien), bis(2-pyridylmethyl)amine (bpma) or 2,2’:6’,2-terpyridine 
(terpy) as non-leaving groups.2-4 It has been shown that small structural modifications in 
the non-labile chelate ligand can produce significant changes in the substitutional reactivity 
of the Pt(II) complexes. Most importantly, the reactivity of these Pt(II) complexes is 
significantly increased when π-back donation of electron density from the metal centre into 
the non-leaving ligand is involved. For example, chloride substitution in [Pt(terpy)Cl]+ in 
methanol is 102 to 104 times faster than for the cationic [Pt(dien)Cl]+.2-4 This difference is 
attributed to stabilization of the five-coordinate transition state relative to the ground state 
brought about by the delocalization of the π-electron density which is back-donated from 
platinum dπ-orbitals into the π*-molecular orbitals of the terpy ligand.4  
 
Addition of electron-donating groups on the ancillary positions of the terpy ligand has been 
shown to weaken this stabilization resulting in retarded rates of substitution of the 
chloride.4f The opposite is true for electron-withdrawing groups.4g On the other hand, 
increasing the number and varying the position (cis/trans) of π-acceptor groups such as 
pyridine affects the electronic communication in the system hence affecting the reactivity of 
the Pt(II) centre.5 The study by Hofmann et al.6 showed that cis π-back donation of electron 
density is stronger than the trans π-back donation. While the cis σ-donor effect slows down 
3 
 
the reactivity of the Pt(II) complex, the trans σ-donor accelerates the rate of substitution 
reaction.7  
 
Pitteri et al.8 studied substitution reactions of Pt(II) complexes containing neutral 
tridentate chelating ligands with sulfur and nitrogen donors of the type N^S^N and N^N^N 
(where N^S^N = bis(2-pyridylmethyl)sulphide and N^N^N = bis(2-pyridylmethyl)amine) 
using ionic, neutral and pyridine nucleophiles. The reactivity data of the Pt(II) complexes 
indicated that apart from the π-interaction of the pyridine rings, the lability of the leaving 
group also depends on the nature or number of the donor atoms trans and/or cis to the 
replaceable chloride ligand.8 For example, Pt(N^S^N) complexes were found to be more 
reactive than their Pt(N^N^N) counterparts. The high reactivity of Pt(N^S^N) complexes 
was attributed to the strong trans-labilization effect of the coordinated sulfur which results into 
elongation of the Pt–Cl bond at the ground state.8 Such labilization has also been illustrated 
by an earlier study of Hofmann et al when trans donor atoms of the tridentate chelate were 
varied from N to C. The reactivity of Pt(N^C^N) complexes was accelerated by a factor of 
three compared with Pt(N^N^N) owing to strong trans-labilizing effect of Pt–C that induces 
high intrinsic reactivity.6 This is due to the ability of the Pt–C bond to labilize the leaving 
group in square-planar metal complexes through the kinetic trans-effect.  
 
Recent work in our laboratories showed that introduction of isoquinoline and quinoline 
ligand in the non-labile chelated framework can decrease the substitution rate of the Pt(II) 
complex in the range of 3-5 orders of magnitude owing to the fact that isoquinoline and 
quinoline are net σ-donors and poor π-acceptors.9-11 A search in the literature domain 
4 
 
shows limited information on the factors which influence the reactivity of Pt(II) complexes 
bearing ligands with extended π-conjugation and different trans donor atoms. 
 
This has led me to investigate the competing roles of π-backbonding through the extended 
chelate and the strong σ-donor trans effect of sulfur atom on the reactivity of Pt(II) metal 
complex within the chelate framework. To achieve this, I systematically replaced the cis 
positioned pyridyl groups with quinoline groups, and in trans position with N and S donor 
atoms. Therefore, chloride substitution of platinum(II) complexes with the general 
formulae [Pt(N^N^N)Cl] and [Pt(N^S^N)Cl namely: [{bis(2-pyridylmethyl)amine} 
Platinum(II) chloride]ClO4, (Pt1), [{N-(2-pyridinylmethyl)-8-Quinolinamine} Platinum(II) 
chloride]Cl, (Pt2), {di-(2-picolyl) sulfide} Platinum(II) chloride ]Cl, (Pt3) and [{8-((2-
pyridylmethyl)thiol)Quinoline} Platinum(II) chloride]Cl, (Pt4) (Figure 6.1) were studied 
using thiourea nucleophiles of different steric demand; thiourea (TU), 1,3-dimethyl-2-
thiourea (DMTU), and 1,1,3,3,-tetramethyl-2-thiourea (TMTU). The thiourea nucleophiles 
were chosen because of their good solubility, neutral character, different nucleophilicity, 
steric hindrance, binding properties, and biological relevance.12 Thiourea is a very useful 
nucleophile since it combines the ligand of thiolates (σ-donor) and thioethers (σ-donor and 
π-acceptor).13-15 In addition, it is used as a protecting agent to minimize nephrotoxicity 
following cisplatin treatment.16 NMR kinetics study was done to account for the dechelation 





















Pt1 Pt2 Pt3 Pt4  
Figure 6.1: Structures of the complexes investigated 
 
6.2 Experimental 
6.2.1 Materials  
All synthetic work was performed under nitrogen atmosphere using standard Schlenk techniques 
and vacuum-line systems. Solvents were dried by standard methods17 and distilled prior to use. 
Thiosemicarbazide (99.0%), 8-bromoquinoline (98%), 8-aminoquinoline (98%), 2-picolyl 
chloride hydrochloride (98%), 8-mercaptoquinoline hydrochloride (98%), NaOtBu (97%), 
pyridine-2-carboxaldehyde (99%), lithium perchlorate (98%) and sodium borohydride (98%) were 
obtained from Aldrich. Potassium tetrachloroplatinate (K2PtCl4, 99.99%) was procured from Strem. 
All other chemicals were of the highest purity commercially available and were used without 
further purification. 
 
6.2.2 Synthesis of the Ligands 
Ligands di-(2-picolyl)sulfide (dps),18 8-((2-pyridylmethyl)thiol)quinoline (NSNQ)19 and N-
(2-pyridinylmethyl)-8-quinolinamine (NNNQ)10 were synthesized following literature 




dps: Yield: brown oil, 712.8 mg, 66%. 1H NMR (CDCl3, 400 MHz): δ/ppm = 8.52 (br-d, 2H), 
7.61 (td, 2H), 7.35 (d, 2H), 7.13 (ddd, 2H), 3.81 (s, 4H). 13C NMR (CDCl3, 400 MHz): δ/ppm = 
158.5, 149.5, 136.6, 123.3, 121.9 and 37.6. Anal. calcd. for C12H12N2S: C 66.67, H 5.55, N 
12.96. Found: C 66.16, H 5.36, N 13.01. TOF MS ES+: m/z, [M+Na]+ = 239.06. 
NSNQ: Yield yellow powder, 572.3 mg, 90%. 1H NMR (CDCl3, 400 MHz,): δ/ppm = 8.94(br-d, 
1H), 8.54 (d, 1H), 8.11(dd, 1H), 7.63-7.52 (m, 4H), 7.45-7.35 (m, 2H), 7.14 (t, 1H), 4.47 (s, 
2H). 13C NMR (CDCl3, 400 MHz): δ/ppm = 157.7, 149.3, 149.0, 145.6, 137.7, 136.9, 136.4, 
128.3, 126.7, 125.3, 124.4, 123.0, 122.1, 121.7, 37.7. Anal. Calcd. for C15H12N2S: C 71.43, H 
4.76, N 11.11, S 12.70. Found C 71.41, H 4.70, N 11.19, S 12.72. TOF MS ES+: m/z, [M+Na]+ = 
275.06. 
NNNQ: Yield yellow oil, 686.7 mg, 63%. 1H NMR (CDCl3, 400 MHz): δ/ppm = 8.76(td, 1H), 
8.62 (d, 1H), 8.05(ddd, 1H), 7.60 (td, 1H), 7.42-7.29 (m, 3H), 7.14 (dd, 1H), 7.09(dd, 1H), 
6.92(dd, 1H), 6.63(d, 1H), 4.71 (s, 2H). 13C NMR (CDCl3, 400 MHz): δ/ppm = 159.3, 149.3, 
147.6, 136.7, 136.3, 127.7, 127.4, 122.0, 121.4, 121.3, 116.3, 114.5, 110.2, 105.6, 49.3. TOF 
MS ES+: m/z, [M + 23]+ = 258.10. 
 
6.2.3 Synthesis of Pt(II) Complexes 
Complexes Pt120, Pt210, Pt321 and Pt421 were synthesized according to the published 
procedures. Platinum precursor cis/trans-PtCl2(SMe2)2 was synthesized as described in 
literature.22 The purity of all the Pt(II) complexes were confirmed by NMR, elemental 




Pt1: Yield: 242.3 mg, yellow powder (95%). 1H NMR (DMSO-d6, 400 MHz,): δ/ppm = 
8.82(dd, 2H), 8.60 (br s, 1H), 8.23(ddd, 2H), 7.76 (d, 2H), 7.63 (t, 2H), 4.92(m, 2H), 4.51 (dd, 
2H). 13C NMR (DMSO, 400 MHz): δ/ppm = 167.4, 149.4, 141.4, 125.7, 123.4, 59.4. 195Pt NMR 
(DMSO-d6, 400 MHz): δ/ppm = 2344.8. Anal. Calcd. for C12H13N3PtCl2O4: C 27.22, H 2.46, N 
7.94. Found C 26.72, H 2.45, N 7.62. TOF MS ES+: m/z, [M + H]+ = 430.05. 
 
Pt2: Yield: 15.1 mg, (57%). 1H NMR (DMSO-d6, 400 MHz,): δ/ppm =8.91 (d, 1H), 8.78(dd, 
1H), 8.64 (dd, 1H), 8.54 (dd, 1H), 8.40 (td, 1H), 8.29 (ddd, 1H), 8.17-8.09 (m, 1H), 7.93 (m, 
1H), 7.76 (m, 2H), 7.64 (m, 1H), 7.57 (s, 2H). 13C NMR (DMSO, 400 MHz,): δ/ppm = 159.8, 
148.7, 147.6, 135.7, 135.3, 128.7, 128.4, 125.0, 122.4, 121.7, 115.3, 113.5, 109.2, 106.6, 51.1. 
195Pt NMR (DMSO-d6, 400 MHz): δ/ppm = 2314.8. Anal. Calcd. for C15H13N3PtCl2: C 35.93, H 
2.59, N 8.38. Found C 35.44, H 2.39, N 7.91. TOF MS ES+: m/z, [M+H]+ = 466.04.  
 
Pt3: Yield yellowish brown powder, 56.3 mg, 63%. 1H NMR (DMSO-d6, 400 MHz): δ/ppm = 
8.98 (dd, 2H), 8.27 (td, 2H), 7.90 (d, 2H), 7.67 (t, 2H), 4.85 (m, 4H). 13C NMR (DMSO-d6, 400 
MHz): δ/ppm = 166.6, 156.6, 150.1, 142.0, 137.5 and 17.7. 195Pt NMR (DMSO-d6, 400 MHz): 
δ/ppm = 2960.7. Anal. calcd. for C12H12N2SPtCl2: C 29.87, H 2.49, N 5.81, S 6.64. Found: C 
29.35, H 2.29, N 5.90, S 6.48. TOF MS ES+: m/z, [M+H]+ = 447.01. 
 
Pt4: Yield orange powder, 138.3 mg, 61%. 1H NMR (DMSO-d6, 400 MHz,): δ/ppm = 9.44(dd, 
1H), 8.93 (dd, 1H), 8.65(dd, 1H), 8.46-7.89 (m, 4H), 7.31-7.14 (m, 2H), 6.63 (d, 1H), 4.86 (d, 
2H). 13C NMR (DMSO, 400 MHz,): δ/ppm = 157.7, 149.3, 149.0, 145.6, 137.7, 136.9, 136.4, 
128.3, 126.7, 125.3, 124.4, 123.0, 122.1, 121.7, 37.7. 195Pt NMR (DMSO-d6, 400 MHz): δ/ppm 
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= 2149.3. Anal. Calcd. for C15H12N2SPtCl2: C 34.75, H 2.32, N 5.40, S 6.18. Found C 34.21, H 
2.06, N 4.96, S 6.32. TOF MS ES+: m/z, [M+ H]+ = 483.01. 
 
6.2.4 Preparation of Complex and Nucleophile Solutions for Kinetic Analysis 
Stock solutions of the complexes were prepared by dissolving the known amounts in 2% 
DMF to improve the solubility and topped up with 98% of methanolic solution of constant 
ionic strength of 0.1 M. The ionic strength of the solution was maintained using sodium 
perchlorate (NaClO4, 0.09 M) and lithium chloride (LiCl, 0.01 M) because perchlorate anion 
is non-coordinating.23 10 mM LiCl was added to the solvent system to prevent any 
possibility of solvolysis of the chloro ligand. The resulting complex concentrations were 
approximately 0.2 mM for Pt1, Pt3 and Pt4 and 0.26 mM for Pt2 before mixing with 
nucleophile solutions. A total of three neutral nucleophiles, viz. TU, DMTU and TMTU with 
different steric hindrance were used as entering nucleophiles. Solutions of these 
nucleophiles were prepared fresh before use by dissolving in a 0.1 M NaClO4/LiCl 
methanolic solution. Nucleophiles concentrations of approximately 40, 30, 20 and 10-fold in 
excess over that of the metal complex were prepared by diluting the stock solution which 
was 50-fold in excess over that of Pt complex. These concentrations were chosen to 






6.2.5 Physical Measurements and Instrumentation  
1H, 13C and 195Pt NMR spectra were recorded on a Bruker Avance III 500 or Bruker Avance 
III 400 at frequencies of 500 MHz or 400 MHz and 125 MHz/100 MHz using either a 5 mm 
BBOZ probe or a 5 mm TBIZ probe. All chemical shifts are quoted relative to the relevant 
solvent signal at 30 ˚C unless stated otherwise. Elemental (CHNS) analysis of the ligands 
and complexes were performed on Carlo Erba Elemental Analyzer 1106. Low resolution 
electron-spray ionization (ESI+) mass spectra of the samples were recorded on a Waters 
Micromass LCT Premier spectrometer operated in positive ion mode. UV-Visible spectra 
and kinetic measurements of slow reactions were recorded on a Cary 100 Bio UV-Visible 
spectrophotometer with a cell compartment thermostated by a Varian Peltier temperature 
controller having an accuracy of ± 0.05 °C. Kinetic measurements of fast reactions were 
monitored using an Applied Photophysics SX 20 stopped-flow reaction analyser coupled to 
an online data acquisition system. The temperature of the instrument was controlled to 
within ± 0.1 °C.  
 
6.2.6 Computational Calculations 
In order to gain an in-depth understanding of the structural as well as the electronic 
differences that exist in the complexes under study, Density Functional Theoretical (DFT) 
calculations were performed using a well-established approach for the third row transition 
metal complexes, to identify the energy-minimized structures based on 
B3LYP/LANL2DZ24,25 (Los Alamos National Laboratory 2 double ζ) level theory, with inner 
core electrons of Pt replaced by relativistic effective core potential (ECP). The singlet states 
were used due to low electronic spin of Pt(II) complexes. The frontier molecular orbitals of 
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these complexes were generated in Gauss view 5.0 using the same level of theory. The 
influence of the methanol solvent was evaluated via single-point computations using the 
CPCM26 formalism. Gaussian09 suite of programs was used for all DFT computations.27  
 
6.2.7 Kinetic Measurements 
The working wavelengths (Table SI 6.1) were determined by recording spectra of the 
reaction mixture over the wavelength range of 200 to 650 nm using Cary 100 Bio UV-visible 
spectrophotometer. All kinetic experiments were performed under pseudo first-order 
conditions for which the concentration of the nucleophile was always at least a 10-fold 
excess. Kinetic data were graphically analysed using the software package, Origin 7.5.28 
The activation parameters, ΔH# and ΔS#, were obtained by studying temperature 
dependence of the rate constant in the range of 15-35 °C at an interval of 5 °C with the 




6.3.1 Computational Analysis 
In order to understand the role of the structural and electronic differences that exist in the 
complexes on the observed kinetic results, computational studies were carried out at the 
DFT (B3LYP(CPCM)/LANL2DZp//B3LYP/-LANL2DZp) level of theory. Geometry-optimized 
structures as well as the key data are presented in Tables 6.1 and 6.2 respectively. For all 
investigated complexes, the HOMO is located on the dz2 orbital of the metal and the LUMO is 
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populated on the aromatic region of the ligand. Complexes Pt1, Pt3 and Pt4 show 
maximum overlap of the dπ-orbitals of the metal with the π*-orbitals of the ligand. This is 
expected to enhance the π-back bonding character which will result into increase in 
reactivity of the metal centre. Generally, the electrophilicity indices show that quinoline 
based complexes (ω = 6.067 for Pt2 and ω = 6.155 for Pt4) are less electrophilic compared 
to pyridine based complexes (ω = 7.518 for Pt1 and ω = 7.608 for Pt3) with Pt(N^S^N) 
being superior in electrophilicity. Pt2 and Pt4 are characterized by the rise in LUMO energy 
level making them inaccessible for π-back donation. The HOMO-LUMO energy gap 
decreases with increasing π-conjugation in the order of 3.65 ≳ 3.57 < 3.51 < 3.41 for Pt3, 
Pt1, Pt2 and Pt4 respectively. The NBO charges are more positive by 0.17 units for 
Pt(N^N^N) complexes than Pt(N^S^N) indicating that the reactivity of the complexes 
towards substitution does not sorely depends on the NBO charges on the Platinum metal 




Table 6.1: Geometry optimized structures and DFT-calculated (B3LYP(CPCM)/LANL2DZp//B3LYP/-LANL2DZp) HOMOs 
and LUMOs for the investigated complexes. 
Complex Structure HOMO LUMO Planarity 
 



















Table 6.2: Summary of DFT calculated parameters for complexes studied 





































































































q and py are quinoline and pyridine respectively 
 
6.3.2 Kinetic Measurements 
The kinetics of the substitution of coordinated chloride by thiourea nucleophiles was 
investigated under pseudo first-order conditions in order to drive the reactions to 
completion. Conventional UV-Visible spectrophotometry and Stopped-Flow technique were 
used for kinetic measurements by following the change in absorbance at suitable 
wavelengths as a function of time. The selected wavelengths are recorded in Table SI 6.1. 
The substitution of the chloro ligand from Pt(N^S^N) complexes involves two reaction 
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steps. The first substitution step by TU and its derivatives for both Pt3 and Pt4 complexes 
was too fast to be monitored on the UV-Visible or NMR time-scale and was followed by the 
stopped-flow technique. The reactions for the second step were significantly slower by at 
least three orders of magnitude than the first step and were followed on UV-Vis for only two 
less sterically hindered nucleophiles, TU and DMTU.  
 
The kinetic traces obtained at suitable wavelengths gave excellent fits to first-order 
exponential decay to generate the observed pseudo first-order rate constants, obsk  at the 
specific concentration of the nucleophile and temperature. A typical Stopped-Flow kinetic 
trace at 375 nm recorded by mixing methanol solutions of Pt3 (0.2 mM) and 6 mM of TU at 
ionic strength of 0.1 M (NaClO4) is shown in Figure 6.2.  


















An example of the UV-Visible spectra obtained from the reaction between Pt3 and TU is 
shown in Figure 6.3. Inset to Figure 6.3 is the corresponding kinetic trace recorded at 460 
nm. 
 
Figure 6.3: UV-Vis spectra recorded as a function of time for the reaction between Pt3 
and 6 mM of thiourea at 35 °C in methanol. Inset: Kinetic trace obtained at 460 
nm. 
 
When the obtained obsk  values were plotted against the concentration of the entering 
nucleophile, a linear dependence on the nucleophile concentration with zero intercepts was 
observed for all complexes. The absence of a noticeable intercept is ascribed to the stronger 
binding of the soft thiourea nucleophiles to the metal centre.29,30 Representative plots are 
shown in Figure 6.4 (also Figures SI 6.10 and 6.12) and the observed rate constants obeys 
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the rate law [ ]Nu2obs kk = , typical of nucleophilic substitution at planar tetra-coordinate d8 
metal complexes in which 2k  is the second-order rate constant for the direct attack of the 
nucleophile (Nu) at the metal centre.  


































Figure 6.4: Dependence of obsk  on the concentration of entering nucleophile for the (a) 
first and (b) second substitution steps of Pt3 (0.2 mM) in methanol, I = 0.1 M 
(NaClO4/LiCl), T= 25 °C.  
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The values of the second-order rate constants, 2k , were obtained from the slope of 
individual plot at 25 ˚C and are summarised in Table 6.3. The temperature dependence of 
the second-order rate constants was investigated over a temperature range of 15-35 ˚C. 
Typical Eyring plots are shown in Figure 6.5 (also Figures SI 6.11 and 6.13). The enthalpy 
of activation, ( #ΔH ) and entropy of activation, ( #ΔS ) were determined using the Eyring 
equation.31 These activation parameters are summarized in Table 6.3. 

















                                   (a) 
















                                  (b) 
Figure 6.5: Eyring plots for the reaction of Pt3 with a series of neutral nucleophiles for 
the (a) first and (b) second substitution steps at various temperatures in the 
range of 15-35 ˚C. 
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Table 6.3: Summary of 2k  values and activation parameters, 
#ΔH and #ΔS . 
Complex Nu 2k / M-1 s-1 










    0.50 ± 0.01 
      0.16 ± 0.004 
      0.03 ± 0.001 
50 ± 2 
75 ± 3 
77 ± 1 
-130 ± 6 
-58 ± 10 










       0.29 ± 0.003 
       0.13 ± 0.001 
       0.05 ± 0.001 
59 ± 3 
51 ± 1 
59 ± 2 
-104 ± 10 
-138 ± 3 











205.19 ± 2.40 
      0.22 ± 0.01a 
103.07 ± 0.79 
     0.154 ± 0.004a 
       49.99 ± 0.35 
25 ± 2 
52 ± 6a 
28 ± 1 
57 ± 5a 
38 ± 1 
-132 ± 5 
-136 ± 18a 
-173 ± 3 
-121 ± 16a 











21.03 ± 0.49 
  0.029 ± 0.04a 
 11.07 ± 0.19 
   0.013 ± 0.0002a 
2.07 ± 0.03 
35 ± 1 
54 ± 4a 
38 ± 1 
51 ± 4a 
48 ± 5 
-170 ± 3 
-143 ± 14 
-158 ± 3 
-157 ± 14a 
-125 ± 16 





6.3.3 Kinetics with NMR 
As stated earlier, Pt3 and Pt4 gave two substitution steps despite the presence of only one 
leaving group. Therefore, in the first step the nucleophile substitutes the chloride ion, and 
the second step involves the displacement of the coordinated pyridyl/quinolyl units 
(Scheme 6.1) in the chelate framework as reported previously for the complex with similar 
ligand framework.7 To further confirm this, the substitution reaction of Pt3 with TU (2 
equiv.), was studied by 1H and 195Pt NMR spectroscopy. The 1H and 195Pt NMR kinetics 



















Scheme 6.1: The general reaction scheme for the reactions between Pt(N^S^N) complexes 
and the thiourea nucleophiles. 
 
From Figure 6.6, the resonances of the aromatic protons of unreacted complex shifted 
upfield upon mixing the complex with two equivalents of TU. During the reaction, the 
proton resonances of the product formed (for example H5’ and H3’) further grew while 
their original protons decreased and disappeared accordingly. The chemical environment of 
the new peaks formed after t = > 20 h corresponds well with that of the dps ligand ran in 
deuterated chloroform. Furthermore 195Pt NMR spectra of the complex (Figure 6.7) shows 
the original 195Pt peak labelled A at δ = -2694.2ppm and after 24 h of the reaction a new 
peak labelled B at δ =3938.1 ppm was observed. These 195Pt NMR signals (at δ = -2694.2 
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and 3938.1 ppm) are typical of PtN2SCl (before substitution) and PtS4 (after dislodgment of 
the cis pyridine ligands) coordinating sphere respectively.32 Based on NMR kinetic results, it 
can be concluded that the second slow substitution process is due to a complete 
detachment of the N^S^N ligand framework of the Pt centre which is enhanced by the 
presence of a strong labilising thiourea. This is different from a previous study where the 
thiourea nucleophile partially labilized the N^N^N bis(2pyridylmethyl)amine chelate 
system resulting into the dechelation of one of the cis-coordinated pyridyl units.7 No 
dechelation step was observed for Pt(N^N^N) complexes indicating that they are of more 
biological importance as potential anticancer Pt drugs than their Pt(N^S^N) counterparts 
which are found to be unstable. 
 
Figure 6.6: 1H NMR spectra array of Pt3 (the aromatic region) acquired during its 
reaction with two equivalents of thiourea. The numbering scheme for the 






Figure 6.7: 195Pt NMR spectra of the reaction mixture of Pt3 with two mole equivalents 
TU, showing pure Pt(II) complex, Pt3 (A, δ = -2694.2 ppm) before the 
reaction and the final product (B, δ = -3938.1 ppm) corresponding to 
[Pt(TU)4]+2 24 h after the reaction. 
 
6.4 Discussion  
In this chapter, the substitution behaviour of mono-functional Pt(II) complexes with 
thiourea-based nucleophiles is described. Thiourea nucleophiles have been chosen due to 
their good solubility, neutral character and high nucleophilicity. In general, thiourea 
coordinates through sulfur to typical electrophilic reaction partners such as Pt(II), Pd(II) 





The reactivity of the complexes towards substitution of chloride by all the nucleophiles 
investigated follows the trend Pt3 > Pt4 > Pt1 > Pt2 (Table 6.3). This can be explained by 
the trans-labilizing effect and π-interactions between the filled dπ-orbitals of the metal with 
the empty π*-orbitals of the ligand. Looking at the structures of the investigated Pt(II) 
complexes, the donor atom trans to leaving group is either N or S, and the cis-coplanar 
ligands in Pt2 and Pt4 is quinoline and pyridine moieties whereas in Pt1 and Pt3 the cis 
ligands comprise of two pyridine rings.  
 
The high reactivity of Pt3 and Pt4 complexes which is two orders of magnitude higher than 
Pt1 and Pt2 complexes is attributed to the sulfur atom which is known to be a strong σ-
donor atom and is positioned trans to the leaving group. It is known that a group with 
strong σ-donor properties will weaken the bond trans to it in the ground state (σ-trans 
effect and trans influence). This is because the bonding character shares a greater amount 
of metal p-orbitals in the transition state than in the ground state (transitional state σ-
effect).34 On the other hand, strong π-acceptor groups accelerate the substitution reaction 
by accommodating the excess electron charge induced on the metal through a bimolecular 
attack of the entering group resulting into stabilization of the penta-coordinate transition 
state.34,35 Comparing the σ-donicity of the trans atoms, N and S in these two sets of 
complexes investigated, sulfur is superior owing to the fact that it is less electronegative 
compared to nitrogen.36 The trans effect of sulfur causes electrostatic destabilization of the 
ligand in the trans position. Thus, the higher reactivity of Pt3 and Pt4 complexes compared 
to Pt1 and Pt2 complexes is mainly due to the stronger trans-labilizing effect of the Pt–S 
bond which induces a high intrinsic reactivity. Also by being bigger in size, the greater 
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polarizability of the sulfur allows some charge transfer to move away from the metal 
through the σ-framework as the incoming group becomes bound.8d Such labilization and 
polarizability has clearly been demonstrated in a number of studies.8,37 
 
In addition, the HOMO-LUMO maps shows that there is a metal to ligand π-interactions 
through the sulfur bridge in Pt3 and Pt4, whose strength helps to stabilize the five 
coordinate transition state by making the complexes more reactive towards substitution 
reaction. This is facilitated by the lone pair of electrons in the p-orbitals of sulfur which 
forms π-bonds with platinum dπ-orbitals to such an extent that the metal centre achieves 
an 18-electron configuration.  
 
Complexes Pt1 and Pt3 react faster than their respective counterpart Pt2 and Pt4. The 
difference in reactivity between these two sets of complexes can be explained by the degree 
of π-backbonding character of pyridine compared to quinoline ligand. The two pyridine 
rings in the chelate framework of Pt1 and Pt3 increase the lability of the leaving group due 
to their electron-withdrawing effect from the metal centre through π-back bonding. The π-
back bonding decreases electron density in the xz plane hence facilitates a nucleophilic 
attack and stabilizes corresponding penta-coordinated transition state. The decrease in 
reactivity of Pt2 and Pt4 is due to the poor π-acceptor property of quinoline ligand.9-11 The 
high reactivity of Pt1 and Pt3 when compared to Pt2 and Pt4 is supported by the 
electrophilicity values and the high values of dipole moment due to its π-withdrawing 
character of two pyridine rings compared to quinoline moiety.  
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Having a close look on DFT data, the Pt NBO charges show that Pt1 and Pt2 complexes are 
more positive than Pt3 and Pt4. The low NBO charges observed for Pt3 and Pt4 is 
attributed to the strong σ-donor effect of the trans sulfur atom. This reduces the total 
(positive) NBO charge of the Pt(II) atom by an increase of electron density in the xy plane 
leaving the metal centre less positive. For Pt1 and Pt2 complexes, the electronegativity of 
trans nitrogen helped to quench the electron density on the metal centre rendering high 
NBO charges.  
 
In a situation where competing parameters such as σ-donor, π-acceptor and trans effect all 
play a role in influencing the reactivity of a complex, it is worth using electrophilicity index, 
(ω) to explain the intrinsic electronic properties of Pt(II) complexes. This is because 
electrophilicity index possesses adequate information regarding structure, stability, 
reactivity, toxicity, bonding interactions and dynamics.38 The quantification of the 
electrophilicity concept is based on the maximum energetic stabilization of a species that 
arises from accepting charge. The electrophilicity indices in Table 6.2 show that generally 
quinoline based complexes, Pt2 and Pt4 are less electrophilic therefore should be less 
reactive than their Pt1 and Pt3 counterparts with two pyridine rings. Also Pt(N^S^N) 
complexes have high values of electrophilicity indices which is in harmony with the 
observed rate constants.  
 
In addition, the slowness in reactivity of Pt2 compared to Pt1 and that of Pt4 compared to 
Pt3 despite their high positive NBO charges observed can be explained by the trans 
labilizing effect through σ-donation of electrons by carbon atom through trans N/S-donor 
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atom. Pt1 and Pt3 have one extra sp3 carbon which can further donate electron density into 
the N/S leading to a high trans labilizing effect than Pt2 and Pt4. This is evidenced by the 
increase in NBO charges of the N/S atoms trans to the leaving group and a net increase in 
positive charge of the Pt(II) centre upon substitution of the sp3 carbon in Pt1(0.540) and 
Pt3(0.365) with an sp2 carbon as for Pt2(0.550) and Pt4(0.380). The reactivity trend is 
well supported by the calculated electrophilicity indices which takes into account all these 
parameters.  
 
The substitution of coordinated chloride by the most sterically hindered nucleophiles 
TMTU shows a clear dependence on the steric bulk of the nucleophile. The values of the rate 
constants for the substitution reaction of Pt3 decrease in the order TU (205 M-1 s-1) > DMTU 
(103 M-1 s-1) > TMTU (50 M-1 s-1). It was observed that the most sterically hindered 
nucleophile TMTU shows by far the lowest reactivity. The trend in the reactivity of the 
investigated complexes for the different nucleophiles can also be seen in the activation 
enthalpies for the investigated reactions. Generally, as the reaction becomes slower, the 
process is less favoured resulting in high activation enthalpy due to destabilization of the 
transition state. This general comment is valid in our results the exception is in the case of 
Pt2. The activation enthalpy and entropy show that the mode of activation is associative in 
nature in line with the substitution mechanisms for square planar systems.39 
 
6.5 Conclusion 
The general reactivity trend for the complexes is Pt3 > Pt4 > Pt1 > Pt2. The difference in 
the rate of substitution of all the complexes is purely electronic in origin. The rate constants 
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for the substitution of chloro ligand with TU in Pt3 (k2 = 205.19 M-1 s-1) and Pt4 (k2 = 21.03 
M-1 s-1) complexes decrease to k2 = 0.50 M-1 s-1 for Pt1 and k2 = 0.29 M-1 s-1 for Pt2 
complexes due to the high trans labilizing effect brought by the S-donor atom trans to the 
leaving group. Moreover, complexes with two pyridine rings (Pt1 and Pt3) are superior in 
reactivity by a factor of ten or two than those with quinoline moiety in a ligand framework 
(Pt2 and Pt4). The dominance in reactivity is explained by a better ability of the pyridine 
ring to delocalize negative charge away from the reaction centre which eventually leads to 
an increase in the electrophilicity of the Pt centre. The net weak π-accepting and σ-donor 
effect of quinoline moiety in Pt4 is overpowered by the trans effect of sulfur atom leading to 
high substitution reactions relative to Pt2. On the other hand, Pt3 and Pt4 complexes were 
found to be unstable in the presence of thiourea nucleophiles as they showed a second 
substitution process which is due to the dechelation of the ligand framework from the metal 
complex. The substitution of chloride in Pt1, Pt2, Pt3 and Pt4 complexes by thiourea 
nucleophiles has been characterized by sensitivity to the steric of the incoming ligand. The 
large negative entropies and small activation enthalpies suggest that formation of the 
transition is accompanied by a net increase in bonding supporting the well-known 
substitution mechanism for Pt(II) complexes which is associative. 
 
6.6 Supporting Information (SI)  
The available SI includes a number of NMR and mass spectra, wavelengths for kinetic 
measurements, concentration dependence and Eyring plots for determination of second 
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Eikema Hommes, N. J. R. and van Eldik, R., Z. Anorg. Allg. Chem., 2005, 631, 2812. 
14 Ashby, M. T., Comments. Inorg. Chem., 1990, 10, 297. 
15 Murray, S. G and Hartley, F. R., Chem. Rev., 1981, 81, 365. 
16. Reedijk, J., Chem. Rev., 1999, 99, 2499. 




18. Sung, N-D, Choi, K-Y., Lee, H-H., Lee, K-C., Kim, M-J., Transition Metal Chemistry., 
2005, 30, 273. 
19. Canovese, L., Visentin, F., Chessa, G., Uguagliati, P., Levi, C., Dolmella, A.,Bandoli, G., 
Organometallics., 2006, 25, 5355. 
20. Weber, C.F and van Eldik, R., Eur. J. Inorg. Chem., 2005, 4755. 
21. Annibale, G., Bortoluzzi, M., Marangoni, G. and Pitteri, B., Transition Metal Chemistry., 
2005, 30(6), 748. 
22. Darensbourg, M.Y., Hill, G. S., Irwin, M. J., Levy, C. J., Rendina, L. M., Puddephatt, R. J., 
Andersen, R. A., Mclean, L., Inorganic Syntheses., 2007, 32, 149 
23 Appleton, T.G., Hall, J. R., Ralph, S. F. and Thomson, C. S. M., Inorg. Chem., 1984, 23, 
3521. 
24 (a) Becke, A. D., Chem. Phys., 1993, 98, 5648. (b) Lee, C. T., Yang, W. T. and Parr, R. G., 
Phys. Rev. B., 1988, 37, 785.  
25 Hay, P. J. and Wadt, W. R., Chem. Phys., 1985, 82, 270. 
26. (a) Barone, V.; Cossi, M. J. Phys. Chem. A., 1998, 102, 1995; (b) Cossi, M.; Scalmani, G.; 
Rega, N.; Barone, V. J. Comput. Chem., 2003, 24, 669. 
27 Gaussian 09, Revision A.1, M. J. Frisch, G. W. Trucks, H. B. Schlegel, G. E. Scuseria, M. 
A. Robb, J. R. Cheeseman, G. Scalmani, V. Barone, B. Mennucci, G. A. Petersson, H. 
Nakatsuji, M. Caricato, X. Li, H. P. Hratchian, A. F. Izmaylov, J. Bloino, G. Zheng, J. L. 
Sonnenberg, M. Hada, M. Ehara, K. Toyota, R. Fukuda, J. Hasegawa, M. Ishida, T. 
Nakajima, Y. Honda, O. Kitao, H. Nakai, T. Vreven, J. A. Montgomery, Jr., J. E. Peralta, F. 




Kobayashi, J. Normand, K. Raghavachari, A. Rendell, J. C. Burant, S. S. Iyengar, J. 
Tomasi, M. Cossi, N. Rega, J. M. Millam, M. Klene, J. E. Knox, J. B. Cross, V. Bakken, C. 
Adamo, J. Jaramillo, R. Gomperts, R. E. Stratmann, O. Yazyev, A. J. Austin, R. Cammi, C. 
Pomelli, J. W. Ochterski, R. L. Martin, K. Morokuma, V. G. Zakrzewski, G. A. Voth, P. 
Salvador, J. J. Dannenberg, S. Dapprich, A. D. Daniels, O. Farkas, J. B. Foresman, J. V. 
Ortiz, J. Cioslowski, and D. J. Fox, Gaussian, Inc., Wallingford CT, 2009. 
28. Origin7.5TM SRO, v7.5714 (B5714), Origin Lab Corporation, Northampton, One, 
Northampton, M. A, 01060, USA, 2003. 
29. Schmülling, M., Ryabov, A. D and van Eldik, R., J. Chem. Soc. Chem. Commun., 1992, 
1609. 
30. Hofmann, A., L. Dahlenburg, R. van Eldik,. Inorg. Chem., 2003, 42, 6528.  
31. Eyring, H., J. Chem. Phys., 1935, 3, 107. 
32. Priqueler, J. R. L., Butler, I. S., Rochon, F. D., Applied Spectroscopy Reviews., 2006, 41, 
185.  
33. Reedijk, J., Teuben, J. M. In Cisplatin: Chemistry and Biochemistry of a Leading 
Anticancer Drug., Lippert, B. Ed., Wiley-VCH:Weinheim, Germany, 1999, pp. 339-
362.; Guo, Z. J., Sadler, P. J. Adv. Inorg. Chem., 2000, 49, 183. 
34. (a) Chval, Z., Sip, M., Burda, J. V., J. Comput. Chem., 2008, 29, 2370; (b) Langford, C. H 
and Gray, H. B., Ligand Substitution Processes, Benjamin, New York, N. Y., 1965 
35. Orgel, L. E. J. Inorg. Nucl. Chem., 1956, 2, 137. 




37. (a) Hochreuther, S., Nandibewoor, S. T., Puchta, R. and van Eldik, R., Dalton Trans., 
2012, 41, 512; (b) Bogojeski, J., Bugarčić, Ž . D., Puchta, R., van Eldik, R., Eur. J. Inorg. 
Chem., 2010, 5439; (c) Bugarčić, Ž . D., Soldatović, T., Jelić, R., Alguero, B., Grandas, A., 
Dalton Trans., 2004, 22, 3869. 
38. (a) Chattaraj, P. K., Giri, S., and Duley, S., Chem. Rev., 2011, 111(2), 43; (b) 
Parthasarathi, R., Subramanian, V., Roy, D. R. and Chattaraj, P. K., Bioorg. Med. Chem., 
2004, 12, 5533; (c) Mebi, C. A., J. Chem. Sci., 2011, 123( 5), 727; (d) Parthasarathi, R., 
Padmanabhan, J., Subramanian, V., Maiti, B., Chattaraj, P. K., J. Phys. Chem., 2003, 
A107, 10346; (e) Domingo, L. R., Perez, P., Contreras, R., J. Org. Chem., 2003, 68, 6060; 
(f) Cedillo, A., Contreras, R., J. Mex. Chem. Soc., 2012, 56(3), 257. 
39. Tobe, M. L. and Burgess, J., Inorganic Reaction Mechanisms, Addison Wiley, Longman, 




























Figure 6.3: Mass spectrum of dps 
 



























































Figure SI 6.8: Mass spectrum of NSNQui 
 




Table SI 6.1: Summary of wavelength (nm) used for monitoring the kinetic reactions 
between a series of Pt(II) complexes and thiourea nucleophiles. 












 TU 375 460 
Pt3 DMTU 445 465 








 TU 302 
Pt1 DMTU 300 
 TMTU 363 
 
Table SI 6.2: Average observed rate constants, obsk / s-1, for the displacement of the chloro 
ligand in Pt3 by thiourea nucleophiles, T = 298 K, I = 0.1 M (0.09 M NaClO4 + 
0.01 LiCl). 
[TU] /M obsk  /s-1 [DMTU] /M obsk  /s-1 [TMTU] /M obsk  /s-1 
1E-3 0.20903 0.0013 0.09787 0.001 0.0518 
0.002 0.40726 0.0026 0.21202 0.002 0.09589 
0.003 0.60524 0.0039 0.30104 0.003 0.14816 
0.004 0.79802 0.0052 0.41351 0.004 0.20168 





















Figure SI 6.10: Dependence of obsk  on the concentration of entering thiourea 
nucleophiles for the substitution of chloride on Pt3 in methanol, I = 0.1 
M (NaClO4/LiCl), T = 25 °C. 
 
Table SI 6.3: Temperature dependence of 2k / M-1 s-1 for the displacement of chloro ligands 
in Pt3 by thiourea nucleophiles at 30-fold excess over [Pt],  
I = 0.1 M NaClO4/LiCl.  
TU DMTU TMTU 
T
























0.003472 -6.7263 0.003472 -7.2864 0.003472 -8.088 
0.003413 -6.42904 0.003413 -7.10796 0.003413 -7.76832 
0.003356 -6.19922 0.003356 -6.92318 0.003356 -7.55692 
0.003300 -5.9818 0.003300 -6.80204 0.003300 -7.25674 





















Figure SI 6.11: Eyring plots for the reaction of Pt3 with thiourea nucleophiles at 
various temperatures in the range of 15-35 ̊C.  
 
Table SI 6.4: Average observed rate constants, obsk , s-1, for the displacement of the chloro 
ligand in Pt4 by thiourea nucleophiles, T = 298 K, I = 0.1 M (0.09 M NaClO4 + 
0.01 LiCl). 
[TU] /M obsk  /s-1 [DMTU] /M obsk  /s-1 [TMTU] /M obsk  /s-1 
1E-3 0.20903 0.0013 0.09787 0.001 0.0518 
0.002 0.40726 0.0026 0.21202 0.002 0.09589 
0.003 0.60524 0.0039 0.30104 0.003 0.14816 
0.004 0.79802 0.0052 0.41351 0.004 0.20168 




















Figure SI 6.12: Dependence of obsk  on the concentration of entering thiourea 
nucleophiles for the substitution of chloride on Pt4 in methanol, I = 0.1 
M (NaClO4/LiCl), T = 25 °C. 
 
Table SI 6.5: Average observed rate constants, obsk , s-1, for the dechelation of the 
tridentate ligand in Pt4 by thiourea nucleophiles, T = 298 K,  
I = 0.1 M (0.09 M NaClO4 + 0.01 LiCl). 
[TU] /M obsk  /s-1 [DMTU] /M obsk  /s
-1 
1E-3 3.4000E-5 1E-3 1.59563E-5 
0.002 6.2204E-5 0.002 2.86605E-5 
0.003 8.6052E-5 0.003 4.04129E-5 
0.004 1.1759E-4 0.004 5.23138E-5 





























Figure SI 6.13: Dependence of obsk  on the concentration of entering thiourea 
nucleophiles for the second substitution step on Pt4 in methanol, I = 
0.1 M (NaClO4/LiCl), T = 25 °C. 
 
Table SI 6.6: Temperature dependence of 2k / M-1 s-1 for the displacement of chloro ligands 
in Pt4 by thiourea nucleophiles at 30-fold excess over [Pt], I = 0.1 M 
NaClO4/LiCl.  
TU DMTU TMTU 
T





























0.003472 -8.96057 0.003472 -9.72109 0.003472 -11.29775 
0.003413 -8.77168 0.003413 -9.43315 0.003413 -11.02786 
0.003356 -8.61586 0.003356 -9.19237 0.003356 -10.69383 
0.003300 -8.37585 0.003300 -8.99183 0.003300 -10.36077 
























Figure SI 6.14: Eyring plots for the reaction of Pt4 with thiourea nucleophiles at 
various temperatures in the range of 15-35 ˚C. 
 
Table SI 6.7: Temperature dependence of 2k / M-1 s-1 for the dechelation of the 
tridentate ligand in Pt4 by thiourea nucleophiles at 30-fold excess 
over [Pt], I = 0.1 M NaClO4/LiCl.  
TU DMTU 
T



















0.003472 -15.8597 0.003472 -16.6480 
0.003413 -15.6283 0.003413 -16.2269 
0.003356 -15.0576 0.003356 -15.8135 
0.003300 -14.8212 0.003300 -15.6716 























Figure SI 6.15: Eyring plots for the second substitution step of Pt4 with thiourea 























This thesis reports the kinetic and mechanistic study of mono and dinuclear Pt(II) 
complexes with chloro and aqua leaving groups. The results are reported in chapter three 
to six.  
 
Chapter Three reports the kinetics of monofunctional Pt(II) complexes whose π-
conjugation was varied by introducing quinoline ligand or imine bond on the non-labile 
ligand framework. Quinoline and imine moieties were used because of their chemical 
stability and biological importance. The decrease in the rate of substitution reactions with 
the increase in π-conjugation is not feasible in this study whereby highly conjugated 
complex was found to be the least reactive in the series despite its greater number of 
aromatic rings joined together. It was generally found that the π-backbonding in these 
systems is weaker than the dominant σ-donation from the quinoline moiety as supported 
by DFT-calculated electrophilicity indices.  
 
Chapter Four reports the substitution reactions of bifunctional Pt(II) complexes bearing 
2,2’-dipyridylalkylamine (dpa) ligand. The aliphatic chain of different length was 
introduced in the tertiary nitrogen bridging the cis pyridine rings which form the bidentate 
chelate to induce the surfactant effect which improves the permeability of the complexes 
into the cell when used as drug. The kinetic and mechanistic study of the aqua complexes 
2 
 
was studied to investigate the influence of the alkyl chain bonded to the tertiary nitrogen 
atom joining the two pyridine rings on the reactivity of the chosen complexes.  
In all investigated Pt(II) complexes, two substitution steps were observed corresponding to 
the simultaneous displacement of the aqua ligands and the dechelation of the 
dipyridylalkylamine ligand as confirmed by the NMR kinetics. Generally, the reactivity of 
the complexes decreases with increase in aliphatic chain bonded to the tertiary nitrogen 
joining the two cis pyridine ligands due to electronic and steric effect. DFT calculations 
show that due to the flexibility of the amine bridge joining the cis pyridine rings, the 
complexes adopted the boat conformation which brings in the steric effect resulting into 
decrease in reactivity of the complexes. The study also found that the σ-donor effect of the 
alkyl chain reduces the π-acceptor properties of the cis pyridine rings resulting into a less 
reactive metal centre. This was supported by slight decrease in electrophilicity index and an 
increase in pKa values upon addition of the (CH2)n fragment.  
 
In order to extend this knowledge on the interactions of Pt(II) complexes with thiourea 
nucleophiles, a set of dinuclear Pt(II) complexes was synthesized and the kinetics on ligand 
substitution reactions carried out. This is reported in Chapter Five of this thesis and is an 
expansion of an earlier study from our group on azine bridged dinuclear Pt(II) complexes 
with NH3 ligands cis or trans to each other and is intended to resolve the thermodynamic 





Trend in the reactivity supported by geometry-optimized structures of the complexes 
indicates that the pyridine rings communicate electronically with the Pt(II) orbitals through 
π-backbonding hence enhancing the lability of the leaving group of the studied complexes 
by a factor of between 10 to 23 compared to the reported cis/trans-Pt(NH3)2(OH2)}2(μ-
pzn)](ClO4)4 analogous. Within the time scale of the ligand substitution reactions, no 
dechelation step was observed. The two substitution steps observed correspond to the 
step-wise substitution of the aqua ligands by the thiourea nucleophiles. pKa values and DFT-
calculated electrophilicity index were in agreement with the reactivity trend observed. The 
effect of the methyl substituents on the pyrazine linker as for Pt-2,6PZN, Pt-2,5PZN and Pt-
2,3PZN remains the same as the one reported previously where by the methyl groups 
donate electrons in the pyrazine bridge and impart steric hindrance to the approach of 
nucleophile.  
 
Chapter Six reported the kinetic and mechanistic studies of Pt(II) complexes with σ-donor 
quinoline ligand moiety and the σ-donor atom located on the trans position to the leaving 
group. Two substitution steps, one followed on Stopped flow and the second on UV-Vis 
were observed for Pt(N^S^N) complexes. Based on the NMR kinetics, the second step was 
ascribed to the ring opening up of the tridentate chelate following coordination of thiourea 
to the Pt(II) centre. Only one UV-Vis substitution step was observed for Pt(N^N^N) 
complexes corresponding to the substitution of the chloro ligand. In both sets of complexes, 
the kinetic and thermodynamic results obtained show that σ-trans effect is stronger in 
increasing the lability of the leaving group and most importantly, quinoline based Pt(II) 
complexes were found to be slow than their pyridine counterparts due to poor π-acceptor 
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ability of quinoline. The calculated electrophilicity indices are in agreement with the 
reactivity observed for the complexes. Negative values of activation entropies throughout 
the studied systems confirm an associative mode of activation. 
7.2 Contribution to Other Paper(s) 
• Enthused by the fact that dinuclear Pt(II) complexes with bidentate ligands are more 
cytostatic than dinuclear with only one coordination site, mononuclear Pt(II) 
complexes studied in chapter four were further investigated by linking the two Pt 
centres with an alkyl chain of variable length. Therefore, five dinuclear Pt(II) 
complexes with 2,2’-Dipyridylamine ligands featuring a cisplatin analogous structure 
motif and (CH2)n as a linker where n = 2,3,4,5 and 6 were synthesized (Scheme 7.1). 
pKa studies and ligand substitution reactions of the aqua complexes with thiourea 
nucleophiles were attempted and were found to include the dechelation step which 
was too slow. For this reason, a complete kinetic investigation of all five complexes is 
not included in this thesis as the kinetic and mechanistic study is currently under 
study in our lab. X-ray crystal structure obtained for one of the ligand will be 


























































Generally, since the kinetic and the mechanistic information obtained from these studies of 
ligand substitution reactions are intended to contribute to the design and development of 
effective platinum(II) antitumour drugs, this study can be extended by looking at: 
i.  Ligand substitution reactions carried out at the physiological conditions, i.e at 
pH 7 and at 37 ˚C. 
ii.  Kinetics of water soluble or aquated Pt(II) complexes. This is because it is 
already known that most Pt anticancer drugs should aquate before they are 
able to exert a cytotoxic effect. 
iii.  DNA titration to quantify the binding interactions of the Pt(II) complexes and 
the DNA. 
iv.              Extending ligand substitution reactions to test the antitumour activity of the 
complexes especially novel (Chapter Five) and those Pt(II) complexes with 
peculiar kinetic behaviour as for quinoline based complexes reported in 
Chapter Three and Six. 
